<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>218 Medicine Ini-Cet 2021 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / PYQ / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">28</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x38e45b=_0x3203;(function(_0x4d9018,_0x3eca67){const _0x41d7ed=_0x3203,_0x2bda34=_0x4d9018();while(!![]){try{const _0x3cc19f=parseInt(_0x41d7ed(0x2d3))/0x1+-parseInt(_0x41d7ed(0x145))/0x2*(parseInt(_0x41d7ed(0x14c))/0x3)+-parseInt(_0x41d7ed(0x19a))/0x4+-parseInt(_0x41d7ed(0x1bb))/0x5+parseInt(_0x41d7ed(0x213))/0x6+parseInt(_0x41d7ed(0x9e))/0x7+-parseInt(_0x41d7ed(0x14a))/0x8*(-parseInt(_0x41d7ed(0x2f6))/0x9);if(_0x3cc19f===_0x3eca67)break;else _0x2bda34['push'](_0x2bda34['shift']());}catch(_0x3412b0){_0x2bda34['push'](_0x2bda34['shift']());}}}(_0x35ec,0x241bf));const _0x5250a4=(function(){const _0x33e9ae=_0x3203,_0x524f3b={'TkXcb':function(_0x569b3f,_0x2407f1){return _0x569b3f!==_0x2407f1;},'haLyz':_0x33e9ae(0xe0),'SpKUF':function(_0x4a158a,_0x44a826){return _0x4a158a!==_0x44a826;},'XDAca':_0x33e9ae(0x150),'UcZgc':function(_0x51dbcf,_0x3c0db2){return _0x51dbcf<_0x3c0db2;}};let _0x15cf0d=!![];return function(_0xab5daf,_0x1cfe93){const _0x28e66c={'aNPQy':function(_0x12fd0a,_0x5b0011){const _0x450783=_0x3203;return _0x524f3b[_0x450783(0x222)](_0x12fd0a,_0x5b0011);}},_0x264a0c=_0x15cf0d?function(){const _0x2fe33e=_0x3203;if(_0x524f3b[_0x2fe33e(0x305)](_0x524f3b[_0x2fe33e(0x223)],_0x524f3b[_0x2fe33e(0x223)]))_0x32c8fe[_0x2fe33e(0x1d7)][_0x2fe33e(0x235)](_0x453325[_0x2fe33e(0x25c)]()[_0x2fe33e(0x2e2)](/ /g,'-'))&&(_0x28e66c['aNPQy'](_0x28ee96[_0x2fe33e(0x276)],_0x1ac7f6[_0x2fe33e(0x2fd)])&&(_0x9d733c[_0x2c2849['questionIndex']][_0x2fe33e(0x304)]=!![]));else{if(_0x1cfe93){if(_0x524f3b[_0x2fe33e(0xf3)](_0x524f3b[_0x2fe33e(0x21f)],_0x2fe33e(0x150)))_0x343016[_0x2fe33e(0x2dc)]=_0x570927;else{const _0x5a3b5d=_0x1cfe93[_0x2fe33e(0x118)](_0xab5daf,arguments);return _0x1cfe93=null,_0x5a3b5d;}}}}:function(){};return _0x15cf0d=![],_0x264a0c;};}()),_0x5a3381=_0x5250a4(this,function(){const _0x375f80=_0x3203,_0x175744={'XTETd':_0x375f80(0x161)};return _0x5a3381[_0x375f80(0x1b7)]()[_0x375f80(0x2a9)](_0x175744[_0x375f80(0x1bf)])['toString']()[_0x375f80(0x26a)](_0x5a3381)[_0x375f80(0x2a9)](_0x175744[_0x375f80(0x1bf)]);});_0x5a3381();const _0x425c8d=(function(){const _0x22882d=_0x3203,_0xb8c9d1={'mTqgu':function(_0x381041,_0x31f976){return _0x381041===_0x31f976;},'ODPeE':'fJVaH','AuOaL':function(_0x44da8e,_0x3ce305){return _0x44da8e===_0x3ce305;},'rbqrD':_0x22882d(0x144),'OonKw':_0x22882d(0x241),'YUVSW':function(_0x449aa3,_0x524112){return _0x449aa3(_0x524112);},'lUSjx':function(_0x2547b3){return _0x2547b3();},'eIfuD':_0x22882d(0x2bc)};let _0x33c12f=!![];return function(_0x4eb06d,_0x45e8f3){const _0x551746=_0x22882d,_0x472616={'aZQHy':function(_0x3ccbed,_0x2d935b){return _0xb8c9d1['YUVSW'](_0x3ccbed,_0x2d935b);},'RYCsF':function(_0x3987e7){const _0x6aaf2e=_0x3203;return _0xb8c9d1[_0x6aaf2e(0x204)](_0x3987e7);},'byaEq':'correct','BCqdT':_0x551746(0x1c8)};if(_0xb8c9d1[_0x551746(0x7f)]===_0x551746(0x2bc)){const _0x185878=_0x33c12f?function(){const _0x1fcaf4=_0x551746;if(_0xb8c9d1['mTqgu'](_0xb8c9d1[_0x1fcaf4(0x27b)],_0x1fcaf4(0x2ec))){if(_0x45e8f3){if(_0xb8c9d1[_0x1fcaf4(0x111)](_0xb8c9d1[_0x1fcaf4(0x2ee)],_0xb8c9d1[_0x1fcaf4(0x29f)]))_0x472616[_0x1fcaf4(0x2d8)](_0x521816,_0x1fcaf4(0x224))&&_0x472616[_0x1fcaf4(0x169)](_0x58cc8d);else{const _0x3c2c1e=_0x45e8f3[_0x1fcaf4(0x118)](_0x4eb06d,arguments);return _0x45e8f3=null,_0x3c2c1e;}}}else _0x345b3b++,_0x17981a[_0x1fcaf4(0x20c)]=_0x472616['byaEq'];}:function(){};return _0x33c12f=![],_0x185878;}else _0x29f40e[_0x551746(0xab)]['toggle'](_0x472616[_0x551746(0x193)],_0x4bb5c0===_0x44e76d);};}()),_0x1f4c1c=_0x425c8d(this,function(){const _0x406e15=_0x3203,_0xafd87b={'gsxXg':function(_0x488cfa,_0x537466){return _0x488cfa(_0x537466);},'puhxG':function(_0xa72ab0,_0xf4c4d7){return _0xa72ab0+_0xf4c4d7;},'JOaLg':_0x406e15(0x2ca),'CoaSv':_0x406e15(0x117),'dSXZQ':_0x406e15(0x1a1),'QeHtY':_0x406e15(0x15e),'KRSKU':_0x406e15(0x2dd),'yplss':_0x406e15(0x2e4),'SrGMN':'table','mgvpp':_0x406e15(0x183)};let _0x1c341d;try{const _0x96f166=_0xafd87b[_0x406e15(0x178)](Function,_0xafd87b[_0x406e15(0x162)](_0xafd87b['puhxG'](_0xafd87b[_0x406e15(0x16a)],_0xafd87b[_0x406e15(0xa4)]),');'));_0x1c341d=_0x96f166();}catch(_0x3af000){_0x1c341d=window;}const _0x3dd9c0=_0x1c341d[_0x406e15(0x147)]=_0x1c341d['console']||{},_0x2a9ddb=[_0xafd87b[_0x406e15(0x30f)],_0xafd87b[_0x406e15(0x253)],_0xafd87b['KRSKU'],_0x406e15(0x177),_0xafd87b[_0x406e15(0x20d)],_0xafd87b[_0x406e15(0x138)],_0xafd87b[_0x406e15(0xf5)]];for(let _0x4236a0=0x0;_0x4236a0<_0x2a9ddb[_0x406e15(0x2fd)];_0x4236a0++){const _0x5cf323=_0x425c8d[_0x406e15(0x26a)][_0x406e15(0x1fc)][_0x406e15(0x232)](_0x425c8d),_0x5b0784=_0x2a9ddb[_0x4236a0],_0x2915be=_0x3dd9c0[_0x5b0784]||_0x5cf323;_0x5cf323[_0x406e15(0x2a2)]=_0x425c8d[_0x406e15(0x232)](_0x425c8d),_0x5cf323[_0x406e15(0x1b7)]=_0x2915be[_0x406e15(0x1b7)]['bind'](_0x2915be),_0x3dd9c0[_0x5b0784]=_0x5cf323;}});_0x1f4c1c();let questionsData=[{'text':'Identify\x20the\x20correct\x20\x27organism-\x20drug\x20to\x20which\x20it\x20is\x20intrinsically\x20resistant\x27\x20pair:','choices':[{'id':0x1,'text':_0x38e45b(0xad)},{'id':0x2,'text':'Aspergillus\x20fumigatus\x20-\x20Micafungin'},{'id':0x3,'text':_0x38e45b(0x218)},{'id':0x4,'text':_0x38e45b(0x24a)}],'correct_choice_id':0x4,'solution':_0x38e45b(0x128),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x29e),'choices':[{'id':0x1,'text':'MS'},{'id':0x2,'text':_0x38e45b(0x6d)},{'id':0x3,'text':_0x38e45b(0x2df)},{'id':0x4,'text':'Tropical\x20spastic\x20paraparesis'}],'correct_choice_id':0x2,'solution':'<p><strong>Multiple\x20sclerosis\x20(MS)</strong>&nbsp;is\x20an\x20autoimmune\x20<strong>demyelinating</strong>&nbsp;and\x20inflammatory\x20disease\x20of\x20the\x20CNS\x20characterized\x20by\x20gliosis\x20and\x20neuronal\x20loss.\x20It\x20is\x20caused\x20by\x20an&nbsp;<strong>autoimmune\x20response</strong>&nbsp;directed\x20against\x20components\x20of\x20the&nbsp;<strong>myelin\x20</strong>sheath<strong>.\x20</strong>Genetic\x20predisposition\x20with\x20<strong>HLA-DRB1</strong>,\x20cigarette\x20smoking,\x20vitamin\x20D\x20deficiency,\x20and\x20exposure\x20to\x20Epstein\x20Barr\x20virus\x20(<strong>EBV</strong>)\x20are\x20known\x20risk\x20factors.&nbsp;Clinical\x20features\x20of\x20MS\x20include:</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201271\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li>Visual\x20impairment\x20due\x20to\x20the\x20involvement\x20of\x20the\x20optic\x20nerve&nbsp;<strong>(optic\x20neuritis).</strong></li>\x0a<li>Involvement\x20of\x20the\x20brainstem\x20causes\x20cranial\x20nerve\x20signs\x20such\x20as&nbsp;<strong>ataxia,\x20nystagmus,</strong>&nbsp;and&nbsp;<strong>internuclear\x20ophthalmoplegia\x20(INO).</strong></li>\x0a<li><strong>Weakness</strong>\x20of\x20limb\x20(usually\x20<strong>UMN</strong>\x20type),\x20facial\x20weakness,\x20<strong>spasticity</strong>,\x20<strong>hyperreflexia</strong>,\x20Babinski\x20signs,&nbsp;<strong>sensory\x20impairment</strong>&nbsp;of\x20the\x20trunk\x20and\x20limbs,&nbsp;and&nbsp;<strong>loss\x20of\x20bladder\x20control.</strong></li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Guillain-Barre\x20syndrome\x20</strong>(<strong>GBS</strong>)&nbsp;is\x20an\x20<strong>acute</strong>\x20inflammatory\x20demyelinating\x20neuropathy\x20causing&nbsp;<strong>rapidly</strong>\x20evolving&nbsp;<strong>ascending&nbsp;paralysis</strong>.&nbsp;\x20It\x20is\x20associated\x20with&nbsp;<strong>diminished\x20reflexes\x20(areflexia)&nbsp;</strong>and\x20autonomic\x20involvement\x20with\x20or\x20without\x20sensory\x20impairment.</p>\x0a<p><strong>Tropical\x20spastic\x20paraparesis\x20</strong>also\x20known\x20as&nbsp;<strong>HTLV-1\x20associated\x20myelopathy</strong><strong>&nbsp;</strong>is\x20a\x20<strong>slowly</strong>\x20progressive\x20<strong>spastic</strong>\x20syndrome\x20with\x20<strong>variable\x20sensory\x20and\x20bladder</strong>\x20disturbance\x20but\x20<strong>no\x20LMN</strong>\x20involvement.\x20Diagnosis\x20is\x20by\x20demonstration\x20of<strong>\x20HTLV-1\x20specific\x20antibody</strong>\x20in\x20serum\x20by\x20<strong>ELISA</strong>\x20and\x20confirmation\x20is\x20done\x20using\x20radioimmunoprecipitation\x20or\x20Western\x20blot\x20analysis.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x26f),'choices':[{'id':0x1,'text':_0x38e45b(0x1cc)},{'id':0x2,'text':_0x38e45b(0xe3)},{'id':0x3,'text':_0x38e45b(0xeb)},{'id':0x4,'text':_0x38e45b(0x13e)}],'correct_choice_id':0x3,'solution':_0x38e45b(0x214),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20newly\x20diagnosed\x20HIV\x20patient\x20presented\x20with\x20fever,\x20cough,\x20and\x20hemoptysis.\x20His\x20sputum\x20sample\x20showed\x20acid-fast\x20bacilli.\x20What\x20is\x20the\x20appropriate\x20management\x20for\x20this\x20patient?','choices':[{'id':0x1,'text':'Start\x20ART\x20if\x20CD4<200'},{'id':0x2,'text':_0x38e45b(0x288)},{'id':0x3,'text':_0x38e45b(0x2a7)},{'id':0x4,'text':'Start\x20ATT\x20and\x20ART\x20simultaneously'}],'correct_choice_id':0x3,'solution':'<p>In\x20an\x20<strong>HIV</strong>\x20patient\x20with\x20<strong>TB</strong>,\x20start\x20<strong>antitubercular\x20therapy\x20(ATT)</strong>\x20first\x20and\x20then\x20start\x20<strong>antiretroviral\x20therapy\x20(ART)</strong>\x20as\x20soon\x20as\x20ATT\x20is\x20tolerated\x20(between\x20<strong>2\x20weeks\x20and\x202\x20months)</strong>\x20by\x20the\x20patient.\x20This\x20is\x20done\x20to\x20avoid<strong>\x20immune\x20reconstitution\x20inflammatory\x20syndrome\x20(IRIS).</strong></p>\x0a<p>Among\x20persons\x20living\x20with\x20<strong>HIV\x20with\x20TB\x20meningitis,</strong>\x20ART\x20should\x20be\x20delayed\x20for\x20at\x20least\x20<strong>4\x20weeks</strong>\x20(and\x20initiated\x20within\x208\x20weeks)\x20after\x20treatment\x20for\x20TB\x20meningitis\x20is\x20initiated.</p>\x0a<p>Patients\x20with<strong>\x20HIV-related\x20TB</strong>\x20may\x20experience\x20a\x20<strong>temporary\x20paradoxical\x20exacerbation</strong>\x20of\x20symptoms\x20and\x20radiographic\x20manifestations\x20of\x20TB\x20after\x20starting<strong>\x20ART\x20(IRIS).</strong>\x20This\x20occurs\x20as\x20a\x20result\x20of\x20<strong>immune</strong>\x20<strong>reconstitution</strong>\x20due\x20to\x20the\x20simultaneous\x20administration\x20of\x20ART\x20and\x20ATT.</p>\x0a<p>It\x20is\x20characterized\x20by\x20high\x20fever,\x20lymphadenopathy,\x20expanding\x20intra-thoracic\x20lesions,\x20and\x20worsening\x20of\x20chest\x20X-ray\x20findings.\x20Diagnosis\x20should\x20be\x20made\x20only\x20after\x20ruling\x20out\x20treatment\x20failure\x20and\x20other\x20infections.\x20For\x20severe\x20cases,\x20<strong>prednisone</strong>\x201-2\x20mg/kg\x20is\x20used\x20for\x201-2\x20weeks\x20and\x20then\x20gradually\x20tapered.</p>\x0a<p>Note:\x20<strong>CBNAAT</strong>\x20is\x20the\x20<strong>preferred</strong>\x20diagnostic\x20technique\x20for\x20testing\x20TB\x20in\x20PLHIV\x20(people\x20living\x20with\x20HIV).\x20Smear\x20microscopy\x20has\x20<strong>poor\x20sensitivity</strong>\x20in\x20detecting\x20TB\x20in\x20PLHIV\x20due\x20to\x20fewer\x20organisms\x20in\x20sputum,\x20and\x20hence\x20is\x20not\x20preferred.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Identify\x20the\x20pathology\x20from\x20the\x20given\x20flow-volume\x20loop:','choices':[{'id':0x1,'text':'Fixed\x20distal\x20airway\x20obstruction'},{'id':0x2,'text':_0x38e45b(0x1cd)},{'id':0x3,'text':_0x38e45b(0x23d)},{'id':0x4,'text':'Variable\x20extrathoracic\x20obstruction'}],'correct_choice_id':0x2,'solution':'<p><strong>Option\x20D:</strong>\x20The\x20image\x20below\x20shows\x20airflow\x20limitation\x20and\x20flattening\x20in\x20the\x20<strong>inspiratory\x20limb</strong>\x20of\x20the\x20loop.\x20It\x20is\x20seen\x20in\x20nonfixed\x20variable\x20extrathoracic\x20obstruction.</p>\x0a<p>Examples:\x20vocal\x20cord\x20paralysis,\x20extrathoracic\x20tracheomalacia,\x20polychondritis,\x20etc.</p>','explanation_video':'','question_images':[_0x38e45b(0x163)],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/0080bcd3ba994b41814ab15ba2ea1347x1279x967.JPEG',_0x38e45b(0x7d),_0x38e45b(0x136),_0x38e45b(0x1ce)]},{'text':_0x38e45b(0x300),'choices':[{'id':0x1,'text':_0x38e45b(0x2b5)},{'id':0x2,'text':'Multiple\x20myeloma'},{'id':0x3,'text':_0x38e45b(0x313)},{'id':0x4,'text':_0x38e45b(0x157)}],'correct_choice_id':0x2,'solution':_0x38e45b(0xb4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x84),'choices':[{'id':0x1,'text':'Test\x20for\x20ANCA'},{'id':0x2,'text':_0x38e45b(0x187)},{'id':0x3,'text':_0x38e45b(0x18b)},{'id':0x4,'text':_0x38e45b(0x1bd)}],'correct_choice_id':0x1,'solution':_0x38e45b(0x14d),'explanation_video':'','question_images':[],'explanation_images':[_0x38e45b(0x1ee)]},{'text':_0x38e45b(0x78),'choices':[{'id':0x1,'text':_0x38e45b(0x287)},{'id':0x2,'text':_0x38e45b(0x249)},{'id':0x3,'text':_0x38e45b(0x134)},{'id':0x4,'text':_0x38e45b(0x105)}],'correct_choice_id':0x1,'solution':_0x38e45b(0x1d3),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/2cdcf8ec7d5f4ec6b32232e7adf9ae52.JPEG'],'explanation_images':[]},{'text':_0x38e45b(0x142),'choices':[{'id':0x1,'text':'1,\x203\x20and\x204'},{'id':0x2,'text':'2,\x203\x20and\x204'},{'id':0x3,'text':_0x38e45b(0x252)},{'id':0x4,'text':'1,\x202,\x203,\x204\x20and\x205'}],'correct_choice_id':0x3,'solution':'<p>The\x20given\x20clinical\x20scenario\x20describes\x20a\x20patient\x20treated\x20with\x20<strong>steroids</strong>\x20and\x20<strong>remedesivir</strong>\x20for<strong>\x20COVID-19</strong>\x20infection\x20being\x20discharged.\x20This\x20patient\x20should\x20be\x20advised\x20to\x20monitor\x20blood\x20<strong>glucose</strong>\x20levels\x20as\x20steroids\x20can\x20worsen\x20glycemic\x20status.\x20He\x20should\x20be\x20advised\x20to\x20watch\x20for\x20headache,\x20nasal\x20discharge,\x20and\x20sinusitis-like\x20symptoms\x20as\x20there\x20is\x20a\x20higher\x20incidence\x20of\x20<strong>mucormycosis</strong>\x20among\x20COVID\x20patients.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x201:</strong>\x20Repeat\x20RT-PCR\x20after\x207\x20days\x20of\x20discharge\x20is\x20not\x20needed\x20as\x20per\x20the\x20updated\x20discharge\x20criteria.</p>\x0a<p><strong>Option\x202:</strong>\x20Anosmia\x20may\x20persist\x20for\x20weeks\x20to\x20months\x20in\x20those\x20who\x20recovered\x20from\x20COVID-19.\x20Its\x20persistence\x20is\x20not\x20a\x20dangerous\x20sign.</p>\x0a<p><strong>Mucormycosis</strong>\x20is\x20most\x20commonly\x20caused\x20by\x20the\x20fungus\x20<strong>Rhizopus</strong>\x20<strong>oryzae</strong>\x20that\x20is\x20acquired\x20through\x20the\x20inhalation\x20of\x20fungal\x20spores\x20from\x20the\x20air.\x20It\x20may\x20occur\x20during\x20<strong>COVID</strong>\x20infection\x20or\x20after\x20a\x20few\x20weeks\x20(usually\x20around\x20the\x203rd\x20week)\x20of\x20recovery\x20from\x20it.</p>\x0a<p><strong>Risk\x20factors</strong>\x20in\x20COVID-19\x20patients\x20include\x20uncontrolled\x20hyperglycemia,\x20misuse\x20and\x20irrational\x20use\x20of\x20steroids,\x20leukopenia,\x20and\x20unhygienic\x20humidifiers.</p>\x0a<p>Symptoms\x20of\x20rhino-orbital-cerebral\x20mucormycosis\x20include\x20facial\x20pain,\x20facial\x20numbness,\x20brownish\x20or\x20blood-tinged\x20nasal\x20discharge,\x20conjunctival\x20suffusion\x20and\x20swelling,\x20black\x20eschar\x20over\x20the\x20face,\x20and\x20hard\x20palate.</p>\x0a<p>The\x20presence\x20of\x20<strong>bilateral\x20proptosis,\x20chemosis,\x20vision\x20loss,</strong>\x20and\x20<strong>ophthalmoplegia</strong>\x20suggests\x20<strong>cavernous\x20sinus\x20thrombosis</strong>\x20which\x20is\x20seen\x20in\x20advanced\x20disease.</p>\x0a<p>Diagnosis\x20is\x20done\x20by\x20<strong>biopsy</strong>\x20with\x20the\x20<strong>histopathological\x20examination</strong>\x20which\x20shows\x20the\x20presence\x20of\x20<strong>ribbon-like\x20aseptate\x20hyphae</strong>\x20(5-15\x20&micro;\x20thick)\x20<strong>branching</strong>\x20at\x20<strong>right</strong>\x20<strong>angles</strong>.</p>\x0a<p>CT\x20chest\x20in\x20pulmonary\x20mucormycosis\x20may\x20show<strong>\x20lobar\x20consolidation,\x20isolated\x20masses,\x20cavities,\x20nodules,\x20pleural\x20effusion,\x20</strong>or<strong>\x20wedge-shaped\x20infarct.</strong>\x20MRI\x20can\x20be\x20utilized\x20to\x20assess\x20the\x20degree\x20of\x20<strong>orbital\x20</strong>and<strong>\x20brain\x20involvement.</strong></p>\x0a<p>Management\x20includes\x20<strong>strict\x20glycemic\x20control.</strong>\x20<strong>Antifungal\x20therapy</strong>\x20started\x20early\x20on\x20high\x20clinical\x20suspicion\x20even\x20prior\x20to\x20microbiological\x20confirmation\x20can\x20reduce\x20mortality.</p>\x0a<p><strong>Liposomal\x20Amphotericin\x20B</strong>\x20(5-10\x20mg/kg)\x20is\x20the\x20drug\x20of\x20choice\x20and\x20has\x20to\x20be\x20continued\x20for\x203-6\x20weeks.\x20It\x20should\x20be\x20diluted\x20in\x205%\x20dextrose\x20and\x20is\x20incompatible\x20with\x20normal\x20saline\x20and\x20Ringer\x20lactate.\x20Step-down\x20therapy\x20is\x20to\x20be\x20done\x20with\x20<strong>oral</strong>\x20<strong>posaconazole</strong>\x20or\x20<strong>isavuconazole</strong>.\x20<strong>Renal\x20function</strong>\x20must\x20be\x20monitored\x20during\x20the\x20entire\x20treatment\x20period.</p>\x0a<p><strong>Blood\x20vessel\x20thrombosis</strong>\x20and\x20<strong>tissue\x20necrosis</strong>\x20in\x20mucormycosis\x20can\x20lead\x20to\x20limited\x20penetration\x20of\x20antifungal\x20drugs\x20at\x20the\x20infection\x20site.\x20To\x20address\x20this,\x20debridement\x20of\x20necrotic\x20tissues\x20is\x20crucial\x20in\x20eradicating\x20the\x20disease.</p>\x0a<p><strong>Revised\x20discharge\x20policy</strong>\x20for\x20COVID-19:</p>\x0a<p>Mild\x20cases\x20discharged\x20after\x20at\x20least\x207\x20days\x20have\x20passed\x20from\x20testing\x20positive\x20and\x20with\x20no\x20fever\x20for\x203\x20consecutive\x20days.\x20No\x20testing\x20is\x20needed\x20prior\x20to\x20discharge.</p>\x0a<p>For\x20moderate\x20cases,\x20in\x20patients\x20whose\x20signs\x20and\x20symptoms\x20resolve\x20and\x20maintain\x20saturation\x20above\x2093%\x20for\x203\x20consecutive\x20days,\x20patient\x20will\x20be\x20discharged\x20as\x20per\x20the\x20advice\x20of\x20the\x20treating\x20medical\x20officer.\x20No\x20testing\x20is\x20needed\x20prior\x20to\x20discharge.</p>\x0a<p>In\x20severe\x20cases\x20including\x20immunocompromised,\x20discharge\x20criteria\x20will\x20be\x20based\x20on\x20clinical\x20recovery\x20at\x20the\x20discretion\x20of\x20the\x20treating\x20medical\x20officer.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2d7),'choices':[{'id':0x1,'text':_0x38e45b(0x2b0)},{'id':0x2,'text':'MRI\x20to\x20look\x20for\x20infarct'},{'id':0x3,'text':_0x38e45b(0x19d)},{'id':0x4,'text':_0x38e45b(0x285)}],'correct_choice_id':0x1,'solution':_0x38e45b(0x1da),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x123),'choices':[{'id':0x1,'text':_0x38e45b(0x159)},{'id':0x2,'text':_0x38e45b(0x1fd)},{'id':0x3,'text':_0x38e45b(0x219)},{'id':0x4,'text':_0x38e45b(0x2c4)}],'correct_choice_id':0x3,'solution':_0x38e45b(0x12c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2de),'choices':[{'id':0x1,'text':_0x38e45b(0x2ea)},{'id':0x2,'text':_0x38e45b(0xbe)},{'id':0x3,'text':_0x38e45b(0xa0)},{'id':0x4,'text':_0x38e45b(0x174)}],'correct_choice_id':0x3,'solution':_0x38e45b(0xbc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x1ba),'choices':[{'id':0x1,'text':_0x38e45b(0x30c)},{'id':0x2,'text':'1,\x202,\x203'},{'id':0x3,'text':_0x38e45b(0xb5)},{'id':0x4,'text':_0x38e45b(0x312)}],'correct_choice_id':0x1,'solution':'<p><strong>Arterial</strong>\x20and\x20<strong>Venous\x20pH</strong>\x20can\x20be\x20used\x20to\x20determine<strong>\x20acid-base\x20imbalance.</strong></p>\x0a<p><strong>Arterial\x20blood\x20gas</strong>\x20(ABG)\x20analysis\x20is\x20the\x20<strong>gold\x20standard</strong>\x20method\x20for\x20the\x20assessment\x20of\x20oxygen\x20and\x20acid-base\x20status.</p>\x0a<p>Venous\x20blood\x20gas\x20(VBG)\x20analysis\x20is\x20increasingly\x20being\x20used\x20as\x20a\x20substitute\x20for\x20ABG\x20as\x20the\x20difference\x20between\x20the\x20pH\x20obtained\x20from\x20VBG\x20and\x20ABG\x20is\x20clinically\x20insignificant\x20(arterial\x20pH\x20typically\x200.03\x20higher\x20than\x20venous\x20pH),\x20thus\x20making\x20venous\x20pH\x20values\x20acceptable.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x203:</strong>\x20The\x20pO2\x20values\x20also\x20show\x20a\x20significant\x20difference,\x20with\x20arterial\x20pO2\x20(normal\x2095mmHg)\x20values\x20typically\x2055mmHg\x20greater\x20than\x20the\x20venous\x20pO2\x20(normal\x2040mmHg),\x20making\x20venous\x20pO2\x20values\x20unacceptable.<br\x20/>\x20<br\x20/><strong>Option\x204:</strong>\x20Venous\x20pCO2\x20(normal\x20range\x2041\x20to\x2051mmHg)\x20values\x20differ\x20significantly\x20from\x20arterial\x20pCO2\x20(normal\x20range\x2035\x20to\x2045mmHg)\x20by\x20a\x20range\x20of\x205\x20to\x2015mmHg\x20which\x20makes\x20venous\x20pCO2\x20values\x20unacceptable.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2b9),'choices':[{'id':0x1,'text':_0x38e45b(0x16d)},{'id':0x2,'text':_0x38e45b(0xc2)},{'id':0x3,'text':_0x38e45b(0x113)},{'id':0x4,'text':'Huntington\x27s\x20chorea'}],'correct_choice_id':0x4,'solution':_0x38e45b(0x2ed),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'For\x20the\x20diagnosis\x20of\x20resistant\x20hypertension,\x20the\x20patient\x20should\x20have\x20uncontrolled\x20hypertension\x20despite\x20taking\x20three\x20antihypertensive\x20drugs.\x20This\x20should\x20include\x20at\x20least\x20one:','choices':[{'id':0x1,'text':'Calcium\x20channel\x20blocker'},{'id':0x2,'text':'Beta\x20blocker'},{'id':0x3,'text':'Alpha\x20blocker'},{'id':0x4,'text':'Diuretic'}],'correct_choice_id':0x4,'solution':'<p>For\x20the\x20diagnosis\x20of<strong>\x20resistant\x20hypertension,</strong>\x20the\x20patient\x20should\x20have\x20<strong>uncontrolled\x20hypertension</strong>\x20despite\x20taking\x20<strong>three</strong>\x20antihypertensive\x20drugs,\x20including\x20at\x20least\x20one\x20<strong>diuretic</strong>.</p>\x0a<p>While\x20a\x20<strong>calcium\x20channel\x20blocker,\x20beta\x20blocker,\x20</strong>or<strong>\x20alpha-blocker</strong>\x20can\x20be\x20part\x20of\x20the\x20antihypertensive\x20regimen,\x20the\x20inclusion\x20of\x20a\x20<strong>diuretic</strong>\x20is\x20necessary\x20for\x20the\x20diagnosis\x20of\x20resistant\x20hypertension.\x20The\x20diuretic\x20helps\x20in\x20addressing<strong>\x20fluid\x20retention</strong>\x20which\x20is\x20often\x20a\x20significant\x20contributor\x20to\x20hypertension.</p>\x0a<p>Resistant\x20hypertension\x20is\x20more\x20common\x20in\x20patients\x20aged\x20<strong>&gt;60\x20years</strong>\x20than\x20in\x20younger\x20patients.\x20It\x20may\x20be\x20related\x20to\x20<strong>nonadherence</strong>\x20to\x20therapy,\x20obesity,\x20and\x20excessive\x20alcohol\x20intake.</p>\x0a<p>In\x20the\x20absence\x20of\x20a\x20specific\x20identifiable\x20cause,\x20<strong>mineralocorticoid\x20receptor\x20antagonists</strong>\x20like\x20spironolactone\x20have\x20been\x20found\x20to\x20be\x20most\x20effective\x20add-on\x20drugs\x20for\x20the\x20treatment\x20of\x20resistant\x20hypertension.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2da),'choices':[{'id':0x1,'text':_0x38e45b(0xc0)},{'id':0x2,'text':_0x38e45b(0xa7)},{'id':0x3,'text':'Gitelman\x20syndrome'},{'id':0x4,'text':'Gordon\x20syndrome'}],'correct_choice_id':0x2,'solution':_0x38e45b(0x11a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x8f),'choices':[{'id':0x1,'text':'Urinary\x20sodium\x20<20\x20mEq/L'},{'id':0x2,'text':_0x38e45b(0x19c)},{'id':0x3,'text':_0x38e45b(0x207)},{'id':0x4,'text':_0x38e45b(0x197)}],'correct_choice_id':0x1,'solution':_0x38e45b(0x2d4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0xd3),'choices':[{'id':0x1,'text':_0x38e45b(0x245)},{'id':0x2,'text':_0x38e45b(0x2c6)},{'id':0x3,'text':_0x38e45b(0x29c)},{'id':0x4,'text':_0x38e45b(0x114)}],'correct_choice_id':0x3,'solution':'<p>All\x20of\x20the\x20given\x20options\x20can\x20cause\x20<strong>hypoxemia</strong>\x20out\x20of\x20which\x20the\x20<strong>alveolar-arterial\x20oxygen\x20gradient\x20(A-a\x20gradient)</strong>\x20remains\x20<strong>normal</strong>\x20in\x20<strong>hypoventilation</strong>.</p>\x0a<p>The\x20A-a\x20gradient\x20or\x20the\x20alveolar-arterial\x20oxygen\x20gradient\x20refers\x20to\x20the\x20<strong>difference</strong>\x20between\x20the\x20<strong>oxygen\x20concentration\x20in\x20the\x20alveoli\x20(PAO<sub>2</sub>)</strong>\x20and\x20oxygen\x20concentration\x20in\x20the\x20<strong>arterial\x20system\x20(PaO<sub>2</sub>).</strong></p>\x0a<p>A-a\x20gradient=&nbsp;PAO<sub>2\x20</sub>-&nbsp;PaO<sub>2</sub></p>\x0a<p>In\x20<strong>hypoventilation</strong>,\x20patients\x20lack\x20oxygen\x20tension\x20in\x20the\x20respiratory\x20system\x20as\x20well\x20as\x20their\x20arterial\x20system.\x20This\x20results\x20in\x20a\x20<strong>decrease\x20in\x20both\x20PAO2\x20and\x20PaO2</strong>\x20and\x20<strong>A-a\x20gradient</strong>\x20remains\x20<strong>normal</strong>.\x20Hypoventilation\x20can\x20be\x20seen\x20in<strong>\x20CNS\x20depression,</strong>\x20neuromuscular\x20diseases\x20such\x20as\x20<strong>myasthenia\x20gravis,</strong>\x20<strong>kyphoscoliosis</strong>,\x20vertebral\x20fractures,\x20etc.</p>\x0a<p><strong>Other\x20options:&nbsp;</strong></p>\x0a<p>Option\x20A-\x20In\x20a\x20<strong>right-to-left\x20shunt</strong>,\x20a\x20portion\x20of\x20the\x20pulmonary\x20blood\x20flow\x20gets\x20shunted\x20away\x20from\x20the\x20alveoli.\x20This\x20results\x20in\x20ventilation\x20without\x20perfusion\x20which\x20causes\x20a\x20higher\x20V/Q\x20ratio.\x20Here,\x20diffusion\x20between\x20capillaries\x20and\x20alveoli\x20is\x20unaffected,&nbsp;\x20but\x20the\x20<strong>arterial\x20PaO<sub>2</sub></strong>\x20is\x20<strong>decreased</strong>\x20due\x20to\x20the\x20lack\x20of\x20oxygenation\x20of\x20the\x20shunted\x20blood.\x20This\x20results\x20in\x20hypoxemia\x20and\x20an\x20<strong>increased\x20A-a\x20gradient.\x20</strong>In\x20the\x20cases\x20of\x20the\x20shunt,\x20oxygenation\x20does\x20not\x20improve\x20hypoxemia.</p>\x0a<p>Option\x20B-\x20<strong>Ventilation/Perfusion\x20(V/Q)\x20mismatch</strong>\x20is\x20the\x20most\x20common\x20cause\x20of\x20hypoxemia.</p>\x0a<p><strong>Low\x20V/Q\x20mismatch</strong>\x20occurs\x20in\x20<strong>chronic\x20obstructive\x20pulmonary\x20disorder</strong>\x20(COPD),\x20<strong>asthma,\x20interstitial\x20lung\x20disease,</strong>\x20etc.\x20In\x20these\x20cases,\x20the\x20<strong>A-a\x20oxygen\x20gradient</strong>\x20is\x20<strong>increased</strong>\x20due\x20to\x20a\x20defect\x20in\x20diffusion\x20resulting\x20in\x20hypoxemia.\x20</p>\x0a<p>A\x20<strong>high\x20V/Q</strong>\x20ratio\x20is\x20seen\x20in<strong>\x20pulmonary\x20embolism</strong>\x20(PE)\x20where\x20there\x20is\x20wasted\x20ventilation.\x20The\x20alveolar\x20oxygen\x20is\x20normal\x20but\x20there\x20is\x20decreased\x20perfusion\x20resulting\x20in\x20<strong>increased\x20A-a\x20gradient.</strong>\x20</p>\x0a<p>Inspiratory\x20hypoxia,\x20seen\x20at\x20h<strong>igh\x20altitudes,</strong>\x20can\x20cause\x20a\x20<strong>V/Q\x20mismatch.</strong>\x20The\x20decreased\x20atmospheric\x20pressure\x20causes\x20a\x20decreased\x20PAO2.\x20There\x20is\x20normal\x20diffusion\x20which\x20suggests\x20a\x20<strong>normal\x20A-a\x20gradient</strong>\x20while\x20the\x20arterial\x20PaO2\x20decreases,\x20leading\x20to\x20<strong>hypoxemia</strong>.</p>\x0a<p>Hypoventilation\x20is\x20the\x20better\x20answer\x20as\x20the\x20cause\x20of\x20the\x20V/Q\x20mismatch\x20is\x20not\x20specified.</p>\x0a<p>Option\x20D:\x20<strong>Alveolar\x20membrane\x20damage</strong>\x20affects\x20diffusion\x20between\x20the\x20alveoli\x20and\x20capillaries.\x20The\x20oxygen\x20levels\x20in\x20the\x20arterial\x20blood\x20decrease\x20even\x20though\x20alveoli\x20are\x20being\x20ventilated.\x20This\x20leads\x20to\x20an\x20<strong>increased\x20A-a\x20gradient.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2c7),'choices':[{'id':0x1,'text':_0x38e45b(0xf7)},{'id':0x2,'text':'Subcutaneous\x20sumatriptan'},{'id':0x3,'text':_0x38e45b(0x280)},{'id':0x4,'text':_0x38e45b(0x97)}],'correct_choice_id':0x2,'solution':_0x38e45b(0x2e5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2b4),'choices':[{'id':0x1,'text':_0x38e45b(0x10a)},{'id':0x2,'text':'Non-cardiovascular\x20death\x20is\x20more\x20in\x20HFrEF\x20-30-40%\x20as\x20compared\x20to\x20HFpEF\x20-15%'},{'id':0x3,'text':'Angiotensin\x20converting\x20enzyme\x20(ACE)\x20inhibitors\x20cause\x20cough\x20in\x2015%\x20and\x20angioedema\x20in\x201%'},{'id':0x4,'text':_0x38e45b(0x28c)}],'correct_choice_id':0x2,'solution':_0x38e45b(0x1e0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x15f),'choices':[{'id':0x1,'text':_0x38e45b(0x168)},{'id':0x2,'text':_0x38e45b(0xdd)},{'id':0x3,'text':_0x38e45b(0xf0)},{'id':0x4,'text':_0x38e45b(0x2ae)}],'correct_choice_id':0x2,'solution':'<p>Revised\x20<strong>WHO\x20classification</strong>\x20of\x20pulmonary\x20hypertension:</p>\x0a<ul>\x0a<li>Group\x20I:\x20Pulmonary\x20arterial\x20hypertension\x20(PAH)</li>\x0a<li>Group\x20II:\x20Pulmonary\x20hypertension\x20with\x20left\x20heart\x20disease</li>\x0a<li>Group\x20III:\x20Pulmonary\x20hypertension\x20associated\x20with\x20lung\x20diseases\x20and/or\x20hypoxemia</li>\x0a<li>Group\x20IV:\x20Pulmonary\x20hypertension\x20due\x20to\x20chronic\x20thrombotic\x20and/or\x20embolic\x20disease\x20(CTEPH)</li>\x0a<li>Group\x20V:\x20Pulmonary\x20hypertension\x20due\x20to\x20miscellaneous\x20causes</li>\x0a</ul>\x0a<p>The\x20table\x20below\x20provides\x20guidance\x20on\x20the\x20prognosis\x20of\x20PAH.</p>\x0a<table\x20style=\x22height:\x20116px;\x20width:\x20324px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22><strong>Determinants</strong>&nbsp;</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22><strong>Low\x20risk&nbsp;</strong></td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22><strong>High\x20risk</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>Clinical\x20evidence\x20of\x20RV\x20failure</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>No</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Yes</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>Progression\x20of\x20symptoms</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Gradual</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>\x0a<p>Rapid</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>Echocardiography</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Minimal\x20RV\x20dysfunction</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Pericardial\x20effusion,\x20significant\x20RV\x20enlargement/dysfunction,\x20right\x20atrial\x20enlargement</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22><strong>WHO\x20functional\x20class&nbsp;</strong></td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22><strong>II,\x20III</strong></td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22><strong>IV</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>6min\x20walk\x20distance</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Longer\x20(&gt;400\x20m)</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Shorter\x20(&lt;300\x20m)</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>BNP</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Minimally\x20elevated</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Significantly\x20elevated</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[_0x38e45b(0x1ff)]},{'text':_0x38e45b(0x172),'choices':[{'id':0x1,'text':_0x38e45b(0x1b4)},{'id':0x2,'text':'1,\x203,\x205\x20only'},{'id':0x3,'text':'3,\x204,\x205\x20only'},{'id':0x4,'text':'1,\x203,\x204\x20and\x205\x20only'}],'correct_choice_id':0x4,'solution':_0x38e45b(0xd5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x273),'choices':[{'id':0x1,'text':_0x38e45b(0x318)},{'id':0x2,'text':'Ocrelizumab'},{'id':0x3,'text':'Fingolimod'},{'id':0x4,'text':'Alemtuzumab'}],'correct_choice_id':0x2,'solution':'<p><strong>Ocrelizumab</strong>\x20is\x20preferred\x20in\x20the\x20management\x20of<strong>\x20primary\x20progressive\x20multiple\x20sclerosis\x20(PPMS).\x20Natalizumab</strong>,\x20<strong>fingolimod</strong>,\x20and\x20<strong>alemtuzumab</strong>\x20are\x20used\x20in\x20the\x20management\x20of\x20relapsing\x20<strong>multiple\x20sclerosis</strong>\x20and\x20not\x20PPMS.</p>\x0a<p><strong>Ocrelizumab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20against\x20<strong>CD20</strong>\x20molecules\x20present\x20on\x20<strong>B\x20cells.</strong>\x20It\x20reduces\x20the\x20progression\x20of\x20the\x20disease\x20and\x20improves\x20other\x20clinical\x20parameters.</p>\x0a<p><strong>Multiple\x20sclerosis</strong>\x20(MS)\x20is\x20an\x20<strong>autoimmune</strong>\x20disease\x20characterized\x20by\x20chronic\x20inflammation,\x20demyelination,\x20gliosis\x20(scarring),\x20and\x20neuronal\x20loss.</p>\x0a<p>Based\x20on\x20<strong>clinical</strong>\x20<strong>course</strong>,\x20MS\x20is\x20<strong>classified</strong>\x20as:</p>\x0a<ul>\x0a<li>Relapsing\x20or\x20bout\x20onset\x20MS\x20(RMS)</li>\x0a<li>Secondary\x20progressive\x20MS\x20(SPMS)</li>\x0a<li>Primary\x20progressive\x20MS\x20(PPMS)</li>\x0a</ul>\x0a<p>The\x20drugs\x20used\x20in\x20the\x20management\x20of\x20RMS\x20are\x20listed\x20in\x20the\x20table\x20below:</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Highly\x20effective</td>\x0a<td>Moderately\x20effective</td>\x0a<td>Modestly\x20effective</td>\x0a</tr>\x0a<tr>\x0a<td>\x0a<ul>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Anti\x20CD20\x20antibodies:\x20Ocrelizumab,\x20Ofatumumab,\x20Rituximab</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Anti\x20integrin\x20antibody:\x20Natalizumab</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Anti\x20CD\x2052\x20antibody:\x20Alemtuzumab</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Mitoxantrone</li>\x0a</ul>\x0a</td>\x0a<td>\x0a<ul>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Sphingosine-1-phosphate\x20inhibitor:\x20Fingolimod</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Dimethyl\x20fumarate</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Cladribine</li>\x0a</ul>\x0a</td>\x0a<td>\x0a<ul>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Glatiramer\x20acetate</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Interferon\x20beta</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Teriflunomide</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>&nbsp;<strong>Siponimod</strong>,\x20a\x20selective\x20<strong>S1P1\x20S1P5\x20modulator,</strong>\x20reduces\x20the\x20risk\x20of\x20progression\x20of\x20SPMS.\x20Ocrelizumab,\x20cladribine\x20and\x20high\x20dose\x20interferon\x20beta\x20can\x20also\x20be\x20used.</p>\x0a<p><strong>Ocrelizumab</strong>\x20is\x20the\x20<strong>first</strong>\x20drug\x20to\x20alter\x20the\x20progression\x20of\x20disability\x20in\x20<strong>PPMS.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x175),'choices':[{'id':0x1,'text':'Acute\x20hepatitis\x20B'},{'id':0x2,'text':'Chronic\x20hepatitis\x20B'},{'id':0x3,'text':'Remote\x20infection\x20with\x20hepatitis\x20B'},{'id':0x4,'text':_0x38e45b(0x130)}],'correct_choice_id':0x3,'solution':'<p><br\x20/>The\x20most\x20probable\x20diagnosis\x20is\x20<strong>remote</strong>\x20infection\x20with\x20<strong>hepatitis\x20B\x20virus\x20(HBV).</strong></p>\x0a<p>A\x20non-reactive\x20HbsAg\x20rules\x20out\x20active\x20HBV\x20infection<strong>\x20(Options\x20A\x20and\x20B).</strong></p>\x0a<p>Non-reactive\x20IgM\x20anti-HbcAg\x20suggests\x20that\x20the\x20patient\x20is\x20not\x20in\x20the\x20window\x20period\x20<strong>(Option\x20C).</strong></p>\x0a<p><strong>Reactive</strong>\x20<strong>IgG</strong>\x20HBcAg\x20is\x20seen\x20in\x20the\x20l<strong>ate\x20convalescence\x20stage</strong>\x20and\x20remains\x20<strong>lifelong</strong>.</p>\x0a<p><strong>Option\x20A:</strong>\x20In\x20acute\x20hepatitis\x20B,\x20HBsAg\x20is\x20reactive,\x20HBeAg\x20can\x20be\x20reactive\x20in\x20highly\x20infectious\x20individuals,\x20and\x20IgM\x20Anti\x20HBcAg\x20is\x20reactive.\x20Anti-Hbs\x20is\x20reactive\x20in\x20recovery.</p>\x0a<p><strong>Option\x20B:</strong>\x20In\x20chronic\x20hepatitis\x20B,\x20HBsAg\x20is\x20reactive,\x20and\x20IgG\x20Anti\x20HBcAg\x20is\x20reactive.\x20Anti-HBs\x20is\x20non-reactive.</p>\x0a<p><strong>Option\x20D:</strong>\x20Core\x20window\x20period\x20is\x20a\x20phase\x20where\x20even\x20though\x20hepatitis\x20infection\x20is\x20present,\x20HBsAg\x20is\x20non-reactive.\x20Diagnosis\x20is\x20based\x20on\x20the\x20presence\x20of\x20IgM\x20Anti\x20HBcAg.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0xcd),'choices':[{'id':0x1,'text':_0x38e45b(0x165)},{'id':0x2,'text':_0x38e45b(0xe3)},{'id':0x3,'text':_0x38e45b(0x269)},{'id':0x4,'text':'1,\x202,\x203\x20and\x204'}],'correct_choice_id':0x2,'solution':_0x38e45b(0x12d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'True\x20about\x20electroencephalogram\x20(EEG)\x20is\x20all\x20except:','choices':[{'id':0x1,'text':_0x38e45b(0x1ad)},{'id':0x2,'text':_0x38e45b(0x20e)},{'id':0x3,'text':'Doing\x20EEG\x20is\x20mandatory\x20for\x20diagnosis\x20of\x20seizures'},{'id':0x4,'text':_0x38e45b(0x1a7)}],'correct_choice_id':0x3,'solution':_0x38e45b(0x26d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x2fe),'choices':[{'id':0x1,'text':_0x38e45b(0x151)},{'id':0x2,'text':'3\x20and\x205'},{'id':0x3,'text':'1\x20and\x202'},{'id':0x4,'text':'2\x20only'}],'correct_choice_id':0x3,'solution':_0x38e45b(0x24b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x38e45b(0x19f),'choices':[{'id':0x1,'text':'1'},{'id':0x2,'text':'2'},{'id':0x3,'text':'3'},{'id':0x4,'text':'4'}],'correct_choice_id':0x2,'solution':'<p>The\x20given\x20clinical\x20scenario\x20of\x20a\x20patient\x20with\x20dyspnea,\x20bilateral\x20pitting\x20pedal\x20edema,\x20abdominal\x20distension,\x20elevated\x20jugular\x20venous\x20pulse\x20(JVP)\x20and\x20a\x20palpable\x20liver\x20are\x20suggestive\x20of\x20<strong>right\x20ventricular\x20(RV)\x20failure.</strong>\x20The\x20history\x20of<strong>\x20chronic\x20smoking</strong>\x20points\x20towards\x20<strong>chronic\x20obstructive\x20pulmonary\x20disease</strong>\x20(COPD)\x20as\x20the\x20etiology\x20for\x20RV\x20failure\x20<strong>(cor\x20pulmonale).</strong>\x20The\x20label\x202\x20points\x20to\x20the\x20right\x20ventricle\x20(RV),\x20which\x20is\x20affected\x20in\x20this\x20patient.</p>\x0a<p><strong>Cor\x20pulmonale</strong>\x20is\x20defined\x20as\x20altered\x20RV\x20structure/function\x20secondary\x20to\x20pulmonary\x20hypertension\x20in\x20the\x20context\x20of\x20chronic\x20lung\x20diseases.</p>\x0a<p>The\x20main\x20pathophysiology\x20behind\x20cor\x20pulmonale\x20is\x20<strong>pulmonary\x20hypertension</strong>\x20and\x20<strong>increased\x20right\x20ventricular\x20(RV)\x20afterload</strong>\x20which\x20is\x20sufficient\x20to\x20cause\x20<strong>RV\x20dilation</strong>\x20with\x20or\x20without\x20<strong>hypertrophy</strong>.\x20Sustained\x20pressure\x20overload\x20leads\x20to\x20RV\x20<strong>dysfunction\x20and\x20failure.</strong></p>\x0a<p><strong>Dyspnea</strong>\x20is\x20the\x20<strong>most\x20common</strong>\x20symptom.\x20Signs\x20include\x20elevated\x20JVP\x20with\x20prominent\x20v\x20waves,\x20hepatomegaly,\x20pulsatile\x20liver,\x20ascites,\x20pedal\x20edema,\x20S3\x20gallop\x20and\x20murmur\x20of\x20tricuspid\x20regurgitation.</p>\x0a<p>The\x20ECG\x20in\x20severe\x20pulmonary\x20hypertension\x20shows\x20<strong>p-pulmonale,\x20right\x20axis\x20deviation,</strong>\x20and\x20<strong>RV\x20hypertrophy.</strong>\x20Echo\x20can\x20be\x20used\x20to\x20measure\x20RV\x20wall\x20thickness\x20and\x20chamber\x20dimensions,\x20while\x20doppler\x20can\x20be\x20used\x20to\x20assess\x20pulmonary\x20artery\x20pressures.&nbsp;</p>\x0a<p>A\x20specimen\x20of\x20the\x20heart\x20with\x20the\x20various\x20parts\x20labeled\x20is\x20given\x20below:</p>','explanation_video':'','question_images':[_0x38e45b(0x1f2)],'explanation_images':[_0x38e45b(0x27a)]}],quizName=_0x38e45b(0xbd);const quizFilename=_0x38e45b(0x259);let hierarchy=[_0x38e45b(0x272),_0x38e45b(0x262),_0x38e45b(0xf2)];if(window[_0x38e45b(0x2f9)][_0x38e45b(0xb6)]['endsWith'](_0x38e45b(0x2ab))){const customData=JSON[_0x38e45b(0x2e8)](localStorage[_0x38e45b(0x7e)](_0x38e45b(0xfb)));if(customData){const mnUNoU=_0x38e45b(0x70)[_0x38e45b(0x1f3)]('|');let pgMWZm=0x0;while(!![]){switch(mnUNoU[pgMWZm++]){case'0':quizName=customData[_0x38e45b(0x22e)];continue;case'1':hierarchy=customData[_0x38e45b(0x270)];continue;case'2':document['getElementById'](_0x38e45b(0x8d))[_0x38e45b(0x2a6)]=hierarchy['join'](_0x38e45b(0x210));continue;case'3':document['title']=quizName+_0x38e45b(0x2a4);continue;case'4':document[_0x38e45b(0x94)](_0x38e45b(0x302))[_0x38e45b(0x2a6)]=questionsData[_0x38e45b(0x2fd)];continue;case'5':questionsData=customData['questions'];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x38e45b(0x167),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x38e45b(0x19e)](),quizStartTime=Date[_0x38e45b(0x19e)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x38e45b(0x2fd)])[_0x38e45b(0x91)](null)[_0x38e45b(0x1e5)](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x38e45b(0x2fd)]};function saveProgress(){const _0x3c0551=_0x38e45b,_0x2fe466={'Kubxr':_0x3c0551(0x1a0),'RycxU':'incomplete'};if(isQuizCompleted)return;const _0x6459da=JSON[_0x3c0551(0x2e8)](localStorage[_0x3c0551(0x7e)](_0x2fe466['Kubxr']))||{};_0x6459da[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x2fe466['RycxU'],'lastSeen':new Date()[_0x3c0551(0x257)]()},localStorage[_0x3c0551(0x127)](_0x2fe466[_0x3c0551(0x1aa)],JSON['stringify'](_0x6459da));}function loadProgress(){const _0x57e26f=_0x38e45b,_0x5d5750={'vGVwV':_0x57e26f(0x1a0),'SQhnF':_0x57e26f(0x2d9)},_0x3b3a9b=JSON['parse'](localStorage['getItem'](_0x5d5750[_0x57e26f(0x310)]))||{},_0x58701d=_0x3b3a9b[quizFilename];if(_0x58701d){const _0x22c908=_0x5d5750[_0x57e26f(0x15a)][_0x57e26f(0x1f3)]('|');let _0x402bff=0x0;while(!![]){switch(_0x22c908[_0x402bff++]){case'0':stats=_0x58701d[_0x57e26f(0x2af)];continue;case'1':return!![];case'2':currentMode=_0x58701d[_0x57e26f(0x153)];continue;case'3':currentQuestionIndex=_0x58701d[_0x57e26f(0x320)];continue;case'4':questionStates=_0x58701d['questionStates'];continue;case'5':console[_0x57e26f(0x1a1)]('Progress\x20loaded.');continue;}break;}}return![];}function clearProgress(){const _0x507923=_0x38e45b,_0x1ed52f={'UQNve':_0x507923(0x1a0),'ZbxPj':_0x507923(0xb9)},_0xf5f16a=JSON[_0x507923(0x2e8)](localStorage['getItem'](_0x1ed52f[_0x507923(0x1ac)]))||{};_0xf5f16a[quizFilename]&&(delete _0xf5f16a[quizFilename],localStorage[_0x507923(0x127)](_0x507923(0x1a0),JSON[_0x507923(0x275)](_0xf5f16a)),console[_0x507923(0x1a1)](_0x1ed52f['ZbxPj']));}function _0x35ec(){const _0x2b3510=['yHYFK','DUdla','wiejN','hVvFb','lUSjx','NFiaF','nav-btn-bookmarked','Urine\x20osmolality\x20>100\x20mOsm/kg','XuQbQ','JmuvL','HklrT','psIhx','status','yplss','Scalp\x20EEG\x20may\x20be\x20helpful\x20in\x20localizing\x20frontal\x20lobe\x20epilepsy','HzCUf','\x20>\x20','pYANk','QIsEq','317064kDzLet','<p>Fasting\x20blood\x20sugar<strong>\x20&gt;126\x20mg/dL</strong>\x20and\x202-hour\x20postprandial\x20blood\x20sugar<strong>\x20&gt;200\x20mg/dl</strong>\x20can\x20be\x20used\x20as\x20screening\x20tests\x20for\x20diabetes\x20in\x20a\x20primary\x20health\x20center\x20(PHC).</p>\x0a<p><strong>HbA1c</strong>\x20estimation\x20is\x20usually\x20unavailable\x20for\x20screening\x20at\x20many\x20PHCs\x20due\x20to\x20low\x20resources.\x20In\x20India,\x20facilities\x20for\x20HbA1c\x20estimation\x20are\x20usually\x20available\x20only\x20at\x20<strong>tertiary\x20centers.</strong></p>\x0a<p>Random\x20blood\x20sugar\x20<strong>&gt;200\x20mg/dL</strong>\x20can\x20be\x20used\x20for\x20diagnosis\x20only\x20if\x20the\x20patient\x20presents\x20with\x20symptoms\x20of\x20diabetes,\x20hence\x20it\x20is\x20<strong>not\x20a\x20useful\x20screening\x20test.</strong></p>','wpaBf','joXoR','question_audio','Candida\x20albicans\x20-\x20Amphotericin\x20B','2\x20and\x203\x20correct','OWnVt','voPsk','NnroD','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','HbbkT','XDAca','SfiXm','BavRX','UcZgc','haLyz','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','totalAttempted','BPfDX','attachMedia','zNQdV','YHlLu','HRylN','open','DQYVD','Ygogv','name','FKWyJ','hidden','correctAnswers','bind','Bookmark','lnGwP','includes','SSGHh','timeDisplay','RsTCn','IUPLy','WkIUv','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','zFCvq','Variable\x20intrathoracic\x20obstruction','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','Bookmarked','jVSeI','YWBzg','correct_choice_id','BUYbM','NTpJA','Right\x20to\x20left\x20shunt','SxPDi','BVUCz','qZLyB','Calcium\x20phosphate','Candida\x20krusei\x20-\x20Fluconazole','<p>The\x20clinical\x20scenario\x20describes\x20an\x20<strong>elderly</strong>\x20patient\x20with<strong>\x20heart\x20failure</strong>\x20who\x20develops\x20<strong>severe\x20respiratory\x20distress</strong>\x20associated\x20with\x20hypoxia,\x20tachycardia,\x20and\x20elevated\x20mean\x20arterial\x20pressure\x20following\x20a\x20<strong>blood\x20transfusion.</strong>\x20The\x20most\x20likely\x20diagnosis\x20is\x20<strong>transfusion-associated\x20circulatory\x20overload\x20(TACO).</strong>\x20The\x20recommended\x20investigations\x20for\x20suspected\x20TACO\x20include\x20<strong>chest\x20X-ray</strong>\x20and\x20<strong>BNP</strong>\x20levels.</p>\x0a<p><strong>Chest\x20X-ray</strong>\x20in\x20TACO\x20may\x20show\x20<strong>bilateral</strong>\x20and\x20<strong>predominant\x20alveolar\x20infiltrates.</strong>\x20<strong>BNP</strong>\x20levels\x20are\x20usually\x20<strong>elevated</strong>\x20in\x20TACO\x20secondary\x20to\x20volume\x20overload.</p>\x0a<p><strong>Anti-leukocyte\x20antibodies</strong>\x20are\x20present\x20in\x20<strong>transfusion-related\x20acute\x20lung\x20injury\x20(TRALI),</strong>\x20not\x20in\x20TACO\x20patients.</p>\x0a<p>TACO\x20is\x20usually\x20a\x20clinical\x20diagnosis\x20suspected\x20in\x20any\x20patient\x20who\x20has\x20acute\x20respiratory\x20distress\x20and/or\x20hypertension\x20during\x20transfusion\x20or\x20within\x206\x20hours\x20of\x20completion.</p>\x0a<p><strong>Risk\x20factors</strong>\x20include\x20older\x20age,\x20pre-existing\x20fluid\x20overload,\x20cardiac\x20dysfunction,\x20renal\x20dysfunction,\x20and\x20transfusion\x20of\x20large\x20volumes\x20of\x20blood\x20components.<br\x20/>Management\x20of\x20TACO\x20involves\x20discontinuing\x20the\x20transfusion\x20and\x20providing\x20oxygen\x20and\x20diuretics.</p>\x0a<p>Identification\x20of\x20at-risk\x20patients,\x20a\x20<strong>slow\x20transfusion\x20rate</strong>\x20(1\x20PRBC\x20over\x203-4\x20hours),\x20close\x20monitoring,\x20and\x20the\x20use\x20of\x20<strong>diuretics</strong>\x20in\x20hemodynamically\x20stable\x20patients\x20with\x20a\x20history\x20of\x20TACO\x20can\x20prevent\x20TACO.</p>\x0a<p>&nbsp;</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Features&nbsp;</td>\x0a<td>TRALI</td>\x0a<td>TACO</td>\x0a</tr>\x0a<tr>\x0a<td>Body\x20temperature</td>\x0a<td>Fever\x20+</td>\x0a<td>Fever\x20+/-</td>\x0a</tr>\x0a<tr>\x0a<td>Blood\x20pressure</td>\x0a<td>Hypotension</td>\x0a<td>Hypertension</td>\x0a</tr>\x0a<tr>\x0a<td>Respiratory\x20symptoms</td>\x0a<td>Acute\x20dyspnea</td>\x0a<td>Acute\x20dyspnea</td>\x0a</tr>\x0a<tr>\x0a<td>Neck\x20veins</td>\x0a<td>Unchanged</td>\x0a<td>Distended</td>\x0a</tr>\x0a<tr>\x0a<td>Chest\x20radiograph</td>\x0a<td>Diffuse\x20bilateral\x20infiltrates</td>\x0a<td>Diffuse\x20bilateral\x20infiltrates</td>\x0a</tr>\x0a<tr>\x0a<td>Ejection\x20fraction</td>\x0a<td>Normal</td>\x0a<td>Decreased</td>\x0a</tr>\x0a<tr>\x0a<td>Pulmonary\x20edema\x20fluid</td>\x0a<td>Exudate</td>\x0a<td>Transudate</td>\x0a</tr>\x0a<tr>\x0a<td>Fluid\x20balance</td>\x0a<td>Neutral\x20or\x20negative</td>\x0a<td>Positive</td>\x0a</tr>\x0a<tr>\x0a<td>Response\x20to\x20diuretics</td>\x0a<td>Inconsistent</td>\x0a<td>Significant\x20improvement</td>\x0a</tr>\x0a<tr>\x0a<td>White\x20cell\x20count</td>\x0a<td>Transient\x20leukopenia\x20may\x20be\x20present</td>\x0a<td>Unchanged</td>\x0a</tr>\x0a<tr>\x0a<td>BNP</td>\x0a<td>Maybe\x20elevated\x20in\x20critically\x20ill\x20patients\x20with\x20TRALI</td>\x0a<td>Elevated</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<div\x20class=\x22layoutArea\x22>&nbsp;</div>','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','tqVuj','question_images','yMBNS','hfxwd','Gireb','3,\x204\x20and\x205','QeHtY','explanation_audio_hin','EjGuA','VqdGa','toISOString','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','218-medicine-ini-cet-2021-9c011e7f.html','WsVCL','filter','toLowerCase','.m3u8','qRWck','resume','qcXck','GFJWy','PYQ','border-gray-600','XZZuC','dataset','FnDVF','Uahfw','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','2,\x203\x20and\x204','constructor','pbeWS','border-green-500','<p>Doing\x20<strong>EEG</strong>\x20is\x20<strong>not</strong>\x20mandatory\x20for\x20the\x20diagnosis\x20of\x20<strong>seizures</strong>.\x20The\x20diagnosis\x20of\x20a\x20seizure\x20in\x20most\x20cases\x20is\x20based\x20only\x20on\x20<strong>clinical</strong>\x20grounds\x20when\x20examination\x20and\x20laboratory\x20studies\x20are\x20often\x20normal.</p>\x0a<p>All\x20patients\x20who\x20are\x20suspected\x20to\x20have\x20a\x20seizure\x20disorder\x20should\x20be\x20evaluated\x20with\x20an\x20EEG.\x20EEG\x20may\x20provide\x20support\x20to\x20the\x20clinical\x20diagnosis,\x20prognosis,\x20and\x20classification\x20of\x20the\x20seizure\x20disorder.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20Approximately\x201&ndash;5%\x20of\x20the\x20population\x20will\x20have\x20epileptiform\x20discharges\x20on\x20EEG.\x20The\x20presence\x20of\x20epileptiform\x20activity\x20on\x20EEG\x20is\x20not\x20specific\x20to\x20epilepsy.\x20Even\x20in\x20known\x20cases\x20of\x20epilepsy,\x20the\x20routine\x20inter-ictal\x20EEG\x20can\x20be\x20normal\x20in\x2060%\x20of\x20cases.\x20Thus,\x20the\x20EEG\x20cannot\x20establish\x20the\x20diagnosis\x20of\x20epilepsy\x20in\x20many\x20cases.</p>\x0a<p><strong>Option\x20B:</strong>\x20Scalp\x20EEG\x20recording\x20is\x20sometimes\x20helpful\x20in\x20the\x20localization\x20of\x20frontal\x20lobe\x20epilepsy\x20but\x20is\x20usually\x20normal\x20or\x20misleading.\x20When\x20focal\x20seizures\x20arise\x20from\x20regions\x20distant\x20from\x20the\x20scalp\x20such\x20as\x20the\x20inferior\x20frontal\x20lobe\x20or\x20medial\x20temporal\x20lobe,\x20the\x20EEG\x20recorded\x20during\x20the\x20seizure\x20may\x20be\x20non-localizing.</p>\x0a<p><strong>Option\x20D:</strong>\x20Progressive\x20multifocal\x20leukoencephalopathy\x20is\x20a\x20demyelinating\x20disease\x20of\x20the\x20central\x20nervous\x20system\x20due\x20to\x20infection\x20by\x20the\x20John\x20Cunningham\x20virus\x20(JC)\x20virus.\x20Electroencephalography\x20(EEG)\x20is\x20characterized\x20by\x20a\x20slow\x20background\x20activity\x20with\x20triphasic\x20waves\x20and\x20slow\x20waves\x20predominantly\x20in\x20the\x20frontal\x20regions.</p>\x0a<p>Characteristic\x20<strong>EEG\x20findings</strong>\x20in\x20different\x20conditions:</p>\x0a<ul>\x0a<li>Typical\x20<strong>absence</strong>\x20seizures:<strong>\x203-Hz\x20spike-and-slow-wave\x20discharges</strong></li>\x0a<li><strong>Lennox-Gastaut\x20syndrome:</strong>\x20Slow\x20(&lt;3\x20Hz)\x20spike-and-wave\x20discharges</li>\x0a<li><strong>Generalized\x20tonic\x20clonic\x20seizure\x20(GTCS)\x20-</strong>\x20in\x20tonic\x20phase,\x20increasing\x20generalized\x20low-voltage\x20fast\x20activity,\x20followed\x20by\x20high-amplitude,\x20polyspike\x20discharges\x20&amp;\x20in\x20clonic\x20phase\x20a\x20spike-and-slow-wave\x20pattern\x20is\x20seen</li>\x0a<li><strong>Creutzfeldt-Jakob\x20disease:</strong>\x20generalized\x20periodic\x20sharp\x20waves</li>\x0a<li><strong>Hepatic\x20encephalopathy:</strong>\x20triphasic\x20waves</li>\x0a</ul>','xrRPv','In\x20a\x20PHC,\x20which\x20of\x20the\x20following\x20initial\x20screening\x20tests\x20are\x20used\x20to\x20diagnose\x20diabetes?','hierarchy','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','Marrow','Which\x20of\x20the\x20following\x20drugs\x20is\x20preferred\x20in\x20the\x20management\x20of\x20primary\x20progressive\x20multiple\x20sclerosis\x20?','eUFTj','stringify','questionIndex','performanceModal','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','vNyZZ','https://dhmbxeygs57ff.cloudfront.net/uploads/20f8fcfb42a241858420a39210256d38x1280x1083.JPEG','ODPeE','RIvuz','ycLVe','bookmarkBtn','XRhTG','100%\x20oxygen\x20at\x206\x20L/minute','Dycwa','solutionContainer','BRytF','accuracyScore','Thrombolysis','WuDNR','Calcium\x20oxalate','Start\x20ART\x20and\x20then\x20ATT\x20after\x202\x20weeks','mQhXI','incorrect','QSrUd','Atrial\x20fibrillation\x20is\x20common\x20in\x20elderly\x20and\x20is\x20the\x20cause\x20of\x20stroke\x20in\x20quarter\x20of\x20the\x20stroke\x20cases','vtLsZ','aiorN','MwAnI','questionMedia','thaGh','solutionAudio','gray','className','SmCLW','Csqqx','gvdzt','incorrectAnswers','uoDyU','index.html','PiwiQ','Hypoventilation','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','A\x2045-year-old\x20male\x20patient\x20presented\x20with\x20a\x20history\x20of\x20bilateral\x20lower\x20limb\x20weakness\x20which\x20progressed\x20to\x20his\x20upper\x20limbs\x20in\x20a\x20year.\x20On\x20examination,\x20he\x20had\x20weakness\x20in\x20both\x20lower\x20limbs\x20and\x20wasting\x20in\x20the\x20left\x20upper\x20limb.\x20Babinski\x20sign\x20was\x20positive\x20and\x20the\x20deep\x20tendon\x20reflexes\x20were\x20absent.\x20He\x20has\x20no\x20sensory\x20loss\x20or\x20any\x20autonomic\x20dysfunction.\x20What\x20is\x20the\x20likely\x20diagnosis?','OonKw','OQYDN','appendChild','__proto__','tUMXc','\x20-\x20Brain\x20And\x20Scalpel','key','textContent','Start\x20ATT\x20and\x20then\x20ART\x20after\x202\x20weeks','ArrowLeft','search','Cfwsz','custom_quiz.html','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','vWCLf','Epoprostenol','stats','CT\x20angiography\x20to\x20look\x20for\x20large\x20vessel\x20occlusion','target','HLQBg','createElement','All\x20are\x20true\x20regarding\x20heart\x20failure\x20except:','Metastatic\x20breast\x20cancer','alcwn','fgdlv','zZqsX','Which\x20of\x20the\x20following\x20does\x20not\x20show\x20both\x20hyperkinetic\x20and\x20hypokinetic\x20movements?','disabled','KTFph','hJvBg','rEQVd','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','kZEVY','UvdkT','ivYtB','uPePo','kOoix','1\x20and\x204\x20correct','gxICV','Ventilation/Perfusion\x20mismatch','Treatment\x20of\x20choice\x20for\x20an\x20acute\x20attack\x20of\x20cluster\x20headache\x20is\x20:','KeuqR','rClAK','return\x20(function()\x20','PJsEu','IxETr','endsWith','contains','HNwfF','reviewQuestionsContainer','NCzXg','ygpZF','294029vGEBGc','<p>In\x20<strong>SIADH</strong>,\x20the\x20kidneys\x20retain\x20water,\x20leading\x20to<strong>\x20volume\x20expansion</strong>\x20and\x20<strong>natriuresis</strong>.\x20Therefore,\x20urinary\x20sodium\x20levels\x20are\x20typically\x20<strong>higher</strong>\x20<strong>than\x2020\x20mEq/L.</strong></p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20B:</strong>\x20SIADH\x20is\x20a\x20condition\x20where\x20there\x20is\x20an\x20inappropriate\x20release\x20of\x20antidiuretic\x20hormone\x20(ADH),\x20leading\x20to\x20impaired\x20water\x20excretion\x20and\x20dilutional\x20hyponatremia.</p>\x0a<p><strong>Option\x20C:</strong>\x20ADH\x20promotes\x20the\x20reabsorption\x20of\x20water\x20and\x20not\x20the\x20solutes\x20resulting\x20in\x20concentrated\x20urine.\x20This\x20is\x20depicted\x20as\x20high\x20urine\x20osmolality.</p>\x0a<p><strong>Option\x20D:</strong>\x20Patients\x20can\x20be\x20hypervolemic\x20due\x20to\x20water\x20retention.\x20However,\x20persistently\x20elevated\x20ADH\x20levels\x20can\x20induce\x20vasopressin\x20escape\x20mechanism,\x20resulting\x20in\x20the\x20typical\x20euvolemic\x20status.</p>\x0a<p>Patients\x20usually\x20present\x20with\x20<strong>hyponatremia</strong>\x20with\x20a\x20<strong>euvolemic</strong>\x20status.</p>\x0a<p><strong>Acute\x20hyponatremia</strong>\x20may\x20present\x20with\x20mild\x20headache,\x20confusion,\x20anorexia,\x20nausea,\x20vomiting,\x20coma,\x20and\x20convulsions.</p>\x0a<p><strong>Chronic\x20hyponatremia</strong>\x20allows\x20cerebral\x20adaptation,\x20and\x20the\x20patients\x20are\x20asymptomatic\x20despite\x20the\x20hyponatremia.</p>\x0a<p>Laboratory\x20findings\x20in\x20<strong>SIADH</strong>\x20include:</p>\x0a<ul>\x0a<li>Hyponatremia:\x20serum\x20Na+&lt;135\x20mEq/L</li>\x0a<li>Urinary\x20Na+\x20&gt;25\x20mEq/L\x20</li>\x0a<li>Urine\x20osmolality\x20&gt;100\x20mOsm/kg</li>\x0a<li>Blood\x20urea\x20nitrogen\x20(BUN)\x20levels\x20are\x20low,\x20usually\x20&lt;10\x20mg/dL</li>\x0a<li>Serum\x20urate\x20is\x20low</li>\x0a<li>Serum\x20K+\x20and\x20serum\x20bicarbonate\x20are\x20normal</li>\x0a</ul>\x0a<p><strong>Mild\x20and\x20symptomatic\x20hyponatremia</strong>\x20can\x20be\x20managed\x20by\x20<strong>restricting\x20fluid\x20intake.</strong></p>\x0a<p><strong>Severe,\x20symptomatic</strong>\x20hyponatremia\x20can\x20be\x20corrected\x20using\x20<strong>hypertonic</strong>\x20<strong>saline</strong>\x20or\x20<strong>vasopressin\x20receptor-2\x20antagonists</strong>\x20(tolvaptan\x20and\x20conivaptan).</p>\x0a<p>Other\x20drugs\x20which\x20are\x20useful\x20in\x20the\x20management\x20are\x20demeclocycline\x20and\x20fludrocortisone.</p>','avgTimeResult','JNmqe','A\x2050-year-old\x20man\x20suddenly\x20developed\x20right-sided\x20weakness\x20and\x20aphasia\x20within\x202\x20hours.\x20His\x20BP\x20recorded\x20was\x20160/110mmHg\x20and\x20NCCT\x20was\x20clear.\x20What\x20is\x20the\x20next\x20step\x20in\x20\x20management?','aZQHy','4|0|3|2|5|1','Which\x20of\x20the\x20following\x20conditions\x20is\x20associated\x20with\x20hypokalemic\x20metabolic\x20alkalosis\x20with\x20hypertension?','GlFtZ','src','info','Which\x20of\x20the\x20following\x20is\x20not\x20a\x20major\x20diagnostic\x20criterion\x20of\x20neuromyelitis\x20optica?','GBS','FbAhl','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','replace','SNEYp','exception','<p>Among\x20the\x20given\x20options,\x20<strong>subcutaneous\x20injection</strong>\x20of\x20<strong>sumatriptan</strong>\x20<strong>(6\x20mg)</strong>\x20is\x20used\x20in\x20the\x20treatment\x20of\x20an\x20<strong>acute\x20attack\x20</strong>of<strong>\x20cluster\x20headache.</strong></p>\x0a<p>The\x20<strong>treatment\x20of\x20choice</strong>\x20for\x20an\x20acute\x20attack\x20of\x20cluster\x20headache\x20is\x20<strong>100\x20%\x20oxygen</strong>\x20at\x20<strong>10-12\x20L\x20/min.</strong>\x20High\x20flow\x20and\x20high\x20oxygen\x20content\x20are\x20important.\x20100\x20%\x20oxygen\x20at\x20<strong>6\x20or\x208\x20L/min\x20(Options\x20C\x20and\x20D)</strong>\x20is\x20<strong>insufficient</strong>.</p>\x0a<p><strong>Oral\x20sumatriptan\x20(Option\x20A)</strong>\x20is\x20<strong>not</strong>\x20effective\x20for\x20the\x20treatment\x20of\x20acute\x20attack\x20of\x20cluster\x20headaches.</p>\x0a<p><strong>Sumatriptan\x20(20\x20mg)</strong>\x20and\x20<strong>zolmitriptan\x20(5\x20mg)</strong>\x20<strong>nasal\x20spray</strong>\x20and\x20noninvasive\x20vagus\x20nerve\x20stimulation\x20(nVNS)\x20can\x20also\x20be\x20used\x20for\x20the\x20treatment\x20of\x20acute\x20episodes\x20of\x20cluster\x20headaches.</p>\x0a<p><strong>Cluster\x20headache</strong>\x20is\x20a\x20rare\x20primary\x20headache\x20characterized\x20by\x20daily\x20attacks\x20of\x20short-duration\x20unilateral\x20headaches\x20lasting\x20<strong>8-10\x20weeks</strong>\x20a\x20year.\x20It\x20presents\x20as\x20severe,\x20brief\x20(15-180\x20minutes)\x20<strong>unilateral\x20retro-orbital\x20pain</strong>\x20with\x20autonomic\x20features,\x20such\x20as\x20unilateral\x20<strong>lacrimation</strong>,\x20<strong>nasal\x20congestion</strong>,\x20and\x20<strong>conjunctival</strong>\x20<strong>injection</strong>.\x20Patients\x20are\x20usually\x20perfectly\x20well\x20in\x20between\x20episodes.<br\x20/><br\x20/><strong>Verapamil</strong>\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>prophylaxis</strong>.\x20Other\x20drugs\x20used\x20are\x20prednisone,\x20topiramate,\x20lithium,\x20gabapentin,\x20melatonin,\x20and\x20greater\x20occipital\x20nerve\x20injection\x20with\x20lidocaine\x20and\x20glucocorticoids.</p>','MfluN','JhOkB','parse','ScpPg','Area\x20postrema\x20syndrome','KHZcj','fJVaH','<p><strong>Huntington\x27s\x20disease\x20</strong>(formerly\x20known\x20as\x20Huntington&rsquo;s\x20chorea)\x20is\x20a<strong>\x20movement\x20disorder</strong>\x20that\x20shows\x20predominantly\x20only\x20<strong>hyperkinetic\x20movements</strong>\x20like\x20chorea.</p>\x0a<p>Hyperkinetic\x20movement\x20disorders\x20include\x20tremor,\x20dystonia,\x20athetosis,\x20chorea,\x20myoclonus,\x20and\x20tics.\x20Hypokinetic\x20movements\x20include\x20rigidity,\x20stiffness,\x20and\x20bradykinesia.</p>\x0a<p>Huntington\x27s\x20disease\x20is\x20a\x20<strong>degenerative</strong>\x20disease\x20of\x20the\x20<strong>caudate</strong>\x20<strong>nucleus</strong>\x20and\x20<strong>putamen</strong>\x20(striate\x20neurons)\x20caused\x20by\x20a\x20<strong>trinucleotide\x20repeat\x20(CAG)</strong>\x20in\x20the\x20Huntingtin\x20gene\x20on\x20<strong>chromosome\x204.</strong>\x20It\x20is\x20inherited\x20in\x20an<strong>\x20autosomal\x20dominant</strong>\x20pattern\x20and\x20is\x20characterized\x20by\x20chorea,\x20dysarthria,\x20gait\x20disturbance,\x20behavioral\x20disturbance\x20and\x20cognitive\x20impairment\x20with\x20dementia.\x20The\x20clinical\x20manifestations\x20increase\x20in\x20severity\x20with\x20each\x20successive\x20generation\x20<strong>(anticipation).</strong>\x20Treatment\x20includes\x20<strong>haloperidol,\x20</strong>and<strong>\x20tetrabenazine.</strong></p>\x0a<p>With\x20advancing\x20disease,\x20a\x20reduction\x20in\x20chorea\x20may\x20be\x20seen\x20along\x20with\x20the\x20emergence\x20of\x20dystonia,\x20rigidity,\x20myoclonus,\x20and\x20bradykinesia.\x20It\x20can\x20also\x20have\x20an\x20akinetic,\x20rigid,\x20or\x20Parkinsonian\x20presentation\x20in\x20younger\x20patients\x20(~10%\x20of\x20cases)\x20known\x20as\x20the\x20Westphal\x20variant.\x20However,\x20the\x20typical\x20presentation\x20of\x20Huntington\x27s\x20disease\x20is\x20characterized\x20by\x20hyperkinetic\x20movements\x20like\x20<strong>chorea</strong>.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20Parkinson\x27s\x20disease\x20is\x20characterized\x20by\x20both\x20hyperkinetic\x20(resting\x20tremor)\x20and\x20hypokinetic\x20(rigidity,\x20stiffness,\x20bradykinesia)\x20movements.</p>\x0a<p><strong>Option\x20B:</strong>\x20The\x20neurological\x20manifestations\x20in\x20Wilson\x27s\x20disease\x20occur\x20due\x20to\x20damage\x20of\x20basal\x20ganglia\x20resulting\x20in\x20dystonia\x20and\x20tremor\x20(hyperkinetic),\x20parkinsonism\x20with\x20bradykinesia\x20(hypokinetic),\x20incoordination,\x20dysarthria,\x20and\x20dysphagia.\x20In\x20advanced\x20disease,\x20the\x20tremor\x20progresses\x20to\x20a\x20characteristic\x20wing-beating\x20flapping\x20tremor.</p>\x0a<p><strong>Option\x20C:</strong>\x20Pantothenate\x20kinase-associated\x20neurodegeneration\x20(PKAN)\x20formerly\x20known\x20as\x20Hallervorden-Spatz\x20disease\x20caused\x20by\x20PANK2\x20gene\x20mutation\x20is\x20the\x20most\x20common\x20form\x20of\x20Neurodegeneration\x20with\x20Brain\x20Iron\x20Accumulation\x20(NBIA)\x20and\x20is\x20manifested\x20as\x20a\x20combination\x20of\x20dystonia\x20(hyperkinetic),\x20parkinsonism\x20(hypokinetic),\x20and\x20spasticity.\x20T2W-MRI\x20shows\x20the\x20characteristic\x20eye\x20of\x20the\x20tiger\x20sign\x20due\x20to\x20iron\x20accumulation\x20in\x20globus\x20pallidus.</p>','rbqrD','ICIOF','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','incomplete','NaPPD','NcVNg','data-option-index','EjUhs','9XbReOs','\x22\x20data-option-index=\x22','totalTime','location','GppwY','FEpyi','HWxUM','length','A\x2062-year-old\x20male\x20patient\x20with\x20heart\x20failure\x20is\x20scheduled\x20for\x20a\x20heart\x20transplant.\x20His\x20renal\x20function\x20test\x20is\x20deranged\x20and\x20hemoglobin\x20is\x206\x20gm%.\x20The\x20physician\x20ordered\x202\x20units\x20of\x20whole\x20blood.\x20Four\x20hours\x20after\x20transfusion,\x20he\x20developed\x20severe\x20respiratory\x20distress.\x20On\x20examination,\x20he\x20is\x20hypoxemic,\x20\x20has\x20tachycardia\x20and\x20his\x20mean\x20arterial\x20pressure\x20is\x20elevated.\x20Which\x20of\x20the\x20following\x20are\x20the\x20best\x20investigations\x20for\x20the\x20above\x20scenario?','question_video','An\x20elderly\x20woman\x20presented\x20with\x20symptoms\x20of\x20confusion,\x20thirst,\x20and\x20abdominal\x20pain.\x20On\x20examination,\x20she\x20had\x20pallor\x20and\x20thoracic\x20spine\x20tenderness.\x20X-ray\x20spine\x20showed\x20osteolytic\x20lesions.\x20Her\x20lab\x20investigations\x20showed\x20the\x20following\x20findings.\x20\x20What\x20is\x20the\x20most\x20likely\x20diagnosis?','rIJsG','totalQuestions','YfaHp','bookmarked','TkXcb','addEventListener','correctCount','yzfPO','qQQsO','lUuXU','button','1,\x202','ctxxS','RXMKm','dSXZQ','vGVwV','qjGSO','1,\x202,\x203,\x204','Primary\x20hyperparathyroidism','accuracy','SgtXu','dvSrF','oPhdt','Natalizumab','CUcNH','fvRSR','markReviewBtn','Estsx','join','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','NewrR','currentQuestionIndex','uuHdo','ALS','KAcxl','ezNks','5|0|1|3|4|2','correct','submitSection','nPrae','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','XEiMS','reduce','questionNav','Identify\x20the\x20urinary\x20crystal\x20shown\x20below:','nav-btn-correct','answered','EUHLb','GiCcl','https://dhmbxeygs57ff.cloudfront.net/uploads/0adba9b55d634cd08f5e15ab97dd37fbx1279x967.JPEG','getItem','eIfuD','OWpvG','ZbAFa','kIDhP','jonVx','A\x20patient\x20presented\x20with\x20sinusitis,\x20ulcerative\x20lesions\x20on\x20the\x20nasopharynx,\x20nodular\x20lesions\x20with\x20cavitations\x20of\x20the\x20lung,\x20and\x20renal\x20failure.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20useful\x20investigation\x20in\x20this\x20patient?','TiQCz','dgaFj','VbFyw','LrHjR','CCJmF','zmyDi','round','</span><span>','quizHierarchy','tbyCw','Which\x20of\x20the\x20following\x20is\x20not\x20true\x20about\x20syndrome\x20of\x20inappropriate\x20antidiuretic\x20hormone\x20secretion\x20(SIADH)?','xbHWi','fill','totalQuestionsResult','vPeUr','getElementById','EqZzE','text','100%\x20oxygen\x20at\x208\x20L/minute','eIkdq','AftJP','padStart','liIDi','VHtPR','click','1555393JCzDSY','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Focal\x20epilepsy','strokeDashoffset','mynwM','YJxBh','CoaSv','QskwH','TJorg','Liddle\x20syndrome','CqYLL','ckGAO','closest','classList','iVSQI','Aspergillus\x20niger\x20-\x20Voriconazole','PQIvo','floor','JkflO','questionStates','VJbtN','kgirq','<p>The\x20given\x20clinical\x20scenario\x20describes\x20an\x20<strong>elderly</strong>\x20woman\x20with<strong>\x20confusion,\x20thirst\x20</strong>and<strong>\x20abdominal\x20pain</strong>\x20along\x20with\x20elevated\x20serum\x20calcium\x20levels\x20(<strong>hypercalcemia</strong>),\x20elevated\x20creatinine\x20suggestive\x20of\x20<strong>renal\x20failure,\x20anemia</strong>\x20and\x20<strong>osteolytic</strong>\x20bone\x20lesions<strong>\x20(CRAB\x20features);</strong>\x20and\x20<strong>hypoalbuminemia</strong>\x20with\x20<strong>elevated\x20total\x20proteins.</strong>\x20The\x20most\x20likely\x20diagnosis\x20is<strong>\x20multiple\x20myeloma\x20(MM).</strong></p>\x0a<p>MM\x20is\x20a\x20<strong>malignant\x20plasma\x20cell\x20dyscrasia</strong>\x20with\x20the\x20proliferation\x20of\x20plasma\x20cells\x20derived\x20from\x20a\x20single\x20clone.\x20It\x20is\x20associated\x20with\x20increased\x20osteoclast\x20activity\x20with\x20suppression\x20of\x20osteoblast\x20activity,\x20causing\x20<strong>punched-out\x20lytic</strong>\x20lesions\x20in\x20the\x20bone\x20and\x20hypercalcemia.</p>\x0a<p>Signs\x20and\x20symptoms\x20include\x20bone\x20pain\x20(most\x20common),\x20pathological\x20fractures,\x20recurrent\x20bacterial\x20infections,\x20normocytic\x20normochromic\x20anemia,\x20elevated\x20ESR,\x20and\x20normal\x20ALP.</p>\x0a<p>Electrophoresis\x20shows\x20<strong>monoclonal\x20elevation</strong>\x20of\x20one\x20immunoglobulin\x20<strong>(M\x20spike)</strong></p>\x0a<p>Urine\x20analysis\x20shows\x20free\x20kappa\x20&amp;\x20lambda\x20light\x20chains\x20<strong>(Bence\x20Jones\x20proteins)</strong></p>\x0a<p>Peripheral\x20smear\x20shows\x20<strong>rouleaux</strong>\x20formation.</p>\x0a<p>The\x20diagnosis\x20of\x20MM\x20is\x20made\x20by\x20using\x20the<strong>\x20Revised\x20International\x20Myeloma\x20Working\x20Group\x20criteria.</strong></p>\x0a<p>Clonal\x20bone\x20marrow\x20plasma\x20cells<strong>\x20&ge;10%</strong>\x20(or)\x20Biopsy-proven\x20bony\x20or\x20extramedullary\x20plasmacytoma\x20and\x20any\x20one\x20or\x20more\x20of\x20the\x20following\x20myeloma-defining\x20events\x20is\x20required\x20to\x20meet\x20the\x20criteria:</p>\x0a<p>Evidence\x20of\x20end-organ\x20damage\x20attributable\x20to\x20the\x20underlying\x20plasma\x20cell\x20proliferative\x20disorder,\x20specifically:\x20<strong>(CRAB\x20features)</strong></p>\x0a<ul>\x0a<li><strong>Hypercalcemia</strong>:\x20Serum\x20calcium\x20level\x20&gt;1\x20mg/dL\x20higher\x20than\x20the\x20upper\x20limit\x20of\x20normal\x20or\x20&gt;11\x20mg/dL</li>\x0a<li><strong>Renal\x20insufficiency:</strong>\x20Creatinine\x20clearance\x20&lt;40\x20mL/min\x20or\x20serum\x20creatinine\x20&gt;2\x20mg/dL</li>\x0a<li><strong>Anemia:</strong>\x20Hemoglobin\x20level\x20of\x20&gt;20\x20g/L\x20(2gm/dl)\x20below\x20the\x20lowest\x20limit\x20of\x20normal,\x20or\x20Hb\x20&lt;10\x20g/dL</li>\x0a<li><strong>Bone\x20lesions</strong>:\x20One\x20or\x20more\x20osteolytic\x20lesions\x20on\x20skeletal\x20radiography,\x20computed\x20tomography\x20(CT),\x20or\x20positron\x20emission\x20tomography\x20(PET-CT).</li>\x0a</ul>\x0a<p>Any\x20<strong>one\x20or\x20more</strong>\x20of\x20the\x20following\x20biomarkers\x20of\x20malignancy:</p>\x0a<ul>\x0a<li>Clonal\x20bone\x20marrow\x20plasma\x20cells\x20&ge;60%</li>\x0a<li>Serum\x20involved/uninvolved\x20free\x20light-chain\x20ratio\x20of\x20100\x20or\x20greater</li>\x0a<li>&gt;1\x20focal\x20lesion\x20on\x20magnetic\x20resonance\x20imaging\x20(MRI)\x20that\x20is\x20at\x20least\x205\x20mm\x20or\x20greater\x20in\x20size.</li>\x0a</ul>\x0a<p><strong>Treatment</strong>\x20includes\x20a\x20combination\x20of\x20<strong>lenalidomide/thalidomide</strong>\x20(immunomodulatory\x20agents),\x20<strong>bortezomib</strong>\x20(proteasome\x20inhibitor),\x20and\x20<strong>dexamethasone</strong>.</p>\x0a<p><strong>International\x20Staging\x20System\x20</strong>(ISS)\x20is\x20used\x20for\x20assessing\x20<strong>prognosis</strong>\x20in\x20multiple\x20myeloma\x20patients.<strong>\x20Serum\x20&beta;2-microglobulin</strong>\x20is\x20the\x20most\x20important\x20prognostic\x20marker.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20The\x20bony\x20metastasis\x20in\x20breast\x20carcinoma\x20is\x20usually\x20osteolytic.\x20However,\x20CRAB\x20features,\x20hypoalbuminemia,\x20and\x20elevated\x20total\x20protein\x20suggest\x20multiple\x20myeloma.</p>\x0a<p><strong>Option\x20C:</strong>\x20Primary\x20hyperparathyroidism\x20is\x20characterized\x20by\x20hypercalcemia\x20and\x20low\x20phosphorus\x20but\x20is\x20not\x20associated\x20with\x20anemia\x20and\x20hypoalbuminemia.</p>\x0a<p><strong>Option\x20D:</strong>\x20Milk-alkali\x20syndrome\x20occurs\x20after\x20ingestion\x20of\x20large\x20amounts\x20of\x20calcium\x20and\x20vitamin\x20D\x20supplementation.\x20It\x20results\x20in\x20hypercalcemia,\x20alkalosis,\x20nephrocalcinosis,\x20and\x20nephrolithiasis.</p>','1,\x20\x202,\x204','pathname','EZKwh','SHOPI','Previous\x20progress\x20cleared.','oQWoe','testModeLegend','<p>Focal\x20epilepsy\x20is\x20<strong>not</strong>\x20considered\x20a\x20major\x20diagnostic\x20criterion\x20of\x20<strong>neuromyelitis\x20optica\x20(NMO).</strong></p>\x0a<p><strong>Neuromyelitis\x20optica\x20(Devic&rsquo;s\x20disease)</strong>\x20is\x20an\x20aggressive\x20inflammatory\x20<strong>demyelinating</strong>\x20disorder\x20characterized\x20by\x20<strong>recurrent</strong>\x20attacks\x20of\x20<strong>optic\x20neuritis\x20and\x20myelitis.</strong></p>\x0a<p>It\x20is\x20associated\x20with\x20a\x20highly\x20specific\x20autoantibody\x20directed\x20against\x20<strong>aquaporin-4(AQP-4).</strong>\x20AQP-4\x20is\x20localized\x20to\x20the\x20<strong>foot</strong>\x20<strong>processes</strong>\x20of\x20astrocytes\x20in\x20close\x20proximity\x20to\x20endothelial\x20surfaces.</p>\x0a<p>The\x20core\x20clinical\x20characteristics\x20include\x20optic\x20neuritis,\x20acute\x20myelitis,\x20area\x20postrema\x20syndrome\x20(unexplained\x20hiccups/\x20nausea/\x20vomiting),\x20acute\x20brainstem\x20syndrome,\x20symptomatic\x20narcolepsy\x20or\x20acute\x20diencephalic\x20clinical\x20syndrome\x20with\x20<strong>Neuromyelitis\x20Optica\x20Spectrum\x20Disorder\x20(NMOSD)-</strong>typical\x20diencephalic\x20MRI\x20lesions,\x20and\x20symptomatic\x20cerebral\x20syndrome\x20with\x20NMSOD-typical\x20brain\x20lesions.</p>\x0a<p>Attacks\x20of\x20optic\x20neuritis\x20are\x20bilateral\x20and\x20severe\x20in\x20NMO,\x20whereas\x20in\x20multiple\x20sclerosis\x20(MS)\x20optic\x20neuritis\x20is\x20usually\x20unilateral.\x20Progressive\x20symptoms\x20are\x20not\x20typical\x20of\x20NMO,\x20unlike\x20in\x20MS.\x20CSF\x20findings\x20in\x20NMO\x20show\x20higher\x20pleocytosis,\x20with\x20neutrophils\x20and\x20eosinophils\x20in\x20acute\x20cases,\x20and\x20rare\x20occurrence\x20of\x20oligoclonal\x20bands,\x20distinguishing\x20it\x20from\x20MS.</p>\x0a<p>Acute\x20attacks\x20of\x20NMO\x20are\x20treated\x20with\x20<strong>high-dose\x20glucocorticoids.</strong>\x20<strong>Plasma\x20exchange</strong>\x20can\x20be\x20used\x20in\x20acute\x20attacks\x20that\x20do\x20not\x20respond\x20to\x20glucocorticoids.</p>\x0a<p>Drugs\x20used\x20for\x20<strong>prophylaxis</strong>\x20against\x20relapses\x20include\x20<strong>mycophenolate\x20mofetil,\x20rituximab,\x20glucocorticoids,\x20</strong>and<strong>\x20azathioprine.</strong>\x20Three\x20monoclonal\x20antibodies\x20approved\x20for\x20attack\x20prevention\x20include\x20<strong>eculizumab</strong>\x20(terminal\x20complement\x20inhibitor),\x20<strong>inebilizumab</strong>\x20(B-cell\x20depleter),\x20and\x20<strong>satralizumab</strong>\x20(IL-6\x20receptor\x20blocker).</p>\x0a<p>NMO\x20typically\x20presents\x20as\x20a\x20recurrent\x20disease,\x20with\x20a\x20monophasic\x20course\x20observed\x20in\x20less\x20than\x2010%\x20of\x20patients.\x20Untreated\x20NMO\x20can\x20lead\x20to\x20disability,\x20including\x20respiratory\x20failure,\x20blindness,\x20and\x20limb\x20paralysis.\x20</p>','218\x20Medicine\x20Ini-Cet\x202021','Acute\x20Myelitis','ujLvk','Bartter\x20syndrome','true','Wilson\x27s\x20disease','aduUy','width','CYyHQ','udsPe','mbwtF','NTfRy','No\x20questions\x20available\x20for\x20this\x20quiz.','Option\x20','notAttempted','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','A\x2060-year-old\x20male\x20patient\x20with\x20critical\x20mitral\x20stenosis\x20presented\x20with\x20atrial\x20fibrillation.\x20He\x20has\x20a\x20history\x20of\x20multiple\x20episodes\x20of\x20transient\x20ischemic\x20attacks.\x20Which\x20of\x20the\x20following\x20are\x20true\x20regarding\x20the\x20prevention\x20of\x20stroke\x20in\x20this\x20patient?','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','solutionVideo','get','completed','QJijG','A\x20patient\x20came\x20with\x20hypoxemia\x20and\x20a\x20normal\x20alveolar-arterial\x20oxygen\x20gradient.\x20What\x20can\x20be\x20the\x20cause?','nav-btn-marked-review','<p>The\x20given\x20clinical\x20scenario\x20of\x20a\x20female\x20patient\x20presenting\x20with\x20<strong>weight\x20loss,</strong>\x20<strong>palpitations</strong>,\x20<strong>exophthalmos</strong>,\x20and\x20diffusely\x20<strong>enlarged\x20thyroid</strong>\x20gland\x20is\x20suggestive\x20of\x20<strong>Graves\x27\x20disease</strong>.</p>\x0a<p>The\x20essential\x20investigations\x20in\x20this\x20patient\x20would\x20be\x20<strong>thyroid\x20function\x20tests,</strong>\x20<strong>ultrasound</strong>\x20of\x20the\x20neck,\x20thyroid\x20<strong>scan</strong>,\x20and\x20<strong>anti-thyroid\x20antibody.</strong>\x20FNAC\x20is\x20not\x20an\x20essential\x20investigation\x20in\x20this\x20condition.\x20<strong>FNAC</strong>\x20should\x20be\x20done\x20on\x20nodules\x20that\x20are\x20not\x20classified\x20as\x20fully\x20benign\x20on\x20ultrasound.</p>\x0a<p>The\x20hyperthyroidism\x20of\x20Graves&rsquo;\x20disease\x20is\x20caused\x20by\x20<strong>thyroid-stimulating\x20immunoglobulin</strong>\x20(TSI)\x20synthesized\x20by\x20lymphocytes\x20in\x20the\x20thyroid\x20gland\x20as\x20well\x20as\x20in\x20bone\x20marrow\x20and\x20lymph\x20nodes.\x20TSI\x20antibodies\x20cause\x20stimulation\x20of\x20the\x20thyroid\x20gland\x20causing\x20features\x20of\x20hyperthyroidism.</p>\x0a<p>Symptoms\x20include\x20hyperactivity,\x20heat\x20intolerance,\x20sweating,\x20palpitations,\x20weakness,\x20weight\x20loss,\x20increased\x20appetite,\x20and\x20diarrhea.</p>\x0a<p>Signs\x20include\x20tachycardia,\x20goiter,\x20tremor,\x20muscle\x20weakness,\x20and\x20atrial\x20fibrillation\x20in\x20the\x20elderly.</p>\x0a<p><strong>Thyroid\x20ophthalmopathy</strong>\x20seen\x20in\x20one-third\x20of\x20patients\x20with\x20Grave&rsquo;s\x20disease.</p>\x0a<p><strong>NO\x20SPECS\x20scoring\x20system</strong>\x20as\x20describe\x20below\x20can\x20be\x20used\x20to\x20evaluate\x20ophthalmopathy.</p>\x0a<ul>\x0a<li><strong>N</strong>o\x20signs\x20or\x20symptoms</li>\x0a<li><strong>O</strong>nly\x20signs\x20(lid\x20retraction,\x20or\x20lag)</li>\x0a<li><strong>S</strong>oft\x20tissue\x20involvement\x20(periorbital\x20edema)</li>\x0a<li><strong>P</strong>roptosis</li>\x0a<li><strong>E</strong>xtraocular\x20muscle\x20involvement</li>\x0a<li><strong>C</strong>orneal\x20involvement</li>\x0a<li><strong>S</strong>ight\x20loss</li>\x0a</ul>\x0a<p><strong>Thyroid\x20dermopathy</strong>\x20usually\x20occurs\x20in\x20the\x20presence\x20of\x20moderate\x20or\x20severe\x20ophthalmopathy.\x20It\x20primarily\x20manifests\x20as\x20noninflamed,\x20indurated\x20plaques\x20with\x20a\x20deep\x20pink\x20or\x20purple\x20color\x20and\x20an<strong>\x20\x22orange\x20skin\x22\x20appearance,</strong>\x20commonly\x20found\x20on\x20the\x20anterior\x20and\x20lateral\x20aspects\x20of\x20the\x20lower\x20leg\x20(known\x20as\x20<strong>pretibial\x20myxedema).</strong></p>\x0a<p>Investigations\x20done\x20in\x20a\x20patient\x20with\x20Graves\x27\x20disease\x20include:</p>\x0a<ul>\x0a<li><strong>Thyroid\x20function\x20tests-</strong>\x20TSH\x20levels\x20are\x20decreased\x20with\x20or\x20without\x20elevated\x20T3\x20and\x20T4\x20levels.</li>\x0a<li><strong>Anti-thyroid\x20antibodies-</strong>\x20Elevated\x20levels\x20of\x20TSH\x20receptor\x20antibodies\x20are\x20diagnostic\x20of\x20Graves\x27\x20disease.\x20Other\x20antibodies\x20like\x20anti-Tg\x20and\x20anti-TPO\x20are\x20elevated\x20in\x20most\x20of\x20the\x20patients.</li>\x0a<li><strong>Ultrasound</strong>\x20of\x20the\x20neck\x20is\x20performed\x20to\x20evaluate\x20vascularity,\x20echogenicity,\x20nodules,\x20and\x20clinical\x20landmarks\x20for\x20surgical\x20planning.</li>\x0a<li>A\x20<strong>radioactive\x20iodine\x20uptake\x20(RAIU)\x20scan</strong>\x20(thyroid\x20scan)\x20should\x20be\x20performed\x20and\x20a\x20diffuse\x20uptake\x20confirms\x20the\x20diagnosis\x20of\x20Graves\x27\x20disease.\x20It\x20is\x20also\x20useful\x20to\x20differentiate\x20TSI-negative\x20Graves\x20disease\x20from\x20toxic\x20nodular\x20disease\x20based\x20on\x20diffuse\x20or\x20nodular\x20uptake\x20patterns.</li>\x0a<li><strong>CT\x20or\x20MRI</strong>\x20scans\x20of\x20the\x20orbits\x20are\x20useful\x20to\x20evaluate\x20Graves&rsquo;\x20ophthalmopathy.</li>\x0a</ul>\x0a<p>Hyperthyroidism\x20can\x20be\x20treated\x20by\x20<strong>antithyroid</strong>\x20<strong>drugs</strong>,\x20r<strong>adioiodine\x20treatment\x20(I131)</strong>,\x20or\x20<strong>thyroidectomy</strong>.</p>','RMHgO','KSADz','uGPxU','No\x20solution\x20provided','jIvqv','explanation_audio_eng','yrPyV','Ambrisentan','TTPkD','RlzVe','TjEwN','vVyjz','GoDYr','2\x20and\x203','OMxLO','selectedAnswer','reload','CjIGt','MfHbj','rVjaq','hQveN','2\x20and\x204','choices','strokeDasharray','nIchm','modeModal','Nifedipine','IbHzB','Medicine','SpKUF','EqfDl','mgvpp','</span></div>','Oral\x20sumatriptan','push','tAOfz','canPlayType','customQuizData','markedForReview','sPoDM','AoLEN','nav-btn-current','qsjLN','avWGB','banCb','lFfup','bzmtc','Cysteine','test','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','isSupported','Regardless\x20of\x20ejection\x20fraction\x20and\x20the\x20type\x20of\x20heart\x20failure,\x20the\x205\x20year\x20mortality\x20rate\x20is\x20around\x2050%','href','bookmarkText','SMLPW','VMtrL','mUVuH','incorrectResult','AuOaL','tkGyT','Neurodegeneration\x20with\x20Brain\x20Iron\x20Accumulation','Alveolar\x20membrane\x20damage','<div\x20class=\x22mt-4\x22><img\x20src=\x22','zfjXB','{}.constructor(\x22return\x20this\x22)(\x20)','apply','LhGEe','<p><strong>Liddle\x27s\x20syndrome&nbsp;</strong>is\x20associated\x20with\x20<strong>hypokalemic</strong>\x20metabolic\x20<strong>alkalosis</strong>\x20with\x20<strong>hypertension.</strong></p>\x0a<p>It\x20is\x20an\x20<strong>autosomal\x20dominant</strong>\x20condition\x20due\x20to\x20a\x20<strong>gain\x20of\x20function\x20mutation</strong>\x20in\x20the\x20<strong>ENaC\x20gene,</strong>\x20which\x20codes\x20for\x20the\x20<strong>epithelial\x20sodium\x20channels</strong>\x20present\x20in\x20the\x20kidney.\x20</p>\x0a<p><strong>Hypertension</strong>\x20is\x20the\x20result\x20of\x20increased\x20sodium\x20retention\x20through\x20<strong>ENaC\x20channel</strong>\x20and\x20<strong>volume\x20expansion.</strong>\x20Volume\x20expansion\x20suppresses\x20renin\x20and\x20aldosterone\x20secretion,\x20leading\x20to<strong>\x20hypokalemic\x20metabolic\x20alkalosis.</strong></p>\x0a<p\x20class=\x22p1\x22>Treatment\x20is\x20with\x20diuretics\x20that\x20directly\x20block\x20the\x20ENaC\x20channels,\x20like&nbsp;<strong>amiloride</strong>&nbsp;and\x20<strong>triamterene.\x20</strong>Spironolactone\x20is\x20not\x20effective\x20as\x20it\x20is\x20an\x20aldosterone-receptor\x20antagonist.</p>\x0a<p\x20class=\x22p1\x22>Other\x20options:</p>\x0a<p\x20class=\x22p1\x22>Option\x20A:\x20<strong>Bartter\x20syndrome</strong>\x20is\x20an\x20<strong>autosomal\x20recessive</strong>\x20disorder\x20occurring\x20due\x20to\x20defects\x20in\x20various\x20genes\x20involved\x20in\x20the\x20regulated\x20<strong>Na+,\x20K+,\x20and\x20Cl&ndash;</strong>\x20transport\x20by\x20the\x20<strong>thick\x20ascending\x20loop\x20of\x20Henle.</strong>\x20There\x20is\x20extracellular\x20fluid\x20volume\x20depletion\x20with\x20low\x20or\x20normal\x20blood\x20pressure.\x20It\x20is\x20characterized\x20by\x20metabolic\x20alkalosis,\x20hypokalemia,\x20hypochloremia,\x20and\x20hypercalciuria.</p>\x0a<p\x20class=\x22p1\x22><br\x20/>Option\x20C:\x20<strong>Gitelman\x20syndrome</strong>\x20is\x20an<strong>\x20autosomal\x20recessive</strong>\x20disorder\x20due\x20to\x20a\x20loss\x20of\x20function\x20mutation\x20in\x20the\x20thiazide-sensitive\x20<strong>Na+-Cl&ndash;\x20cotransporter</strong>\x20of\x20the\x20distal\x20convoluted\x20tubule.\x20It\x20is\x20characterized\x20by\x20hypokalemic\x20metabolic\x20alkalosis\x20with\x20hypomagnesemia\x20and\x20hypocalciuria\x20with\x20low\x20blood\x20pressure.</p>\x0a<p\x20class=\x22p1\x22>Option\x20D-\x20<strong>Gordon\x20syndrome&nbsp;</strong>is\x20a\x20state\x20of\x20pseudohypoaldosteronism.\x20It\x20is\x20characterized\x20by\x20hypertension,\x20<strong>hyperkalemia</strong>,\x20metabolic\x20<strong>acidosis,</strong>\x20and\x20low-normal\x20plasma\x20renin\x20activity\x20and\x20aldosterone\x20concentrations.</p>','LAvHE','xSsCA','progressBar','gpfnn','VPMTX','remove','timerContainer','innerHTML','In\x20atrial\x20fibrillation,\x20choose\x20the\x20correct\x20statements:','xQAox','CluMm','FYHJu','setItem','<p>Among\x20the\x20given\x20options,\x20<strong>Candida\x20krusei</strong>\x20shows\x20an<strong>\x20intrinsic\x20resistance\x20</strong>to\x20<strong>fluconazole.&nbsp;</strong>The\x20<strong>primary</strong>\x20or\x20<strong>intrinsic</strong>\x20resistance\x20of\x20C.\x20krusei\x20to\x20azoles\x20(<strong>fluconazole</strong>\x20and\x20<strong>itraconazole</strong>)\x20is\x20mediated\x20through\x20<strong>reduced</strong>\x20<strong>susceptibility</strong>\x20of\x20the\x20target\x20<strong>enzyme&nbsp;</strong>(lanosterol\x2014&alpha;-demethylase)<strong>&nbsp;</strong>to\x20inhibition\x20by\x20these\x20drugs.\x20However,\x20improved\x20<strong>susceptibility</strong>\x20is\x20seen\x20with\x20newer\x20generation\x20azoles\x20such\x20as\x20<strong>voriconazole</strong>.</p>\x0a<p>Life-threatening\x20systemic\x20infections\x20caused\x20by\x20<strong>Candida</strong>\x20and\x20<strong>Aspergillus</strong>\x20species\x20are\x20usually\x20seen\x20in\x20<strong>severely\x20ill</strong>\x20and\x20<strong>immunocompromised</strong>\x20patients\x20such\x20as\x20HIV,\x20chemotherapy-induced\x20neutropenia,\x20and\x20transplant\x20recipients\x20on\x20immunosuppressants.\x20C.\x20albicans\x20and\x20C.\x20dubliniensis\x20are\x20most\x20susceptible\x20to\x20currently\x20available\x20azoles,\x20C.\x20glabrata\x20is\x20less\x20susceptible,\x20whereas\x20<strong>C.\x20krusei\x20is\x20intrinsically\x20resistant\x20to\x20fluconazole.&nbsp;</strong>Resistance\x20occurs\x20due\x20to\x20overexpression\x20or\x20point\x20mutation\x20in\x20the\x20gene\x20encoding\x20the\x20target\x20enzyme&nbsp;<strong>lanosterol\x2014&alpha;-demethylase.\x20Voriconazole&nbsp;</strong>is\x20the\x20preferred\x20therapy\x20for\x20multi-drug\x20resistant\x20infection\x20with\x20C.\x20krusei.</p>\x0a<p><strong>C.\x20albicans</strong>&nbsp;showing\x20<strong>resistance</strong>\x20to\x20<strong>Amphotericin\x20B</strong>\x20has\x20been\x20increasingly\x20reported\x20over\x20the\x20past\x20several\x20years.\x20But\x20this\x20is\x20a\x20<strong>secondary</strong>\x20<strong>resistance</strong>&nbsp;due\x20to\x20alteration\x20or\x20a\x20<strong>decrease</strong>\x20<strong>in</strong>\x20the\x20amount\x20of\x20<strong>ergosterol</strong>\x20in\x20the\x20cell\x20membrane.</p>\x0a<p><strong>Aspergillus\x20fumigatus,\x20</strong>the&nbsp;most\x20common\x20species\x20to\x20cause\x20Aspergillus\x20infection\x20worldwide,\x20also\x20shows\x20an\x20<strong>intrinsic\x20resistance</strong>\x20to\x20<strong>fluconazole.&nbsp;</strong>It\x20is\x20<strong>susceptible</strong>\x20to\x20echinocandins\x20like\x20<strong>micafungin,\x20</strong>which\x20acts\x20by<strong>\x20inhibiting\x20beta-(1,3)-D-glucan\x20synthase,\x20</strong>an\x20enzyme\x20necessary\x20for\x20the\x20synthesis\x20of\x20the&nbsp;<strong>cell\x20wall.</strong></p>\x0a<p><strong>A.\x20niger&nbsp;</strong>is\x20a\x20common\x20cause\x20of\x20<strong>otomycosis</strong>\x20and\x20is\x20<strong>susceptible</strong>\x20to\x20azoles\x20like\x20<strong>voriconazole</strong>,\x20amphotericin\x20B,\x20and\x20echinocandins.</p>','removeItem','markReviewText','SlpqY','<p>Statements\x20<strong>2\x20and\x203</strong>\x20are\x20correct.</p>\x0a<p><strong>Novel\x20Oral\x20Anticoagulants\x20(NOACs)</strong>\x20also\x20known\x20as\x20<strong>direct\x20oral\x20anticoagulants</strong>&nbsp;are\x20a\x20new\x20class\x20of\x20anticoagulants\x20that\x20include\x20oral\x20thrombin\x20inhibitor\x20(dabigatran)\x20and\x20oral\x20factor\x20Xa\x20inhibitors\x20like\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban.\x20They\x20are\x20easier\x20to\x20use,\x20achieve\x20reliable\x20anticoagulation,\x20and\x20do\x20not\x20require\x20dosage\x20adjustment\x20based\x20on\x20blood\x20tests.\x20They\x20have\x20a<strong>\x20lower\x20risk\x20of\x20intracranial\x20hemorrhage</strong>&nbsp;compared\x20to\x20warfarin\x20and\x20are\x20used\x20as\x20alternatives\x20to\x20warfarin\x20for\x20patients\x20who\x20have\x20atrial\x20fibrillation.</p>\x0a<p>Anticoagulation\x20with\x20<strong>warfarin</strong>\x20or\x20<strong>NOACs</strong>\x20should\x20be\x20given\x20in\x20patients\x20with\x20<strong>ischemic\x20stroke\x20due\x20to\x20atrial\x20fibrillation</strong>.\x20In\x20patients\x20with\x20small\x20or\x20moderate-sized\x20infarcts\x20and\x20no\x20intracranial\x20bleeding,\x20<strong>warfarin</strong>\x20can\x20be\x20started\x20soon\x20<strong>(after\x2024\x20hours</strong>)\x20after\x20admission.\x20The\x20risks\x20of\x20transformation\x20to\x20hemorrhagic\x20stroke\x20are\x20minimal.\x20<strong>NOACs</strong>\x20should\x20be\x20started\x20<strong>after\x2048\x20hours</strong>\x20as\x20they\x20have\x20a\x20more\x20rapid\x20anticoagulant\x20effect.</p>\x0a<p>Statement\x203:\x20NOACs\x20are\x20<strong>contraindicated</strong>\x20in\x20patients\x20with<strong>\x20prosthetic\x20mechanical\x20heart\x20valves</strong>\x20due\x20to\x20a\x20lack\x20of\x20sufficient\x20evidence.</p>\x0a<p>Statement\x201:\x20NOACs\x20are\x20<strong>not\x20used</strong>\x20in\x20the\x20treatment\x20of\x20<strong>moderate\x20to\x20severe\x20mitral\x20stenosis</strong>\x20(MS)\x20due\x20to\x20limited\x20clinical\x20evidence\x20supporting\x20their\x20efficacy\x20and\x20safety\x20in\x20MS.&nbsp;<strong>Warfarin</strong>\x20is\x20the\x20recommended\x20anticoagulant\x20for\x20patients\x20with\x20<strong>MS</strong>\x20and\x20<strong>mechanical\x20prosthetic\x20valves.</strong></p>\x0a<p>Statement\x204:\x20<strong>Beta-blockers</strong>\x20and\x20<strong>calcium\x20channel\x20blockers</strong>\x20are\x20the\x20<strong>first\x20line\x20drugs</strong>\x20used\x20to\x20acheive\x20rate\x20control\x20in\x20atrial\x20fibrillation.&nbsp;</p>\x0a<p>&nbsp;</p>','<p>Statements<strong>\x202\x20and\x203</strong>\x20are\x20<strong>true</strong>\x20regarding\x20the\x20prevention\x20of\x20stroke\x20in\x20this\x20patient.</p>\x0a<p><strong>Statement\x201:</strong>\x20Clopidogrel\x20combined\x20with\x20aspirin\x20is\x20better\x20than\x20aspirin\x20alone\x20for\x20stroke\x20prevention.\x20<strong>Warfarin\x20is\x20superior</strong>\x20to\x20antiplatelets\x20in\x20stroke\x20prevention.</p>\x0a<p><strong>Statement\x202:</strong>\x20Warfarin\x20is\x20the\x20recommended\x20anticoagulant\x20for\x20patients\x20with\x20<strong>mitral\x20stenosis\x20(MS)</strong>\x20and<strong>\x20mechanical\x20prosthetic\x20valves.</strong></p>\x0a<p><strong>Statement\x203:</strong>\x20Direct\x20oral\x20anticoagulants\x20(DOACs)\x20like\x20dabigatran,\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban\x20are\x20not\x20used\x20in\x20the\x20treatment\x20of\x20moderate\x20to\x20severe\x20MS\x20and\x20in\x20patients\x20with\x20prosthetic\x20heart\x20valves\x20due\x20to\x20limited\x20clinical\x20evidence.</p>\x0a<p><strong>DOACs</strong>\x20have\x20a\x20<strong>lower</strong>\x20<strong>risk</strong>\x20of\x20intracranial\x20hemorrhage\x20compared\x20to\x20warfarin\x20and\x20are\x20as\x20effective\x20as\x20warfarin\x20for\x20stroke\x20prevention\x20in\x20valvular\x20heart\x20disease\x20(except\x20moderate\x20to\x20severe\x20mitral\x20stenosis\x20or\x20a\x20mechanical\x20heart\x20valve),\x20ischemic\x20stroke\x20or\x20TIA,\x20and\x20AF.</p>\x0a<p><strong>Statement\x204:</strong>\x20Mitral\x20valvotomy\x20is\x20not\x20recommended\x20for\x20the\x20prevention\x20of\x20stroke\x20in\x20this\x20patient.\x20It\x20is\x20indicated\x20in\x20<strong>symptomatic</strong>\x20(New\x20York\x20Heart\x20Association\x20Functional\x20Class\x20II-IV)\x20patients\x20with\x20<strong>isolated\x20severe\x20mitral\x20stenosis,</strong>\x20whose\x20effective\x20orifice<strong>\x20(valve\x20area)\x20is\x20&lt;\x201.5\x20cm2</strong>\x20in\x20normal-sized\x20adults.\x20It\x20is\x20<strong>contraindicated</strong>\x20in\x20cases\x20of<strong>\x20left\x20atrial\x20thrombus.</strong></p>','nav-btn-answered','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','Core\x20window\x20period','toggle','optionsContainer','sbQeJ','Uric\x20acid','TmdVI','https://dhmbxeygs57ff.cloudfront.net/uploads/9b7ff9aff2ef46e1b8363e4e90c5ac28x1279x967.JPEG','notAttemptedResult','SrGMN','aKpSp','solutionImages','scoreCircle','navBtn_','RFVoH','1,\x202\x20and\x203','prevBtn','getAttribute','BOMCu','During\x20the\x20discharge\x20of\x20a\x20COVID\x20patient\x20who\x20was\x20treated\x20with\x20steroids\x20and\x20remdesivir,\x20which\x20of\x20the\x20following\x20will\x20you\x20inform\x20him\x20about?','add','wOKLk','160REenak','onclick','console','YfaKw','rbpfv','1599624AcIkFo','studyModeLegend','5736rHqDhe','<p>The\x20given\x20patient\x20has\x20the\x20involvement\x20of\x20<strong>upper\x20respiratory\x20tract</strong>\x20(chronic\x20sinusitis,\x20ulcerations\x20on\x20nasopharynx),\x20<strong>lower\x20respiratory\x20tract</strong>\x20(nodular\x20lesions\x20with\x20lung\x20cavitations),\x20and\x20<strong>kidneys</strong>\x20(renal\x20failure)\x20which\x20are\x20suggestive\x20of\x20<strong>granulomatosis\x20with\x20polyangiitis</strong>\x20(Wegener\x27s\x20granulomatosis)\x20and\x20testing\x20for\x20cytoplasmic\x20ANCA\x20(<strong>c-ANCA</strong>)\x20would\x20be\x20the\x20most\x20helpful\x20investigation\x20in\x20this\x20condition.</p>\x0a<p>Granulomatosis\x20with\x20polyangiitis\x20is\x20a\x20granulomatous\x20and\x20<strong>necrotizing</strong>\x20<strong>vasculitis</strong>\x20of\x20the\x20<strong>small</strong>\x20arteries\x20and\x20veins\x20that\x20mainly\x20affects:</p>\x0a<ul>\x0a<li><strong>Upper\x20respiratory\x20tract:</strong>\x20chronic\x20<strong>sinusitis</strong>,\x20serous\x20otitis\x20media\x20due\x20to\x20eustachian\x20tube\x20blockage,\x20nasal\x20septal\x20perforation,\x20and\x20mucosal\x20<strong>ulceration</strong>\x20of\x20the\x20nasopharynx.</li>\x0a<li><strong>Lower\x20respiratory\x20tract:</strong>\x20presenting\x20with\x20cough,<strong>&nbsp;</strong><strong>hemoptysis,</strong>&nbsp;dyspnea,\x20and\x20persistent\x20pneumonitis.<strong>&nbsp;</strong>Lung\x20involvement\x20typically\x20appears\x20as\x20multiple,\x20bilateral\x20<strong>nodular</strong>&nbsp;<strong>cavitary</strong>\x20<strong>infiltrates</strong>.</li>\x0a<li><strong>Kidneys</strong>:\x20focal\x20or\x20segmental&nbsp;<strong>glomerulonephritis</strong>\x20presenting\x20with\x20proteinuria,\x20hematuria,\x20and\x20hypertension.\x20If\x20left\x20untreated\x20it\x20can\x20lead\x20to\x20rapidly\x20progressive\x20glomerulonephritis.</li>\x0a</ul>\x0a<p>Apart\x20from\x20these\x20organs,\x20it\x20can\x20also\x20affect\x20the\x20eyes\x20and\x20skin.\x20Skin\x20lesions\x20present\x20as\x20<strong>palpable\x20purpura</strong>\x20or\x20<strong>subcutaneous</strong>\x20<strong>nodules</strong>.</p>\x0a<p>Lab\x20investigations\x20will\x20show&nbsp;<strong>anemia,&nbsp;</strong>leucocytosis,\x20elevated\x20ESR,\x20and\x20<strong>high\x20titers</strong>\x20of\x20cytoplasmic\x20ANCA\x20(<strong>c-ANCA</strong>)\x20targetted\x20against\x20<strong>anti-proteinase-3</strong>\x20(anti-PR-3)<strong>.</strong>&nbsp;The\x20specificity\x20of\x20a\x20positive\x20PR-3\x20ANCA\x20for\x20Wegener\x27s\x20is\x20very\x20high,\x20especially\x20in\x20the\x20presence\x20of\x20active\x20glomerulonephritis.\x20Following\x20treatment,\x20PR-3\x20ANCA\x20titers\x20fall\x20and\x20subsequent\x20rise\x20in\x20titers\x20is\x20predictive\x20of\x20<strong>relapse</strong>.<strong>&nbsp;</strong>Chest\x20radiograph\x20will\x20show\x20<strong>multiple,\x20bilateral\x20cavitating\x20nodules\x20</strong>and\x20<strong>pulmonary\x20infiltrates</strong>.</p>\x0a<p>The\x20diagnosis\x20is\x20<strong>confirmed</strong>\x20by\x20the\x20presence\x20of\x20<strong>necrotizing\x20granulomatous\x20vasculitis</strong>\x20on\x20<strong>biopsy</strong>.\x20This\x20finding\x20is\x20commonly\x20seen\x20in\x20the\x20tissues\x20obtained\x20from\x20the\x20<strong>lungs</strong>,\x20upper\x20airways,\x20skin,\x20and\x20rarely\x20in\x20the\x20kidneys.</p>\x0a<p>The\x20radiograph\x20below\x20shows\x20cavitating\x20nodules\x20in\x20a\x20patient\x20with\x20granulomatosis\x20with\x20polyangiitis\x20(Wegener\x27s).</p>','block','.option-button','pjLyW','4\x20and\x205','timed_exam','currentMode','EqNFm','XyCZr','FwbHi','Milk\x20alkali\x20syndrome','Not\x20Attempted','1,\x202,\x203\x20and\x204\x20correct','SQhnF','querySelectorAll','SIRLj','fromCharCode','warn','A\x2035-year-old\x20female\x20patient\x20with\x20class\x20II\x20pulmonary\x20hypertension\x20presents\x20with\x20a\x20negative\x20vasoreactivity\x20test.\x20Which\x20of\x20the\x20following\x20is\x20used\x20in\x20the\x20next\x20step\x20of\x20management?','WpSjs','(((.+)+)+)+$','puhxG','https://cdn1.dailyrounds.org/uploads/8e975e35ca394842a564002a6f641a73.JPEG','red','1\x20only','cOnUO','study','Iloprost','RYCsF','JOaLg','green','OsBPz','Parkinson\x27s\x20disease','IzJmH','KZuCg','YGJxc','testModeReviewLegend','A\x2030-year-old\x20female\x20patient\x20came\x20to\x20the\x20outpatient\x20department\x20with\x20complaints\x20of\x20neck\x20swelling.\x20She\x20gives\x20a\x20history\x20of\x20weight\x20loss\x20and\x20palpitations.\x20On\x20examination,\x20she\x20has\x20exophthalmos\x20and\x20a\x20diffusely\x20enlarged\x20thyroid\x20gland.\x20What\x20are\x20the\x20essential\x20investigations\x20that\x20should\x20be\x20done\x20for\x20the\x20patient?','timeSpent','Optic\x20neuritis','The\x20blood\x20investigation\x20of\x20a\x20patient\x20is\x20given\x20below.\x20What\x20is\x20the\x20probabale\x20diagnosis?','none','error','gsxXg','yEiGQ','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','JGBkB','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','WbzMn','explanation_video','qEGzq','kyMeX','quizPerformanceData','unXyb','trace','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','yjoFs','RnOkE','Biopsy\x20to\x20show\x20granuloma','Ulqsh','HugUY','yRPND','AFB\x20staining\x20of\x20sputum','KPRrH','AGoVC','Uqmrk','ChMyY','HqklG','TXbIE','div','BCqdT','bzTzI','NlqIC','loadSource','Patient\x20can\x20be\x20clinically\x20euvolemic\x20to\x20hypervolemic','UGmml','vAdWD','1120612GOZJTb','owRoh','Serum\x20sodium\x20<135\x20mEq/L','Tab\x20labetalol\x2010\x20mg\x20stat','now','A\x20chronic\x20smoker\x20presented\x20with\x20shortness\x20of\x20breath,\x20bilateral\x20pitting\x20pedal\x20edema,\x20and\x20abdominal\x20distension.\x20On\x20examination,\x20jugular\x20venous\x20pulse\x20was\x20found\x20to\x20be\x20elevated\x20and\x20liver\x20was\x20palpable\x208\x20cm\x20below\x20the\x20costal\x20margin.\x20An\x20abnormality\x20in\x20which\x20of\x20the\x20following\x20structures\x20is\x20responsible\x20for\x20the\x20patient\x27s\x20symptoms?','userHistory','log','koejA','bAIOk','dXydd','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','VwxVm','Progressive\x20multifocal\x20leukoencephalopathy\x20shows\x20triphasic\x20and\x20slow\x20waves\x20on\x20EEG','startAt','hDTRi','Kubxr','oEEBB','UQNve','1-5%\x20of\x20the\x20population\x20can\x20have\x20epileptiform\x20discharges','5|0|2|1|4|3','uerqp','pMDmm','koaYD','statsBar','ikvzD','1,\x202,\x203,\x204,\x20and\x205','explanation_images','AFCcU','toString','flex','FzLvX','Acid-base\x20imbalance\x20is\x20suspected\x20in\x20a\x20patient.\x20Which\x20of\x20the\x20following\x20would\x20you\x20use\x20to\x20determine\x20it?','940045eOEfoS','JEXLf','BAL','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','XTETd','jlSgb','HuuoV','zLcKG','timed_study','Vrrit','TDrxJ','display','OmCmi','selected','bookmarkedQuestions','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','totalTimeResult','1\x20and\x202','Fixed\x20central\x20airway\x20obstruction','https://dhmbxeygs57ff.cloudfront.net/uploads/d654d63968a24c23abee8962cbd54874x978x662.PNG','HiGSt','ulQUG','style','vojEx','<p>The\x20given\x20urinary\x20crystal\x20is\x20the\x20<strong>bipyramidal</strong>\x20or<strong>\x20envelope-shaped\x20crystals</strong>\x20of<strong>\x20calcium\x20oxalate\x20dihydrate.</strong>\x20Risk\x20factors\x20for\x20calcium\x20oxalate\x20stones\x20include\x20<strong>higher\x20urine\x20calcium,\x20urine\x20oxalate,\x20</strong>and<strong>\x20lower\x20urine\x20citrate.</strong></p>\x0a<p><strong>Oxalate-rich</strong>\x20<strong>foods</strong>\x20like\x20spinach,\x20rhubarb,\x20almonds,\x20and\x20potatoes\x20should\x20be\x20avoided.\x20Avoiding\x20high-dose\x20vitamin\x20C\x20supplements\x20reduces\x20endogenous\x20oxalate\x20production.</p>\x0a<p><strong>Chlorthalidone</strong>\x20can\x20lower\x20urine\x20calcium\x20excretion\x20and\x20can\x20reduce\x20the\x20recurrence\x20of\x20calcium\x20oxalate\x20stones.\x20Consumption\x20of\x20fruits\x20and\x20vegetables\x20or\x20supplemental\x20alkali\x20is\x20advised\x20to\x20increase\x20urine\x20citrate,\x20which\x20is\x20a<strong>\x20natural\x20inhibitor</strong>\x20of\x20calcium\x20oxalate\x20and\x20calcium\x20phosphate\x20stones.</p>','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','Marked','cZkcR','quizFile','wPeIM','rclnV','<p>The\x20next\x20step\x20in\x20management\x20would\x20be\x20<strong>CT\x20angiography.</strong>\u00a0<strong>NCCT\x20and\x20CT\x20angiography</strong>\x20must\x20be\x20<strong>done\x20concurrently</strong>\u00a0during\x20stroke\x20evaluation.\x20The\x20given\x20features\x20of\x20hemiparesis\x20with\x20aphasia\x20and\x20a\x20clear\x20NCCT\x20are\x20suggestive\x20of\x20an\x20acute\x20<strong>ischemic\x20stroke</strong>\x20with\x20a\x20<strong>proximal\x20large\x20vessel\x20occlusion</strong>.\u00a0</p>\x0a<p>Though\x20thrombolysis\x20is\x20the\x20treatment\x20of\x20choice,\x20occlusions\x20in\x20large\x20vessels\x20often\x20fail\x20to\x20open\x20up\x20with\x20thrombolysis\x20alone.\x20Hence,\x20<strong>mechanical</strong>\x20<strong>thrombectomy\x20is\x20also\x20indicated</strong>\x20and\x20should\x20be\x20done\x20ideally\x20within\x20<strong>6\x20hours</strong>\x20and\x20not\x20beyond\x2024\x20hours\x20of\x20symptom\x20onset.</p>\x0a<p><strong>CT\x20angiography\x20</strong>determines\x20if\x20there\x20is\x20an\x20emergent\x20large\x20vessel\x20occlusion\x20(ELVO),\x20and\x20can\x20be\x20used\x20to\x20triage\x20patients\x20for\x20management\x20by\x20intra-arterial\x20mechanical\x20thrombectomy\x20using\x20a\x20retriever\x20device.\u00a0</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20D:</strong>\x20Thrombolysis\x20with\x20alteplase\x20is\x20the\x20first-line\x20therapy\x20for\x20acute\x20ischemic\x20stroke\x20and\x20should\x20be\x20initiated\x20within\x204.5\x20hours\x20of\x20symptom\x20onset.\x20However,\x20<strong>mechanical\x20thrombectomy</strong>\x20is\x20<strong>indicated</strong>\x20as\x20well\x20for\x20acute\x20ischemic\x20stroke\x20due\x20to\x20a\x20<strong>large\x20artery\x20occlusion</strong>\x20in\x20the\x20anterior\x20circulation.\x20Thus,\x20<strong>CT\x20angiography\x20</strong>to\x20look\x20for<strong>\x20large\x20vessel\x20occlusion</strong>\x20would\x20be\x20the\x20next\x20best\x20step\x20in\x20the\x20management.</p>\x0a<p><strong>Option\x20B:</strong>\x20MRI\x20with\x20diffusion-weighted\x20imaging\x20(DWI)\x20is\x20superior\x20to\x20NCCT\x20for\x20detecting\x20an\x20acute\x20infarct.\x20However,\x20MRI\x20is\x20not\x20preferred\x20to\x20NCCT\x20because\x20of\x20longer\x20scan\x20completion\x20time,\x20limited\x20availability\x20in\x20emergency\x20settings,\x20and\x20higher\x20cost.</p>\x0a<p><strong>Option\x20C:</strong>\x20Labetalol,\x20nicardipine,\x20and\x20clevidipine\x20are\x20the\x20first-line\x20anti-hypertensive\x20agents\x20used\x20in\x20the\x20acute\x20phase\x20of\x20stroke.\x20The\x20blood\x20pressure\x20goals\x20in\x20ischemic\x20stroke\x20are:</p>\x0a<ul>\x0a<li>If\x20the\x20patient\x20is\x20to\x20receive\x20thrombolytic\x20therapy,\x20maintain\x20BP\x20≤185/110\x20mmHg.</li>\x0a<li>After\x20thrombolytic\x20therapy,\x20maintain\x20BP\x20≤180/105\x20mmHg\x20for\x20at\x20least\x20the\x20next\x2024\x20hours.</li>\x0a<li>If\x20not\x20treated\x20with\x20thrombolytic\x20therapy,\x20BP\x20should\x20not\x20be\x20treated\x20acutely\x20unless\x20it\x20is\x20more\x20than\x20220/120\x20mmHg.\x20BP\x20should\x20be\x20lowered\x20cautiously\x20by\x20only\x2015\x20percent\x20in\x20the\x20first\x2024\x20hours\x20in\x20order\x20to\x20preserve\x20perfusion\x20to\x20the\x20ischemic\x20penumbra.</li>\x0a</ul>\x0a<p>\u00a0</p>','solution','IWDlF','QMMOA','aCgYA','forEach','<p><strong>Non-cardiovascular\x20deaths</strong>\x20are\x20more\x20in\x20heart\x20failure\x20with\x20<strong>preserved</strong>\x20ejection\x20fraction\x20(HFpEF)\x20as\x20compared\x20to\x20heart\x20failure\x20with\x20reduced\x20ejection\x20fraction\x20(HFrEF).</p>\x0a<p><strong>Non-cardiac\x20causes</strong>\x20accounted\x20for\x20<strong>62%</strong>\x20of\x20deaths\x20in\x20HFpEF,\x20<strong>54%</strong>\x20in\x20HFmrEF\x20(heart\x20failure\x20with\x20mildly\x20reduced\x20ejection\x20fraction),\x20and\x20<strong>35%</strong>\x20in\x20HFrEF.\x20Cancer\x20was\x20twice\x20as\x20frequent\x20as\x20a\x20cause\x20of\x20death\x20in\x20HFpEF\x20and\x20HFmrEF\x20versus\x20HFrEF.</p>\x0a<p>Heart\x20failure\x20is\x20divided\x20according\x20to\x20the\x20ejection\x20fraction:</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x2087\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li>Heart\x20failure\x20with\x20<strong>preserved\x20ejection\x20fraction</strong>\x20<strong>(HFpEF)</strong>:\x20Left\x20ventricular\x20ejection\x20fraction\x20is\x20<strong>&gt;40-50%</strong></li>\x0a<li>Heart\x20failure\x20with\x20<strong>reduced\x20ejection\x20fraction\x20(HFrPF):</strong>&nbsp;Left\x20ventricular\x20ejection\x20fraction\x20is\x20<strong>&lt;40%</strong></li>\x0a</ul>\x0a<p>Patients\x20with\x20a\x20left\x20ventricular\x20ejection\x20fraction\x20between\x2040%\x20and\x2050%\x20are\x20considered\x20to\x20have\x20borderline\x20or\x20mid-range\x20EF.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p>Option\x20A:\x20\x27Regardless\x20of\x20the\x20EF\x20and\x20the\x20type\x20of\x20heart\x20failure,\x20the\x205-year\x20mortality\x20rate\x20is\x20around\x2050%\x27\x20is\x20a\x20true\x20statement.\x20The\x20development\x20of\x20symptomatic\x20heart\x20failure\x20has\x20a\x20poor\x20prognosis.\x2030-40%\x20of\x20patients\x20die\x20within\x201\x20year\x20of\x20diagnosis.\x20<strong>More\x20than\x2050%</strong>\x20(60-70%)\x20die\x20within\x205\x20years.</p>\x0a<p>Option\x20C:&nbsp;Angiotensin-converting\x20enzyme\x20(ACE)\x20inhibitors\x20cause\x20cough\x20in\x20<strong>15%</strong>\x20and\x20rashes\x20and\x20angioedema\x20in<strong>\x201%</strong>.\x20ACE\x20inhibitors\x20inhibit\x20the\x20angiotensin-converting\x20enzyme\x20and\x20inhibit\x20the\x20conversion\x20of\x20angiotensin\x20I\x20to\x20angiotensin\x20II.\x20ACE\x20also\x20splits\x20bradykinin,\x20substance\x20P,\x20enkephalins,\x20etc.\x20The\x20bradykinin\x20and\x20substance\x20P\x20which\x20are\x20not\x20broken\x20down\x20lead\x20to\x20cough,\x20urticaria,\x20and\x20rarely\x20angioedema.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20263\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Option\x20D:\x20The\x20prevalence\x20of\x20atrial\x20fibrillation\x20increases\x20with\x20age,\x20and\x20&gt;95%\x20of\x20AF\x20patients\x20are\x20<strong>&gt;60\x20years</strong>\x20of\x20age.\x20Atrial\x20fibrillation\x20increases\x20the\x20risk\x20of\x20stroke\x20by\x20five-fold\x20and\x20is\x20estimated\x20to\x20be\x20the\x20cause\x20of\x20<strong>25%\x20of\x20strokes</strong>.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','cVjle','currentQuestion','nvKVG','border-red-500','map','iTIKS','VgdNE','IPwCY','tBkoD','fpqQp','zosDy','ZeWZF','application/vnd.apple.mpegurl','https://dhmbxeygs57ff.cloudfront.net/uploads/b3e170e22ce1491fa9047ef06e13bc16x358x285.PNG','nav-btn-incorrect','\x22\x20data-src=\x22','gLaIi','https://cdn1.dailyrounds.org/uploads/2f76f0e1f4c54dd0acdfdbe17fe53558.JPEG','split','correctResult','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','oxKAa','rggvJ','bUXPW','ArrowRight','ItsiX','Zjhae','prototype','1,\x202,\x20and\x203\x20correct','JSdew','https://dhmbxeygs57ff.cloudfront.net/uploads/e78da2196a8f48dc97e5db27603061c7x1280x1794.JPEG'];_0x35ec=function(){return _0x2b3510;};return _0x35ec();}function markQuizAsCompleted(){const _0x24a359=_0x38e45b,_0x5eb297={'kIDhP':_0x24a359(0xd1)},_0xfc60d1=JSON[_0x24a359(0x2e8)](localStorage['getItem']('userHistory'))||{},_0x3f3f3e=questionsData[_0x24a359(0x2fd)],_0x3348a4=stats[_0x24a359(0x231)]||0x0;_0xfc60d1[quizFilename]={'score':_0x3348a4,'total':_0x3f3f3e,'status':_0x5eb297[_0x24a359(0x82)],'completedOn':new Date()[_0x24a359(0x257)]()},localStorage['setItem'](_0x24a359(0x1a0),JSON['stringify'](_0xfc60d1));}const urlParams=new URLSearchParams(window['location'][_0x38e45b(0x2a9)]),startAt=parseInt(urlParams[_0x38e45b(0xd0)](_0x38e45b(0x1a8))),resume=urlParams['get'](_0x38e45b(0x25f))===_0x38e45b(0xc1);function goBack(){const _0x3de900=_0x38e45b,_0x37fdd4={'UGmml':function(_0x1dc164){return _0x1dc164();}};if(!isQuizCompleted)_0x37fdd4[_0x3de900(0x198)](saveProgress);window[_0x3de900(0x2f9)][_0x3de900(0x10b)]=document['referrer']||_0x3de900(0x29a);}function selectMode(_0x516124){const _0x2019c1=_0x38e45b,_0x3b64ac={'QMMOA':_0x2019c1(0xef),'EqNFm':_0x2019c1(0x176),'KTFph':function(_0x20a900){return _0x20a900();}};currentMode=_0x516124,document[_0x2019c1(0x94)](_0x3b64ac[_0x2019c1(0x1dd)])[_0x2019c1(0x1d1)][_0x2019c1(0x1c6)]=_0x3b64ac[_0x2019c1(0x154)],_0x3b64ac[_0x2019c1(0x2bb)](initializeQuiz);}function initializeQuiz(){const _0x22d0c3=_0x38e45b,_0x36155a={'NCHGG':_0x22d0c3(0x27e),'UQCOR':'markReviewBtn','tuHaw':_0x22d0c3(0x171),'uerqp':function(_0x4d3ab1,_0x2f714c){return _0x4d3ab1===_0x2f714c;},'cOnUO':_0x22d0c3(0x106),'zzuUk':'statsBar','uPePo':'none','PiwiQ':_0x22d0c3(0x14b),'HqklG':_0x22d0c3(0x14e),'JGBkB':_0x22d0c3(0xbb),'yjoFs':_0x22d0c3(0x72),'gpfnn':_0x22d0c3(0x1b8),'HugUY':_0x22d0c3(0x1c3),'vtLsZ':function(_0x54dbf1,_0x5854ec){return _0x54dbf1===_0x5854ec;},'EENyA':_0x22d0c3(0x152),'RnOkE':_0x22d0c3(0x230),'tkGyT':function(_0x588557,_0x1dfbb4){return _0x588557>=_0x1dfbb4;},'iTIKS':function(_0x19636a){return _0x19636a();}};quizStartTime=Date[_0x22d0c3(0x19e)]();const _0x577e25=document[_0x22d0c3(0x94)](_0x36155a['NCHGG']),_0x1d1341=document[_0x22d0c3(0x94)](_0x36155a['UQCOR']),_0x518386=document['getElementById'](_0x36155a['tuHaw']),_0x4893f3=_0x36155a[_0x22d0c3(0x1af)](currentMode,_0x36155a[_0x22d0c3(0x166)])||currentMode==='timed_exam';document[_0x22d0c3(0x94)](_0x36155a['zzuUk'])[_0x22d0c3(0x1d1)][_0x22d0c3(0x1c6)]=_0x4893f3?_0x36155a['uPePo']:_0x22d0c3(0x14e),document['getElementById'](_0x36155a[_0x22d0c3(0x29b)])[_0x22d0c3(0x1d1)][_0x22d0c3(0x1c6)]=_0x4893f3?_0x36155a[_0x22d0c3(0x2c2)]:_0x36155a[_0x22d0c3(0x190)],document[_0x22d0c3(0x94)](_0x36155a[_0x22d0c3(0x17b)])[_0x22d0c3(0x1d1)]['display']=_0x4893f3?_0x36155a['HqklG']:_0x22d0c3(0x176),document['getElementById'](_0x36155a[_0x22d0c3(0x185)])[_0x22d0c3(0x1d1)][_0x22d0c3(0x1c6)]=_0x4893f3?_0x36155a[_0x22d0c3(0x190)]:_0x36155a[_0x22d0c3(0x2c2)],_0x577e25[_0x22d0c3(0x1d1)]['display']=_0x4893f3?_0x36155a[_0x22d0c3(0x2c2)]:_0x36155a['gpfnn'],_0x1d1341[_0x22d0c3(0x1d1)][_0x22d0c3(0x1c6)]=_0x4893f3?_0x36155a['gpfnn']:_0x36155a[_0x22d0c3(0x2c2)],_0x518386[_0x22d0c3(0x1d1)][_0x22d0c3(0x1c6)]=_0x4893f3?_0x36155a[_0x22d0c3(0x11e)]:_0x36155a[_0x22d0c3(0x2c2)],(_0x36155a[_0x22d0c3(0x1af)](currentMode,_0x36155a[_0x22d0c3(0x189)])||_0x36155a[_0x22d0c3(0x28d)](currentMode,_0x36155a['EENyA']))&&document[_0x22d0c3(0x94)](_0x22d0c3(0x121))[_0x22d0c3(0xab)]['remove'](_0x36155a[_0x22d0c3(0x186)]),!isNaN(startAt)&&_0x36155a[_0x22d0c3(0x112)](startAt,0x0)&&startAt<questionsData[_0x22d0c3(0x2fd)]&&(currentQuestionIndex=startAt),_0x36155a[_0x22d0c3(0x1e6)](loadBookmarkedQuestions),generateQuestionNav(),_0x36155a['iTIKS'](updateStats),displayQuestion();}function generateQuestionNav(){const _0x3e5834=_0x38e45b,_0x16f445={'qjGSO':function(_0x4c03ea,_0x29428c){return _0x4c03ea<_0x29428c;},'mWpUp':function(_0x184051,_0x3f1154){return _0x184051!==_0x3f1154;},'rClAK':_0x3e5834(0x2fa),'vWCLf':_0x3e5834(0x30b),'RXMKm':function(_0x27ce05,_0xff36c7){return _0x27ce05+_0xff36c7;},'eUFTj':_0x3e5834(0x1a5),'KPRrH':function(_0xa445eb){return _0xa445eb();}},_0x8d4b83=document[_0x3e5834(0x94)](_0x3e5834(0x77));_0x8d4b83[_0x3e5834(0x122)]='';for(let _0x1ca65a=0x0;_0x16f445[_0x3e5834(0x311)](_0x1ca65a,questionsData[_0x3e5834(0x2fd)]);_0x1ca65a++){if(_0x16f445['mWpUp'](_0x16f445[_0x3e5834(0x2c9)],_0x16f445[_0x3e5834(0x2c9)])){const _0x2b56e9=_0x382bab[_0x3e5834(0x2e8)](_0x23f39a[_0x3e5834(0x7e)](_0x3e5834(0x1c9)))||[];_0x2b56e9[_0x3e5834(0x1df)](_0x3e15af=>{const _0x447ad0=_0x3e5834;_0x3e15af['quizFile']['includes'](_0x4dbf1f[_0x447ad0(0x25c)]()[_0x447ad0(0x2e2)](/ /g,'-'))&&(_0x3e15af[_0x447ad0(0x276)]<_0x1ded0c[_0x447ad0(0x2fd)]&&(_0x30e4ef[_0x3e15af['questionIndex']]['bookmarked']=!![]));});}else{const _0x2106b5=document[_0x3e5834(0x2b3)](_0x16f445[_0x3e5834(0x2ad)]);_0x2106b5[_0x3e5834(0x2a6)]=_0x16f445[_0x3e5834(0x30e)](_0x1ca65a,0x1),_0x2106b5[_0x3e5834(0x294)]=_0x16f445[_0x3e5834(0x274)],_0x2106b5[_0x3e5834(0x146)]=()=>jumpToQuestion(_0x1ca65a),_0x2106b5['id']=_0x3e5834(0x13c)+_0x1ca65a,_0x8d4b83[_0x3e5834(0x2a1)](_0x2106b5);}}_0x16f445[_0x3e5834(0x18c)](updateQuestionNav);}function updateQuestionNav(){const _0x38d4ae=_0x38e45b,_0x5dbd07={'yRPND':function(_0x717771,_0x3aa7f4){return _0x717771-_0x3aa7f4;},'mynwM':function(_0x52fc12){return _0x52fc12();},'SfiXm':function(_0x48211c,_0x46ca55){return _0x48211c===_0x46ca55;},'VgdNE':'selected','GlFtZ':'Option\x20','gvdzt':'.option-button','FwbHi':function(_0x13081f,_0x5d9b2a){return _0x13081f(_0x5d9b2a);},'TTPkD':'data-option-index','CqYLL':_0x38d4ae(0x301),'gLaIi':function(_0x217617,_0x206cf5){return _0x217617===_0x206cf5;},'zFCvq':function(_0x3227c1,_0x45390a){return _0x3227c1===_0x45390a;},'fJUjs':'MVMQS','IUPLy':_0x38d4ae(0xff),'mkfGg':_0x38d4ae(0x206),'BWdSL':function(_0x11daef,_0x3d2d00){return _0x11daef===_0x3d2d00;},'fpqQp':_0x38d4ae(0x316),'EDvzK':_0x38d4ae(0xd4),'CluMm':function(_0x448e6d,_0x7c93f5){return _0x448e6d===_0x7c93f5;},'fAjan':'timed_study','hdjvl':_0x38d4ae(0xc8),'ecAmS':_0x38d4ae(0x79),'EqfDl':_0x38d4ae(0x28a),'hVvFb':_0x38d4ae(0x1ef),'pbeWS':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','aCgYA':_0x38d4ae(0x139),'JNmqe':function(_0x26487a,_0x1c04b8){return _0x26487a!==_0x1c04b8;},'joXoR':_0x38d4ae(0x12e)};for(let _0x80198b=0x0;_0x80198b<questionsData['length'];_0x80198b++){if(_0x5dbd07[_0x38d4ae(0x220)](_0x5dbd07['CqYLL'],_0x5dbd07[_0x38d4ae(0xa8)])){const _0x246f5a=document[_0x38d4ae(0x94)](_0x38d4ae(0x13c)+_0x80198b),_0x41541d=questionStates[_0x80198b];let _0x396279='';if(_0x5dbd07[_0x38d4ae(0x1f1)](_0x80198b,currentQuestionIndex))_0x5dbd07[_0x38d4ae(0x23c)](_0x5dbd07['fJUjs'],_0x38d4ae(0x170))?(_0x346b40&&(_0x30a0fc[_0x2b8a4d][_0x38d4ae(0x173)]+=_0x5dbd07[_0x38d4ae(0x18a)](_0x2768cd[_0x38d4ae(0x19e)](),_0x35b2ae)),_0x359045=_0x138533,_0x5dbd07['mynwM'](_0x383d3d),_0x5dbd07[_0x38d4ae(0xa2)](_0x3f0658)):_0x396279=_0x5dbd07[_0x38d4ae(0x239)];else{if(_0x41541d[_0x38d4ae(0x304)])_0x396279=_0x5dbd07['mkfGg'];else{if(_0x41541d[_0x38d4ae(0xfc)]){if(_0x5dbd07['BWdSL']('dvSrF',_0x5dbd07[_0x38d4ae(0x1ea)]))_0x396279=_0x5dbd07['EDvzK'];else{if(_0x2ab9cd)_0x41f6d2[_0x38d4ae(0x122)]+=_0x38d4ae(0x115)+_0x4251eb+_0x38d4ae(0x1d4);}}else{if(_0x5dbd07[_0x38d4ae(0x125)](currentMode,_0x38d4ae(0x167))||_0x5dbd07['zFCvq'](currentMode,_0x5dbd07['fAjan'])){if(_0x5dbd07['hdjvl']===_0x38d4ae(0x17f))_0x5dbd07[_0x38d4ae(0xa2)](_0x57e671);else{if(_0x5dbd07[_0x38d4ae(0x125)](_0x41541d[_0x38d4ae(0x20c)],_0x38d4ae(0x71)))_0x396279=_0x5dbd07['ecAmS'];else{if(_0x5dbd07[_0x38d4ae(0x125)](_0x41541d[_0x38d4ae(0x20c)],_0x5dbd07[_0x38d4ae(0xf4)]))_0x396279=_0x5dbd07[_0x38d4ae(0x203)];else _0x396279=_0x5dbd07[_0x38d4ae(0x26b)];}}}else{if(_0x5dbd07[_0x38d4ae(0x1de)]===_0x5dbd07[_0x38d4ae(0x1de)]){if(_0x5dbd07[_0x38d4ae(0x2d6)](_0x41541d['selectedAnswer'],null))_0x396279=_0x5dbd07[_0x38d4ae(0x216)];else _0x396279=_0x38d4ae(0x23b);}else{_0x4d6f4c['totalAttempted']++,_0x292ae4[_0x38d4ae(0xcb)]--;if(_0x450824)_0x6428bd['correctAnswers']++;else _0xe33271[_0x38d4ae(0x298)]++;}}}}}_0x246f5a['className']=_0x38d4ae(0x278)+_0x396279;}else{const _0x4cd1e1={'oPhdt':function(_0x14b995,_0x4dc6b1){const _0x1221ae=_0x38d4ae;return _0x5dbd07[_0x1221ae(0x220)](_0x14b995,_0x4dc6b1);},'iVSQI':_0x5dbd07[_0x38d4ae(0x1e7)],'uLOKT':function(_0x2f7dfa,_0x2d677c){return _0x2f7dfa+_0x2d677c;},'WSQXo':_0x5dbd07[_0x38d4ae(0x2db)],'xbHWi':_0x5dbd07[_0x38d4ae(0x297)],'dVWij':function(_0x528aa2,_0x3cadcf){const _0x274167=_0x38d4ae;return _0x5dbd07[_0x274167(0x156)](_0x528aa2,_0x3cadcf);},'rOPqN':_0x5dbd07[_0x38d4ae(0xde)]};_0x9f456d[_0x38d4ae(0xec)][_0x38d4ae(0x1df)]((_0x70c322,_0xc811f3)=>{const _0x1e35bc=_0x38d4ae,_0x4433e1=_0x5a8dcc[_0x1e35bc(0x15d)](0x41+_0xc811f3),_0x4a21bb=_0x4cd1e1[_0x1e35bc(0x317)](_0xcf7a71,_0xc811f3),_0x345e06=_0x11c570[_0x1e35bc(0x2b3)](_0x1e35bc(0x192));_0x345e06[_0x1e35bc(0x122)]=_0x1e35bc(0x107)+(_0x4a21bb?_0x4cd1e1[_0x1e35bc(0xac)]:'')+_0x1e35bc(0x2f7)+_0xc811f3+_0x1e35bc(0x31e)+_0x4433e1+_0x1e35bc(0x23e)+(_0x70c322['text']||_0x4cd1e1['uLOKT'](_0x4cd1e1['WSQXo'],_0x4cd1e1['uLOKT'](_0xc811f3,0x1)))+_0x1e35bc(0x184),_0x241f13['appendChild'](_0x345e06);}),_0x58ab6e['addEventListener'](_0x38d4ae(0x9d),function(_0x554524){const _0x548c31=_0x38d4ae,_0x32d12c=_0x554524['target']['closest'](_0x4cd1e1[_0x548c31(0x90)]);if(_0x32d12c){const _0x5c58d3=_0x4cd1e1['dVWij'](_0x492ae6,_0x32d12c[_0x548c31(0x140)](_0x4cd1e1['rOPqN']));_0x54e62f(_0x5c58d3);}});}}}function jumpToQuestion(_0xd05d10){const _0xe357eb=_0x38e45b,_0x258be0={'SMLPW':function(_0x49d830,_0x2f07d1){return _0x49d830>=_0x2f07d1;},'VHtPR':function(_0x37285e,_0xbcbb7e){return _0x37285e<_0xbcbb7e;},'GiCcl':function(_0x264dbd,_0x420a18){return _0x264dbd===_0x420a18;},'rEQVd':_0xe357eb(0x256),'KHZcj':function(_0x5d6686){return _0x5d6686();}};if(_0x258be0[_0xe357eb(0x10d)](_0xd05d10,0x0)&&_0x258be0[_0xe357eb(0x9c)](_0xd05d10,questionsData[_0xe357eb(0x2fd)])){if(questionStartTime){if(_0x258be0[_0xe357eb(0x7c)](_0x258be0['rEQVd'],_0x258be0[_0xe357eb(0x2bd)]))questionStates[currentQuestionIndex][_0xe357eb(0x173)]+=Date[_0xe357eb(0x19e)]()-questionStartTime;else{const _0x5b7c14=_0x538367?function(){if(_0x25f829){const _0x220690=_0x32f32f['apply'](_0xa6a7eb,arguments);return _0x25339c=null,_0x220690;}}:function(){};return _0x4f2554=![],_0x5b7c14;}}currentQuestionIndex=_0xd05d10,displayQuestion(),_0x258be0[_0xe357eb(0x2eb)](saveProgress);}}function updateStats(){const _0x26085f=_0x38e45b,_0x5a380d={'mbwtF':function(_0x1fcfe0,_0x5675ac){return _0x1fcfe0===_0x5675ac;},'ulQUG':'timed_study','KAcxl':_0x26085f(0x307),'dtEIj':'incorrectCount','dMyuU':_0x26085f(0x225),'TXbIE':function(_0x21f86c,_0x36fab3){return _0x21f86c*_0x36fab3;},'tAOfz':function(_0x3cb128,_0x17f9a6){return _0x3cb128/_0x17f9a6;},'YfaKw':_0x26085f(0x314),'IWDlF':function(_0x226301,_0x52b8d7){return _0x226301+_0x52b8d7;},'bAIOk':function(_0xecc596,_0x1a55a4){return _0xecc596/_0x1a55a4;},'oQWoe':function(_0x1142e5,_0x56cc31){return _0x1142e5%_0x56cc31;},'ZOpfG':'timeSpent'};if(_0x5a380d[_0x26085f(0xc7)](currentMode,_0x26085f(0x167))||currentMode===_0x5a380d[_0x26085f(0x1d0)]){document[_0x26085f(0x94)](_0x5a380d[_0x26085f(0x6e)])[_0x26085f(0x2a6)]=stats[_0x26085f(0x231)],document[_0x26085f(0x94)](_0x5a380d['dtEIj'])[_0x26085f(0x2a6)]=stats[_0x26085f(0x298)],document[_0x26085f(0x94)](_0x5a380d['dMyuU'])['textContent']=stats[_0x26085f(0x225)];const _0x3aa705=stats['totalAttempted']>0x0?Math['round'](_0x5a380d[_0x26085f(0x191)](_0x5a380d[_0x26085f(0xf9)](stats[_0x26085f(0x231)],stats['totalAttempted']),0x64)):0x0;document['getElementById'](_0x5a380d[_0x26085f(0x148)])[_0x26085f(0x2a6)]=_0x5a380d[_0x26085f(0x1dc)](_0x3aa705,'%'),stats[_0x26085f(0x2f8)]=questionStates[_0x26085f(0x76)]((_0x46fb2c,_0x2c1a36)=>_0x46fb2c+_0x2c1a36[_0x26085f(0x173)],0x0);const _0x58915e=Math[_0x26085f(0xaf)](stats[_0x26085f(0x2f8)]/0x3e8),_0xea73d3=Math[_0x26085f(0xaf)](_0x5a380d[_0x26085f(0x1a3)](_0x58915e,0x3c)),_0xf43c58=_0x5a380d[_0x26085f(0xba)](_0x58915e,0x3c);document[_0x26085f(0x94)](_0x5a380d['ZOpfG'])[_0x26085f(0x2a6)]=_0x5a380d[_0x26085f(0x1dc)](_0x5a380d['IWDlF'](_0xea73d3,':'),_0xf43c58[_0x26085f(0x1b7)]()[_0x26085f(0x9a)](0x2,'0'));}}function setupVideo(_0x281044,_0x53f437){const _0x3b79b6=_0x38e45b,_0x27ca13={'hQveN':_0x3b79b6(0x1ed)};if(Hls[_0x3b79b6(0x109)]()){const _0x4001a0=new Hls();_0x4001a0[_0x3b79b6(0x196)](_0x53f437),_0x4001a0['attachMedia'](_0x281044);}else _0x281044['canPlayType'](_0x27ca13[_0x3b79b6(0xea)])&&(_0x281044[_0x3b79b6(0x2dc)]=_0x53f437);}function displayQuestion(){const _0x310b3e=_0x38e45b,_0x3a27e1={'zNQdV':_0x310b3e(0x1ed),'mUVuH':function(_0x232d0f,_0x4448eb){return _0x232d0f!==_0x4448eb;},'tbyCw':_0x310b3e(0x89),'nPrae':function(_0xdfb123,_0x27f3d8){return _0xdfb123+_0x27f3d8;},'FzLvX':function(_0x366fbd,_0x4f297a){return _0x366fbd===_0x4f297a;},'dWoeI':_0x310b3e(0x192),'AHrdf':_0x310b3e(0x1c8),'xrRPv':function(_0x5a29f1){return _0x5a29f1();},'qZLyB':_0x310b3e(0x119),'IoMFF':_0x310b3e(0x14f),'jIvqv':_0x310b3e(0x243),'HNwfF':_0x310b3e(0xfe),'vNyZZ':function(_0x3ffe5c,_0x278473){return _0x3ffe5c(_0x278473);},'eNxDA':_0x310b3e(0x2f4),'YJxBh':'questionText','xSsCA':_0x310b3e(0xc9),'lnGwP':function(_0x133680,_0x27f918){return _0x133680*_0x27f918;},'Gireb':function(_0x7109eb,_0x5736d1){return _0x7109eb/_0x5736d1;},'yrPyV':_0x310b3e(0x11d),'qSxzc':function(_0x16fa46,_0x437985){return _0x16fa46+_0x437985;},'owRoh':_0x310b3e(0x282),'mQhXI':_0x310b3e(0x230),'NcVNg':'No\x20question\x20text\x20available','sbQeJ':'optionsContainer','bzTzI':_0x310b3e(0x7a),'ItsiX':_0x310b3e(0x9d),'VJbtN':function(_0x3b8f28,_0x59db3d){return _0x3b8f28===_0x59db3d;},'qRWck':_0x310b3e(0x1c3),'TmdVI':function(_0x291d9d,_0xc7ee32){return _0x291d9d===_0xc7ee32;}};if(!questionsData||_0x3a27e1[_0x310b3e(0x1b9)](questionsData[_0x310b3e(0x2fd)],0x0)){document[_0x310b3e(0x94)](_0x3a27e1[_0x310b3e(0xa3)])[_0x310b3e(0x122)]=_0x3a27e1[_0x310b3e(0x11c)];return;};const _0x5b13e8=questionsData[currentQuestionIndex];questionStartTime=Date[_0x310b3e(0x19e)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x193e43=_0x3a27e1[_0x310b3e(0x234)](_0x3a27e1[_0x310b3e(0x251)](currentQuestionIndex+0x1,questionsData[_0x310b3e(0x2fd)]),0x64);document[_0x310b3e(0x94)](_0x3a27e1[_0x310b3e(0xdc)])['style'][_0x310b3e(0xc4)]=_0x3a27e1['qSxzc'](_0x193e43,'%'),document['getElementById'](_0x310b3e(0x1e2))[_0x310b3e(0x2a6)]=currentQuestionIndex+0x1,_0x3a27e1['xrRPv'](updateQuestionNav),document[_0x310b3e(0x94)](_0x310b3e(0x13f))[_0x310b3e(0x2ba)]=_0x3a27e1[_0x310b3e(0x1b9)](currentQuestionIndex,0x0),document[_0x310b3e(0x94)](_0x3a27e1[_0x310b3e(0x19b)])[_0x310b3e(0xab)][_0x310b3e(0x143)](_0x3a27e1[_0x310b3e(0x289)]),document[_0x310b3e(0x94)](_0x3a27e1['YJxBh'])[_0x310b3e(0x122)]=_0x5b13e8[_0x310b3e(0x96)]||_0x3a27e1[_0x310b3e(0x2f3)];let _0x24b90d='';if(_0x5b13e8[_0x310b3e(0x217)])_0x24b90d+=_0x310b3e(0x17a)+_0x5b13e8[_0x310b3e(0x217)]+_0x310b3e(0x29d);if(_0x5b13e8[_0x310b3e(0x2ff)])_0x24b90d+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x5b13e8['question_video']+_0x310b3e(0x1be);_0x5b13e8[_0x310b3e(0x24e)]&&_0x5b13e8[_0x310b3e(0x24e)][_0x310b3e(0x1df)](_0x4247d0=>{const _0x56b212=_0x310b3e;if(_0x3a27e1[_0x56b212(0x10f)](_0x3a27e1[_0x56b212(0x8e)],_0x56b212(0x89))){if(_0x3aa30d[_0x56b212(0x109)]()){const _0x3ed53e=new _0x570bb6();_0x3ed53e[_0x56b212(0x196)](_0x501c58),_0x3ed53e[_0x56b212(0x227)](_0x2c58d3);}else _0x365f52[_0x56b212(0xfa)](_0x3a27e1[_0x56b212(0x228)])&&(_0x341c8e[_0x56b212(0x2dc)]=_0x5f3d9b);}else{if(_0x4247d0)_0x24b90d+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0x4247d0+_0x56b212(0x74);}});document[_0x310b3e(0x94)](_0x310b3e(0x290))['innerHTML']=_0x24b90d;const _0x2560ee=document['getElementById'](_0x3a27e1[_0x310b3e(0x133)]);_0x2560ee[_0x310b3e(0x122)]='',_0x2560ee['classList'][_0x310b3e(0x120)](_0x3a27e1[_0x310b3e(0x194)]),_0x5b13e8[_0x310b3e(0xec)]&&Array['isArray'](_0x5b13e8[_0x310b3e(0xec)])&&(_0x5b13e8['choices'][_0x310b3e(0x1df)]((_0x26c0a8,_0xd85b23)=>{const _0x3993c0=_0x310b3e,_0x49d2e3=String[_0x3993c0(0x15d)](_0x3a27e1[_0x3993c0(0x73)](0x41,_0xd85b23)),_0x116c98=_0x3a27e1[_0x3993c0(0x1b9)](selectedOption,_0xd85b23),_0x243484=document[_0x3993c0(0x2b3)](_0x3a27e1['dWoeI']);_0x243484[_0x3993c0(0x122)]=_0x3993c0(0x107)+(_0x116c98?_0x3a27e1['AHrdf']:'')+'\x22\x20data-option-index=\x22'+_0xd85b23+_0x3993c0(0x31e)+_0x49d2e3+_0x3993c0(0x23e)+(_0x26c0a8['text']||_0x3993c0(0xca)+(_0xd85b23+0x1))+_0x3993c0(0x184),_0x2560ee[_0x3993c0(0x2a1)](_0x243484);}),_0x2560ee[_0x310b3e(0x306)](_0x3a27e1[_0x310b3e(0x1fa)],function(_0x33e102){const _0x344349=_0x310b3e;if(_0x3a27e1[_0x344349(0x248)]===_0x3a27e1[_0x344349(0x248)]){const _0xc4017a=_0x33e102[_0x344349(0x2b1)][_0x344349(0xaa)](_0x3a27e1['IoMFF']);if(_0xc4017a){if(_0x3a27e1[_0x344349(0x1b9)](_0x3a27e1[_0x344349(0xda)],_0x3a27e1[_0x344349(0x2cf)])){const _0x4a45fc=_0x5d0580[_0x344349(0x118)](_0x50f500,arguments);return _0x2fb1a8=null,_0x4a45fc;}else{const _0x711c04=_0x3a27e1[_0x344349(0x279)](parseInt,_0xc4017a[_0x344349(0x140)](_0x3a27e1['eNxDA']));_0x3a27e1['vNyZZ'](selectOption,_0x711c04);}}}else _0x3a27e1[_0x344349(0x26e)](_0x39dd65);})),_0x3a27e1['xrRPv'](updateBookmarkButton),_0x3a27e1[_0x310b3e(0x26e)](updateMarkReviewButton),(_0x3a27e1[_0x310b3e(0xb2)](currentMode,_0x3a27e1[_0x310b3e(0x25e)])||_0x3a27e1[_0x310b3e(0x135)](currentMode,_0x310b3e(0x152)))&&!isQuizCompleted&&startTimer();}function selectOption(_0x31e81b){const _0x1b7b8f=_0x38e45b,_0x98523f={'XuQbQ':_0x1b7b8f(0x1c8),'uuWeJ':_0x1b7b8f(0x132),'GFJWy':'answered','DQYVD':_0x1b7b8f(0x14f),'XRhTG':function(_0x2e3ab4,_0x40c37c){return _0x2e3ab4===_0x40c37c;},'IbHzB':_0x1b7b8f(0x167),'rggvJ':'timed_study','NewrR':function(_0x560fc6){return _0x560fc6();},'SgtXu':function(_0x2537ec,_0x251a8d){return _0x2537ec===_0x251a8d;},'LrHjR':'gedTw','AvOBT':function(_0x5232aa){return _0x5232aa();}},_0x571bfa=document['getElementById'](_0x98523f['uuWeJ']);if(_0x571bfa['classList'][_0x1b7b8f(0x2ce)](_0x98523f[_0x1b7b8f(0x261)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x1b7b8f(0x173)]+=Date[_0x1b7b8f(0x19e)]()-questionStartTime,questionStartTime=Date[_0x1b7b8f(0x19e)]());selectedOption=_0x31e81b,questionStates[currentQuestionIndex]['selectedAnswer']=_0x31e81b,document['querySelectorAll'](_0x98523f[_0x1b7b8f(0x22c)])[_0x1b7b8f(0x1df)]((_0x94dc6c,_0x568ce3)=>{const _0x390300=_0x1b7b8f;_0x94dc6c['classList'][_0x390300(0x131)](_0x98523f[_0x390300(0x208)],_0x568ce3===_0x31e81b);});if(_0x98523f[_0x1b7b8f(0x27f)](currentMode,_0x98523f[_0x1b7b8f(0xf1)])||_0x98523f[_0x1b7b8f(0x27f)](currentMode,_0x98523f[_0x1b7b8f(0x1f7)]))_0x98523f[_0x1b7b8f(0x31f)](processAnswer);else{if(_0x98523f['SgtXu']('gedTw',_0x98523f[_0x1b7b8f(0x88)]))_0x98523f[_0x1b7b8f(0x315)](questionStates[currentQuestionIndex][_0x1b7b8f(0x20c)],'not_attempted')&&(questionStates[currentQuestionIndex][_0x1b7b8f(0x20c)]=_0x98523f[_0x1b7b8f(0x261)],stats[_0x1b7b8f(0x225)]++,stats[_0x1b7b8f(0xcb)]--),_0x98523f['AvOBT'](updateQuestionNav);else{const _0x2027bf=_0xa88e[_0x1b7b8f(0x118)](_0x5afefb,arguments);return _0x34d11a=null,_0x2027bf;}}_0x98523f[_0x1b7b8f(0x31f)](saveProgress);}function processAnswer(){const _0xd0988=_0x38e45b,_0x2b14ec={'RFVoH':_0xd0988(0x1a0),'bjoYI':_0xd0988(0xb9),'WkIUv':function(_0x37bbf2,_0x1eac0a){return _0x37bbf2===_0x1eac0a;},'OQYDN':'not_attempted','JmuvL':function(_0x22613c,_0x26d0de){return _0x22613c!==_0x26d0de;},'ycLVe':_0xd0988(0xb3),'gjRpf':'incorrect','PQIvo':function(_0xadda93){return _0xadda93();},'BVUCz':function(_0x293d1a,_0x4b499f){return _0x293d1a(_0x4b499f);}},_0x489410=questionsData[currentQuestionIndex],_0x197cc2=_0x489410[_0xd0988(0x242)];if(_0x2b14ec['WkIUv'](selectedOption,null))return;const _0x4b8fe5=_0x489410[_0xd0988(0xec)][selectedOption],_0x2b8794=_0x4b8fe5['id']===_0x197cc2;if(_0x2b14ec[_0xd0988(0x23a)](questionStates[currentQuestionIndex][_0xd0988(0x20c)],_0x2b14ec[_0xd0988(0x2a0)])){if(_0x2b14ec[_0xd0988(0x209)](_0x2b14ec[_0xd0988(0x27d)],_0x2b14ec['ycLVe'])){const _0x35b668=_0xd90d65[_0xd0988(0x2e8)](_0x5f1ede[_0xd0988(0x7e)](_0x2b14ec[_0xd0988(0x13d)]))||{};_0x35b668[_0x25e4a1]&&(delete _0x35b668[_0x27b6a1],_0x314c2e[_0xd0988(0x127)](_0x2b14ec['RFVoH'],_0x57432d[_0xd0988(0x275)](_0x35b668)),_0xc5107c[_0xd0988(0x1a1)](_0x2b14ec['bjoYI']));}else{stats[_0xd0988(0x225)]++,stats[_0xd0988(0xcb)]--;if(_0x2b8794)stats[_0xd0988(0x231)]++;else stats['incorrectAnswers']++;}}questionStates[currentQuestionIndex][_0xd0988(0x20c)]=_0x2b8794?_0xd0988(0x71):_0x2b14ec['gjRpf'],_0x2b14ec[_0xd0988(0xae)](updateStats),_0x2b14ec[_0xd0988(0x247)](showInlineFeedback,_0x2b8794),updateQuestionNav();}function showInlineFeedback(_0x46a6e8){const _0x5f0f94=_0x38e45b,_0x24db42={'qcXck':function(_0x5921c9){return _0x5921c9();},'WoEaA':_0x5f0f94(0x2e9),'YHlLu':_0x5f0f94(0x1c8),'unXyb':function(_0x540bd7,_0x29e03a){return _0x540bd7===_0x29e03a;},'nvKVG':_0x5f0f94(0x71),'uoDyU':_0x5f0f94(0x28a),'BhzRO':function(_0x47167e,_0x439a20){return _0x47167e!==_0x439a20;},'eIkdq':_0x5f0f94(0x167),'JZcGQ':'answered'};if(_0x24db42['BhzRO'](currentMode,_0x24db42[_0x5f0f94(0x98)])&&currentMode!==_0x5f0f94(0x1c3))return;const _0x554570=document[_0x5f0f94(0x94)]('optionsContainer'),_0x4b5bca=_0x554570[_0x5f0f94(0x15b)]('.option-button'),_0x43ceec=questionsData[currentQuestionIndex],_0x3f1844=_0x43ceec[_0x5f0f94(0x242)];let _0x1e1931=_0x43ceec[_0x5f0f94(0xec)]['findIndex'](_0x3689ab=>_0x3689ab['id']===_0x3f1844);_0x554570['classList'][_0x5f0f94(0x143)](_0x24db42['JZcGQ']),_0x4b5bca[_0x5f0f94(0x1df)]((_0x581c9b,_0x4e8641)=>{const _0x3e3df2=_0x5f0f94;if(_0x24db42['WoEaA']===_0x3e3df2(0x2e9)){_0x581c9b[_0x3e3df2(0xab)][_0x3e3df2(0x120)](_0x24db42[_0x3e3df2(0x229)]);if(_0x24db42[_0x3e3df2(0x182)](_0x4e8641,_0x1e1931))_0x581c9b[_0x3e3df2(0xab)][_0x3e3df2(0x143)](_0x24db42[_0x3e3df2(0x1e3)]);else{if(_0x4e8641===selectedOption&&!_0x46a6e8)_0x581c9b[_0x3e3df2(0xab)]['add'](_0x24db42[_0x3e3df2(0x299)]);}}else _0x24db42[_0x3e3df2(0x260)](_0x1d5381);}),showSolution();}function showSolution(){const _0x2e0a6e=_0x38e45b,_0x4a0052={'BPfDX':function(_0x25f3bf){return _0x25f3bf();},'QskwH':function(_0xabe181,_0x4f9323){return _0xabe181!==_0x4f9323;},'bUXPW':'timed_study','WuDNR':'solutionText','bzmtc':_0x2e0a6e(0xd9),'HRylN':_0x2e0a6e(0xcf),'cOfXj':function(_0x2d0d8a,_0x1f82e3,_0x384463){return _0x2d0d8a(_0x1f82e3,_0x384463);},'zosDy':_0x2e0a6e(0x1d8),'HklrT':_0x2e0a6e(0x230),'cZkcR':_0x2e0a6e(0x292),'CUcNH':function(_0x73d597,_0x113680){return _0x73d597===_0x113680;},'QSrUd':_0x2e0a6e(0x1cf),'KeuqR':_0x2e0a6e(0x13a)};if(_0x4a0052['QskwH'](currentMode,_0x2e0a6e(0x167))&&_0x4a0052[_0x2e0a6e(0xa5)](currentMode,_0x4a0052[_0x2e0a6e(0x1f8)]))return;const _0x48b853=questionsData[currentQuestionIndex];document[_0x2e0a6e(0x94)](_0x4a0052[_0x2e0a6e(0x286)])[_0x2e0a6e(0x122)]=_0x48b853[_0x2e0a6e(0x1db)]||_0x4a0052[_0x2e0a6e(0x104)];const _0x1684a2=document[_0x2e0a6e(0x94)](_0x4a0052[_0x2e0a6e(0x22a)]),_0x6a8c31=document[_0x2e0a6e(0x94)]('explanationVideoPlayer'),_0x5a028e=_0x48b853['explanation_video'];if(_0x5a028e){_0x1684a2[_0x2e0a6e(0xab)][_0x2e0a6e(0x120)](_0x2e0a6e(0x230));if(_0x5a028e[_0x2e0a6e(0x235)](_0x2e0a6e(0x25d)))_0x4a0052['cOfXj'](setupVideo,_0x6a8c31,_0x5a028e);else _0x6a8c31[_0x2e0a6e(0x2dc)]=_0x5a028e;}else _0x2e0a6e(0x1d8)===_0x4a0052[_0x2e0a6e(0x1eb)]?_0x1684a2[_0x2e0a6e(0xab)][_0x2e0a6e(0x143)](_0x4a0052[_0x2e0a6e(0x20a)]):_0x4a0052[_0x2e0a6e(0x226)](_0x468d97);const _0x3a4629=document[_0x2e0a6e(0x94)](_0x4a0052[_0x2e0a6e(0x1d6)]);_0x3a4629[_0x2e0a6e(0x122)]='';_0x48b853[_0x2e0a6e(0xdb)]&&(_0x4a0052[_0x2e0a6e(0x319)](_0x4a0052[_0x2e0a6e(0x28b)],'HiGSt')?_0x3a4629[_0x2e0a6e(0x122)]+=_0x2e0a6e(0x108)+_0x48b853['explanation_audio_eng']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>':_0x223fe2[_0x1b7b07['questionIndex']]['bookmarked']=!![]);_0x48b853['explanation_audio_hin']&&(_0x3a4629[_0x2e0a6e(0x122)]+=_0x2e0a6e(0x258)+_0x48b853[_0x2e0a6e(0x254)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');const _0x286461=document[_0x2e0a6e(0x94)](_0x4a0052[_0x2e0a6e(0x2c8)]);_0x286461['innerHTML']='',_0x48b853[_0x2e0a6e(0x1b5)]&&_0x48b853['explanation_images'][_0x2e0a6e(0x1df)](_0x32e738=>{const _0x20c5a1=_0x2e0a6e;if(_0x32e738)_0x286461['innerHTML']+=_0x20c5a1(0x115)+_0x32e738+_0x20c5a1(0x1d4);}),document[_0x2e0a6e(0x94)](_0x2e0a6e(0x282))[_0x2e0a6e(0xab)][_0x2e0a6e(0x120)](_0x4a0052[_0x2e0a6e(0x20a)]);}function submitQuiz(){const _0x52c2a1=_0x38e45b,_0x3acd07={'jonVx':function(_0x2d989e,_0x19074a){return _0x2d989e!==_0x19074a;},'zmyDi':function(_0x473aa6,_0x549190){return _0x473aa6===_0x549190;},'FYHJu':_0x52c2a1(0x71),'ICIOF':_0x52c2a1(0x28a),'Ulqsh':function(_0x51cf2e,_0x1ee53b){return _0x51cf2e(_0x1ee53b);},'fQEFN':function(_0xc6980b,_0x331432){return _0xc6980b(_0x331432);},'SSGHh':_0x52c2a1(0x2e1),'VMtrL':function(_0x5c3d44,_0x462750){return _0x5c3d44-_0x462750;},'PvDLt':function(_0xffb06a,_0x219c26){return _0xffb06a-_0x219c26;},'zLcKG':function(_0x58a125,_0x4dfc18){return _0x58a125+_0x4dfc18;},'lzQLh':'quizPerformanceData','KSADz':function(_0x33da15){return _0x33da15();},'MfHbj':function(_0x4542a2,_0x33aabb,_0x32c35b,_0x9e3f1b,_0x11e434){return _0x4542a2(_0x33aabb,_0x32c35b,_0x9e3f1b,_0x11e434);},'JEXLf':function(_0x59c46e,_0x2340e9){return _0x59c46e-_0x2340e9;}};if(timer)_0x3acd07[_0x52c2a1(0x188)](clearInterval,timer);if(!_0x3acd07['fQEFN'](confirm,_0x3acd07[_0x52c2a1(0x236)]))return;isQuizCompleted=!![];let _0x102017=0x0,_0x467a8c=0x0;const _0x112339=_0x3acd07[_0x52c2a1(0x10e)](Date['now'](),quizStartTime);questionsData[_0x52c2a1(0x1df)]((_0x11fde6,_0x80bf77)=>{const _0x37dddc=_0x52c2a1,_0x3c0e29=questionStates[_0x80bf77];_0x3acd07[_0x37dddc(0x83)](_0x3c0e29['selectedAnswer'],null)&&(_0x3acd07[_0x37dddc(0x8a)](_0x11fde6[_0x37dddc(0xec)][_0x3c0e29['selectedAnswer']]['id'],_0x11fde6[_0x37dddc(0x242)])?(_0x102017++,_0x3c0e29['status']=_0x3acd07[_0x37dddc(0x126)]):(_0x467a8c++,_0x3c0e29['status']=_0x3acd07[_0x37dddc(0x2ef)]));});const _0x1d87d2=JSON[_0x52c2a1(0x2e8)](localStorage[_0x52c2a1(0x7e)](_0x52c2a1(0x181)))||[];_0x1d87d2[_0x52c2a1(0xf8)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x52c2a1(0x19e)](),'totalTime':_0x112339,'stats':{'correct':_0x102017,'incorrect':_0x467a8c,'notAttempted':_0x3acd07['PvDLt'](questionsData[_0x52c2a1(0x2fd)],_0x3acd07[_0x52c2a1(0x1c2)](_0x102017,_0x467a8c))}}),localStorage[_0x52c2a1(0x127)](_0x3acd07['lzQLh'],JSON[_0x52c2a1(0x275)](_0x1d87d2)),stats[_0x52c2a1(0x231)]=_0x102017,stats['incorrectAnswers']=_0x467a8c,_0x3acd07[_0x52c2a1(0xd7)](markQuizAsCompleted),_0x3acd07[_0x52c2a1(0xe8)](showPerformanceAnalysis,_0x102017,_0x467a8c,_0x3acd07[_0x52c2a1(0x1bc)](questionsData[_0x52c2a1(0x2fd)],_0x3acd07['zLcKG'](_0x102017,_0x467a8c)),_0x112339);}function showPerformanceAnalysis(_0x47cbdd,_0x3b6a48,_0x2a3c3e,_0x2d3cf8){const _0x36620a=_0x38e45b,_0x3838e6={'FbAhl':_0x36620a(0x277),'Uahfw':function(_0x155110,_0x39f632){return _0x155110>_0x39f632;},'AftJP':function(_0x45ec59,_0x443bb7){return _0x45ec59+_0x443bb7;},'LMOwc':function(_0x5b4ce5,_0x6b9252){return _0x5b4ce5*_0x6b9252;},'EZKwh':function(_0x539bd0,_0x5b3c2a){return _0x539bd0/_0x5b3c2a;},'zfjXB':function(_0x2426d4,_0x57ecd2){return _0x2426d4*_0x57ecd2;},'ACchj':function(_0x25eb7f,_0x13eef5){return _0x25eb7f-_0x13eef5;},'vPeUr':function(_0x2ef6dd,_0xf001de){return _0x2ef6dd*_0xf001de;},'vjcVY':_0x36620a(0x284),'nIchm':_0x36620a(0x92),'ZeWZF':_0x36620a(0x1f4),'DFoNT':_0x36620a(0x110),'HuuoV':_0x36620a(0x137),'WbzMn':function(_0x32c6a0,_0x4018aa){return _0x32c6a0/_0x4018aa;},'sPoDM':function(_0x203ffa,_0x9666a6){return _0x203ffa%_0x9666a6;},'voPsk':_0x36620a(0x1cb),'LGISD':function(_0x1e2e27,_0x3a14fb){return _0x1e2e27/_0x3a14fb;},'rbpfv':_0x36620a(0x2d5),'kALSx':_0x36620a(0x230)},_0x5b69b4=document['getElementById'](_0x3838e6[_0x36620a(0x2e0)]),_0x310813=_0x3838e6[_0x36620a(0x267)](_0x3838e6[_0x36620a(0x99)](_0x47cbdd,_0x3b6a48),0x0)?Math[_0x36620a(0x8b)](_0x3838e6['LMOwc'](_0x3838e6[_0x36620a(0xb7)](_0x47cbdd,_0x3838e6[_0x36620a(0x99)](_0x47cbdd,_0x3b6a48)),0x64)):0x0,_0x232b16=_0x3838e6[_0x36620a(0x116)](0x2,Math['PI'])*0x41,_0x264bd4=document[_0x36620a(0x94)](_0x36620a(0x13b));_0x264bd4[_0x36620a(0x1d1)][_0x36620a(0xed)]=_0x232b16+'\x20'+_0x232b16,_0x264bd4[_0x36620a(0x1d1)][_0x36620a(0xa1)]=_0x3838e6['ACchj'](_0x232b16,_0x3838e6[_0x36620a(0x93)](_0x310813/0x64,_0x232b16)),document[_0x36620a(0x94)](_0x3838e6['vjcVY'])['textContent']=_0x310813+'%',document[_0x36620a(0x94)](_0x3838e6[_0x36620a(0xee)])[_0x36620a(0x2a6)]=questionsData[_0x36620a(0x2fd)],document[_0x36620a(0x94)](_0x3838e6[_0x36620a(0x1ec)])[_0x36620a(0x2a6)]=_0x47cbdd,document[_0x36620a(0x94)](_0x3838e6['DFoNT'])[_0x36620a(0x2a6)]=_0x3b6a48,document[_0x36620a(0x94)](_0x3838e6[_0x36620a(0x1c1)])[_0x36620a(0x2a6)]=_0x2a3c3e;const _0x398350=Math['floor'](_0x3838e6[_0x36620a(0x17d)](_0x2d3cf8,0xea60)),_0x2d28b9=Math[_0x36620a(0xaf)](_0x3838e6['EZKwh'](_0x3838e6[_0x36620a(0xfd)](_0x2d3cf8,0xea60),0x3e8));document[_0x36620a(0x94)](_0x3838e6[_0x36620a(0x21b)])['textContent']=_0x398350+':'+_0x2d28b9[_0x36620a(0x1b7)]()[_0x36620a(0x9a)](0x2,'0');const _0x23a7d7=_0x2d3cf8/questionsData['length'],_0x3baac1=Math['floor'](_0x3838e6['LGISD'](_0x23a7d7,0xea60)),_0xcb4f5b=Math[_0x36620a(0xaf)](_0x3838e6[_0x36620a(0xb7)](_0x3838e6[_0x36620a(0xfd)](_0x23a7d7,0xea60),0x3e8));document['getElementById'](_0x3838e6[_0x36620a(0x149)])['textContent']=_0x3baac1+':'+_0xcb4f5b[_0x36620a(0x1b7)]()[_0x36620a(0x9a)](0x2,'0'),_0x5b69b4[_0x36620a(0xab)][_0x36620a(0x120)](_0x3838e6['kALSx']);}function closePerformanceModal(){const _0x443157=_0x38e45b,_0x519aa4={'SlpqY':_0x443157(0x277),'cdngG':_0x443157(0x230)};document[_0x443157(0x94)](_0x519aa4[_0x443157(0x12b)])[_0x443157(0xab)][_0x443157(0x143)](_0x519aa4['cdngG']);}function reviewQuestions(){const _0x1af7f0=_0x38e45b,_0x1ae351={'WldHd':function(_0x4c018f){return _0x4c018f();},'JkflO':function(_0x173747,_0x48a131){return _0x173747===_0x48a131;},'ChMyY':_0x1af7f0(0x26c),'liIDi':function(_0x2105c3,_0x2683e4){return _0x2105c3===_0x2683e4;},'yHYFK':'fcDjz','lFfup':_0x1af7f0(0x158),'YhwQp':function(_0x3f8761,_0x59504c){return _0x3f8761!==_0x59504c;},'kUtHi':function(_0x299052,_0x51c7e7){return _0x299052===_0x51c7e7;},'oEEBB':_0x1af7f0(0x71),'RMHgO':_0x1af7f0(0x28a),'OWnVt':'Incorrect','alcwn':function(_0x2703d3,_0x3ffbfc){return _0x2703d3+_0x3ffbfc;},'aduUy':function(_0x215df0,_0x3cff1d){return _0x215df0===_0x3cff1d;},'XttuO':_0x1af7f0(0x164),'NFiaF':_0x1af7f0(0x293),'OmCmi':'No\x20solution\x20available.','ezNks':'questionReviewSection','NTpJA':_0x1af7f0(0x230),'IPwCY':_0x1af7f0(0x2d0)};document[_0x1af7f0(0x94)](_0x1ae351[_0x1af7f0(0x6f)])['classList'][_0x1af7f0(0x120)](_0x1ae351[_0x1af7f0(0x244)]);const _0x584e64=document['getElementById'](_0x1ae351[_0x1af7f0(0x1e8)]);_0x584e64['innerHTML']='',questionsData[_0x1af7f0(0x1df)]((_0x1d541e,_0x37eab2)=>{const _0x12c321=_0x1af7f0,_0x294738={'dgaFj':function(_0x82f7c3,_0x2a394a){const _0x301f63=_0x3203;return _0x1ae351[_0x301f63(0xb0)](_0x82f7c3,_0x2a394a);},'LAvHE':'NaPPD','wpaBf':function(_0x44ee9c,_0x351658){return _0x1ae351['JkflO'](_0x44ee9c,_0x351658);},'ZYmSa':_0x1ae351[_0x12c321(0x18f)],'MwAnI':function(_0x339f97,_0x4f99b1){return _0x339f97+_0x4f99b1;}};if(_0x1ae351[_0x12c321(0x9b)](_0x1ae351[_0x12c321(0x200)],_0x12c321(0xc5)))_0x1ae351['WldHd'](_0x3206df);else{const _0x25005f=questionStates[_0x37eab2],_0x1977d5=_0x1d541e[_0x12c321(0x242)];let _0x555952='not-attempted',_0x40533c=_0x1ae351[_0x12c321(0x103)];if(_0x1ae351['YhwQp'](_0x25005f[_0x12c321(0xe5)],null)){const _0xc147ca=_0x1d541e['choices'][_0x25005f['selectedAnswer']];_0x1ae351['kUtHi'](_0xc147ca['id'],_0x1977d5)?(_0x555952=_0x1ae351[_0x12c321(0x1ab)],_0x40533c='Correct'):(_0x555952=_0x1ae351['RMHgO'],_0x40533c=_0x1ae351[_0x12c321(0x21a)]);}const _0x38c03a=document[_0x12c321(0x2b3)]('div');_0x38c03a[_0x12c321(0x294)]='review-question\x20'+_0x555952;let _0xbf9dc8=(_0x1d541e['choices']||[])[_0x12c321(0x1e5)]((_0x4385e9,_0x227931)=>{const _0x92aa51=_0x12c321,_0xd8554c={'koaYD':function(_0x1e9ac0,_0x432c38,_0x5c8d30){return _0x1e9ac0(_0x432c38,_0x5c8d30);}};if(_0x294738[_0x92aa51(0x86)](_0x92aa51(0x2f2),_0x294738[_0x92aa51(0x11b)])){const _0x5f3ce9=_0x294738[_0x92aa51(0x215)](_0x25005f[_0x92aa51(0xe5)],_0x227931),_0x23b17f=_0x294738['wpaBf'](_0x4385e9['id'],_0x1977d5);let _0xedb11a=_0x92aa51(0x263);if(_0x23b17f)_0xedb11a=_0x294738['ZYmSa'];else{if(_0x5f3ce9)_0xedb11a=_0x92aa51(0x1e4);}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0xedb11a+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+String[_0x92aa51(0x15d)](_0x294738[_0x92aa51(0x28f)](0x41,_0x227931))+_0x92aa51(0x8c)+_0x4385e9[_0x92aa51(0x96)]+_0x92aa51(0xf6);}else{const _0xa2421=_0x566f43['dataset']['src'];if(_0xa2421&&_0xa2421['includes']('.m3u8'))_0xd8554c[_0x92aa51(0x1b1)](_0x30adf6,_0xd0d9a3,_0xa2421);else _0xa2421&&(_0x21a9d1[_0x92aa51(0x2dc)]=_0xa2421);}})[_0x12c321(0x31d)]('');const _0xf8a680=_0x1d541e[_0x12c321(0x17e)]?'<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-'+_0x37eab2+_0x12c321(0x1f0)+_0x1d541e['explanation_video']+_0x12c321(0x17c):'';let _0x556378='';if(_0x1d541e['explanation_audio_eng'])_0x556378+=_0x12c321(0x2f0)+_0x1d541e[_0x12c321(0xdb)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x1d541e['explanation_audio_hin'])_0x556378+=_0x12c321(0x1ca)+_0x1d541e[_0x12c321(0x254)]+_0x12c321(0x29d);let _0x2244ed=(_0x1d541e['explanation_images']||[])[_0x12c321(0x1e5)](_0x13182c=>_0x13182c?_0x12c321(0x115)+_0x13182c+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')[_0x12c321(0x31d)]('');_0x38c03a[_0x12c321(0x122)]=_0x12c321(0x2ac)+_0x1ae351[_0x12c321(0x2b6)](_0x37eab2,0x1)+_0x12c321(0x268)+(_0x555952===_0x1ae351[_0x12c321(0x1ab)]?_0x12c321(0x16b):_0x1ae351[_0x12c321(0xc3)](_0x555952,_0x1ae351[_0x12c321(0xd6)])?_0x1ae351['XttuO']:_0x1ae351[_0x12c321(0x205)])+'-600\x20text-white\x22>'+_0x40533c+_0x12c321(0x24c)+_0x1d541e[_0x12c321(0x96)]+_0x12c321(0x271)+_0xbf9dc8+_0x12c321(0x1f5)+(_0x1d541e[_0x12c321(0x1db)]||_0x1ae351[_0x12c321(0x1c7)])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0xf8a680+_0x12c321(0x9f)+_0x556378+_0x12c321(0x9f)+_0x2244ed+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x584e64[_0x12c321(0x2a1)](_0x38c03a);}}),_0x1ae351['WldHd'](initializeReviewVideos);}function initializeReviewVideos(){const _0x4eff64=_0x38e45b,_0x22366e={'zZqsX':function(_0x14afd8){return _0x14afd8();},'ujLvk':_0x4eff64(0x1b8),'MwrfW':'.m3u8','ivYtB':function(_0x32943d,_0x27d06d){return _0x32943d!==_0x27d06d;},'PJsEu':_0x4eff64(0x1c0),'JcSGc':'ZwRHk','rMcXH':function(_0x40db9a,_0x53f744,_0x58482e){return _0x40db9a(_0x53f744,_0x58482e);}};document[_0x4eff64(0x15b)]('video[data-src]')['forEach'](_0x248d65=>{const _0x431e47=_0x4eff64,_0x445ddd={'dMLCy':function(_0x50f998){const _0x148d9c=_0x3203;return _0x22366e[_0x148d9c(0x2b8)](_0x50f998);},'uGPxU':_0x431e47(0xef),'FKdDd':_0x22366e[_0x431e47(0xbf)]},_0x245e7e=_0x248d65[_0x431e47(0x265)][_0x431e47(0x2dc)];if(_0x245e7e&&_0x245e7e[_0x431e47(0x235)](_0x22366e['MwrfW']))_0x22366e[_0x431e47(0x2c1)](_0x22366e[_0x431e47(0x2cb)],_0x22366e['JcSGc'])?_0x22366e['rMcXH'](setupVideo,_0x248d65,_0x245e7e):(_0x445ddd['dMLCy'](_0xfa6eb8),_0x10b83d[_0x431e47(0x94)](_0x445ddd[_0x431e47(0xd8)])[_0x431e47(0x1d1)][_0x431e47(0x1c6)]=_0x445ddd['FKdDd']);else _0x245e7e&&(_0x248d65['src']=_0x245e7e);});}function retakeQuiz(){const _0x5172b9=_0x38e45b,_0x287bfb={'lUuXU':_0x5172b9(0xef),'TDrxJ':_0x5172b9(0x176),'dXydd':function(_0x508827){return _0x508827();},'Cfwsz':function(_0xf5f1d4,_0x203387){return _0xf5f1d4(_0x203387);},'YBvfo':function(_0x1b7bfc,_0x44a729){return _0x1b7bfc===_0x44a729;},'cVlzw':'IzJmH','pYANk':_0x5172b9(0xfb),'cBIiR':function(_0xcd3b58){return _0xcd3b58();}};_0x287bfb[_0x5172b9(0x2aa)](confirm,_0x5172b9(0xcc))&&(window[_0x5172b9(0x2f9)][_0x5172b9(0xb6)][_0x5172b9(0x2cd)](_0x5172b9(0x2ab))&&(_0x287bfb['YBvfo'](_0x5172b9(0x16e),_0x287bfb['cVlzw'])?localStorage[_0x5172b9(0x129)](_0x287bfb[_0x5172b9(0x211)]):(_0x522a8c[_0x5172b9(0x94)](_0x287bfb[_0x5172b9(0x30a)])[_0x5172b9(0x1d1)][_0x5172b9(0x1c6)]=_0x287bfb[_0x5172b9(0x1c5)],_0x287bfb[_0x5172b9(0x1a4)](_0x1cabae))),_0x287bfb['cBIiR'](clearProgress),location[_0x5172b9(0xe6)]());}function loadBookmarkedQuestions(){const _0x30d72d=_0x38e45b,_0x289d5b={'Dycwa':function(_0x406955,_0x2f0ed1){return _0x406955!==_0x2f0ed1;},'ZbAFa':_0x30d72d(0xe7),'Vrrit':function(_0x3bed02,_0x4dcdff){return _0x3bed02<_0x4dcdff;},'EqZzE':function(_0x38b799,_0x155f71){return _0x38b799!==_0x155f71;},'rVpxm':'gLHLZ'},_0x2e3dce=JSON[_0x30d72d(0x2e8)](localStorage[_0x30d72d(0x7e)](_0x30d72d(0x1c9)))||[];_0x2e3dce[_0x30d72d(0x1df)](_0x492a94=>{const _0x5c21e3=_0x30d72d,_0x595bb2={'BavRX':_0x5c21e3(0x1a0),'qsjLN':function(_0x218e5f){return _0x218e5f();},'QTNZA':_0x5c21e3(0x1b8)};if(_0x289d5b[_0x5c21e3(0x281)](_0x5c21e3(0x31c),_0x5c21e3(0x1d2))){if(_0x492a94[_0x5c21e3(0x1d7)][_0x5c21e3(0x235)](quizName['toLowerCase']()[_0x5c21e3(0x2e2)](/ /g,'-'))){if(_0x289d5b[_0x5c21e3(0x81)]===_0x5c21e3(0xe7))_0x289d5b[_0x5c21e3(0x1c4)](_0x492a94[_0x5c21e3(0x276)],questionsData[_0x5c21e3(0x2fd)])&&(_0x289d5b[_0x5c21e3(0x95)]('CmCeP',_0x289d5b['rVpxm'])?questionStates[_0x492a94['questionIndex']][_0x5c21e3(0x304)]=!![]:(_0x5c4a71[_0x490bd6][_0x5c21e3(0x173)]+=_0x2730a0['now']()-_0x3d34b5,_0x417016=_0x3fd24f[_0x5c21e3(0x19e)]()));else{const _0x252064=_0x1ea516[_0x5c21e3(0x2e8)](_0x1ad9dd[_0x5c21e3(0x7e)](_0x595bb2[_0x5c21e3(0x221)]))||{},_0xda44e9=_0x252064[_0x423997];if(_0xda44e9){const _0x280778=_0x5c21e3(0x1ae)[_0x5c21e3(0x1f3)]('|');let _0x375db9=0x0;while(!![]){switch(_0x280778[_0x375db9++]){case'0':_0x29deca=_0xda44e9['stats'];continue;case'1':_0x1a2f59=_0xda44e9[_0x5c21e3(0x153)];continue;case'2':_0x4089e2=_0xda44e9[_0x5c21e3(0x320)];continue;case'3':return!![];case'4':_0x409830[_0x5c21e3(0x1a1)]('Progress\x20loaded.');continue;case'5':_0x592ed2=_0xda44e9[_0x5c21e3(0xb1)];continue;}break;}}return![];}}}else _0x595bb2[_0x5c21e3(0x100)](_0x42ca71)?(_0x1d724d[_0x5c21e3(0x94)](_0x5c21e3(0xef))[_0x5c21e3(0x1d1)][_0x5c21e3(0x1c6)]=_0x5c21e3(0x176),_0x595bb2[_0x5c21e3(0x100)](_0xaa2746)):(_0x296460(),_0x42a76e[_0x5c21e3(0x94)](_0x5c21e3(0xef))[_0x5c21e3(0x1d1)][_0x5c21e3(0x1c6)]=_0x595bb2['QTNZA']);});}function toggleBookmark(){const _0x14bc7b=_0x38e45b,_0x8664f6={'UvdkT':function(_0x127a47,_0x19e3c0){return _0x127a47===_0x19e3c0;},'avWGB':_0x14bc7b(0x1e1),'yFiaT':_0x14bc7b(0x15c),'HLQBg':function(_0x337a72){return _0x337a72();},'pIkcK':function(_0x3ef034){return _0x3ef034();}},_0x2650d8=!questionStates[currentQuestionIndex][_0x14bc7b(0x304)];questionStates[currentQuestionIndex][_0x14bc7b(0x304)]=_0x2650d8;let _0x49b85d=JSON['parse'](localStorage[_0x14bc7b(0x7e)]('bookmarkedQuestions'))||[];if(_0x2650d8){const _0x473327={'quizName':quizName,'quizFile':window[_0x14bc7b(0x2f9)]['pathname']['split']('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0x49b85d['push'](_0x473327);}else _0x8664f6[_0x14bc7b(0x2c0)](_0x8664f6[_0x14bc7b(0x101)],_0x8664f6['yFiaT'])?_0x189a25[_0x14bc7b(0x1b5)][_0x14bc7b(0x1df)](_0x55cc96=>{const _0x842932=_0x14bc7b;if(_0x55cc96)_0x13c56d[_0x842932(0x122)]+=_0x842932(0x115)+_0x55cc96+_0x842932(0x1d4);}):_0x49b85d=_0x49b85d[_0x14bc7b(0x25b)](_0xa10fb5=>!(_0xa10fb5[_0x14bc7b(0x1d7)][_0x14bc7b(0x235)](quizName[_0x14bc7b(0x25c)]()[_0x14bc7b(0x2e2)](/ /g,'-'))&&_0xa10fb5['questionIndex']===currentQuestionIndex));localStorage[_0x14bc7b(0x127)]('bookmarkedQuestions',JSON['stringify'](_0x49b85d)),_0x8664f6[_0x14bc7b(0x2b2)](updateBookmarkButton),_0x8664f6['pIkcK'](updateQuestionNav);}function updateBookmarkButton(){const _0x1de4d9=_0x38e45b,_0x196c5a={'IhJSC':_0x1de4d9(0x27e),'aiorN':_0x1de4d9(0x10c),'udsPe':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','WUxOl':_0x1de4d9(0x23f)},_0x3b6af6=document[_0x1de4d9(0x94)](_0x196c5a['IhJSC']),_0x5929be=document[_0x1de4d9(0x94)](_0x196c5a[_0x1de4d9(0x28e)]),_0x4b4332=questionStates[currentQuestionIndex][_0x1de4d9(0x304)];_0x3b6af6[_0x1de4d9(0x294)]=_0x4b4332?_0x1de4d9(0x12f):_0x196c5a[_0x1de4d9(0xc6)],_0x5929be[_0x1de4d9(0x2a6)]=_0x4b4332?_0x196c5a['WUxOl']:_0x1de4d9(0x233);}function toggleMarkForReview(){const _0x560b93={'jFRTC':function(_0x5a3faf){return _0x5a3faf();}};questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex]['markedForReview'],updateMarkReviewButton(),_0x560b93['jFRTC'](updateQuestionNav);}function updateMarkReviewButton(){const _0x3bf2b1=_0x38e45b,_0x284dc3={'ikvzD':_0x3bf2b1(0x31b),'fgdlv':_0x3bf2b1(0x12a),'yMBNS':_0x3bf2b1(0xce),'SmCLW':_0x3bf2b1(0x2be),'fOYCK':_0x3bf2b1(0x1d5),'GoDYr':'Mark\x20for\x20Review'},_0x2f9ecc=document[_0x3bf2b1(0x94)](_0x284dc3[_0x3bf2b1(0x1b3)]),_0xb5e485=document['getElementById'](_0x284dc3[_0x3bf2b1(0x2b7)]),_0x33d393=questionStates[currentQuestionIndex][_0x3bf2b1(0xfc)];_0x2f9ecc['className']=_0x33d393?_0x284dc3[_0x3bf2b1(0x24f)]:_0x284dc3[_0x3bf2b1(0x295)],_0xb5e485[_0x3bf2b1(0x2a6)]=_0x33d393?_0x284dc3['fOYCK']:_0x284dc3[_0x3bf2b1(0xe2)];}function previousQuestion(){const _0x2e800e=_0x38e45b,_0x1688b4={'kOoix':function(_0x3c1bc6,_0x2f5725){return _0x3c1bc6>_0x2f5725;},'rVjaq':function(_0x31c40a,_0x465b21){return _0x31c40a-_0x465b21;},'Tpjka':function(_0x302d9d){return _0x302d9d();}};_0x1688b4[_0x2e800e(0x2c3)](currentQuestionIndex,0x0)&&(questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x1688b4[_0x2e800e(0xe9)](Date['now'](),questionStartTime)),currentQuestionIndex--,displayQuestion(),_0x1688b4['Tpjka'](saveProgress));}function nextQuestion(){const _0x38ef18=_0x38e45b,_0x3c19bd={'SNEYp':function(_0x15253f){return _0x15253f();},'KZuCg':function(_0x282c8d,_0x4dcd2d){return _0x282c8d<=_0x4dcd2d;},'SxPDi':function(_0x2309c1,_0xe7b40d){return _0x2309c1(_0xe7b40d);},'xQAox':function(_0x1115f3,_0x4db91d){return _0x1115f3===_0x4db91d;},'banCb':_0x38ef18(0x152),'EUHLb':function(_0x464fe){return _0x464fe();},'PlWyE':function(_0x38c408){return _0x38c408();},'Syrfp':function(_0x1f94f4,_0x293d76){return _0x1f94f4-_0x293d76;},'kyMeX':function(_0x1b2703,_0x2be740){return _0x1b2703<_0x2be740;},'VbFyw':function(_0x2a6423,_0x33171a){return _0x2a6423===_0x33171a;},'SHOPI':_0x38ef18(0x309),'Tdzja':function(_0x3c77af,_0x237db1){return _0x3c77af===_0x237db1;},'AGoVC':'test','wiejN':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','gucLg':_0x38ef18(0x31a),'HzCUf':'rBDEC','IKqiD':_0x38ef18(0x20b),'MdEOl':_0x38ef18(0x308),'eQTqn':function(_0x46c2af,_0x5292dd){return _0x46c2af(_0x5292dd);},'cxMbW':_0x38ef18(0x21d),'yEiGQ':function(_0x57771d,_0x3c2790){return _0x57771d!==_0x3c2790;},'HWxUM':_0x38ef18(0x1f6),'thaGh':'KIMOc','IxETr':function(_0x2bca9b){return _0x2bca9b();},'RsTCn':function(_0x288d2c){return _0x288d2c();}};questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x3c19bd['Syrfp'](Date[_0x38ef18(0x19e)](),questionStartTime));if(_0x3c19bd[_0x38ef18(0x180)](currentQuestionIndex,questionsData[_0x38ef18(0x2fd)]-0x1)){if(_0x3c19bd[_0x38ef18(0x87)](_0x38ef18(0x160),_0x3c19bd[_0x38ef18(0xb8)])){const _0x25c387=new _0x21242a();_0x25c387[_0x38ef18(0x196)](_0x2e414a),_0x25c387[_0x38ef18(0x227)](_0x13560e);}else currentQuestionIndex++,_0x3c19bd[_0x38ef18(0x2e3)](displayQuestion),saveProgress();}else{if(_0x3c19bd['Tdzja'](currentMode,_0x3c19bd[_0x38ef18(0x18d)])||currentMode===_0x38ef18(0x152))confirm(_0x3c19bd[_0x38ef18(0x202)])&&(_0x3c19bd['gucLg']!==_0x3c19bd[_0x38ef18(0x20f)]?_0x3c19bd['SNEYp'](submitQuiz):(_0x26dab1--,_0x3c19bd[_0x38ef18(0x2e3)](_0x3b6d2b),_0x3c19bd[_0x38ef18(0x16f)](_0x1301ab,0x0)&&(_0x3c19bd[_0x38ef18(0x246)](_0x180db6,_0x160295),_0x3c19bd[_0x38ef18(0x124)](_0x1b90ef,_0x3c19bd[_0x38ef18(0x102)])?_0x3c19bd[_0x38ef18(0x2e3)](_0x304f19):_0x3c19bd[_0x38ef18(0x7b)](_0x3747b8))));else{if(_0x3c19bd['IKqiD']===_0x3c19bd['MdEOl']){if(_0x323bd3){const _0x2860ae=_0x391c38[_0x38ef18(0x118)](_0x508f77,arguments);return _0x5b4723=null,_0x2860ae;}}else _0x3c19bd['eQTqn'](confirm,_0x3c19bd['cxMbW'])&&(_0x3c19bd[_0x38ef18(0x179)](_0x3c19bd[_0x38ef18(0x2fc)],_0x3c19bd[_0x38ef18(0x291)])?(currentQuestionIndex=0x0,_0x3c19bd[_0x38ef18(0x2cc)](displayQuestion),_0x3c19bd[_0x38ef18(0x238)](saveProgress)):_0x3c19bd['PlWyE'](_0x26c549));}}}function _0x3203(_0x2187d0,_0x58a3f2){const _0x2a3305=_0x35ec();return _0x3203=function(_0x1f4c1c,_0x425c8d){_0x1f4c1c=_0x1f4c1c-0x6c;let _0x17907e=_0x2a3305[_0x1f4c1c];return _0x17907e;},_0x3203(_0x2187d0,_0x58a3f2);}function startTimer(){const _0x38b2bb=_0x38e45b,_0x56cf4c={'muAaW':_0x38b2bb(0x31b),'tqVuj':function(_0x12e1b0,_0x3b08bf){return _0x12e1b0===_0x3b08bf;},'uuHdo':_0x38b2bb(0x106),'vAdWD':function(_0x21052c,_0x174603){return _0x21052c===_0x174603;},'pMDmm':_0x38b2bb(0x152),'ctxxS':_0x38b2bb(0x1b2),'OsBPz':_0x38b2bb(0x176),'AFCcU':_0x38b2bb(0x14e),'NnroD':'studyModeLegend','MshcM':_0x38b2bb(0x72),'FnDVF':_0x38b2bb(0x1b8),'XZZuC':function(_0x558ecc,_0xaeb0a1){return _0x558ecc===_0xaeb0a1;},'gxICV':function(_0x1c42ae,_0x242aa8){return _0x1c42ae===_0x242aa8;},'rPCTr':_0x38b2bb(0x121),'zsIRG':'hidden','ckGAO':function(_0x40b5e3,_0x40df1d){return _0x40b5e3>=_0x40df1d;},'FEpyi':function(_0x1be048,_0x22f097){return _0x1be048<_0x22f097;},'jVSeI':function(_0x36982b){return _0x36982b();},'OWpvG':_0x38b2bb(0xfb),'WsVCL':function(_0x2b8a44,_0x454412){return _0x2b8a44<=_0x454412;},'RIvuz':_0x38b2bb(0x296),'QIsEq':'XAgUv','HrVen':function(_0x461649,_0x4ae595){return _0x461649(_0x4ae595);},'QJijG':function(_0xa34ebe,_0x427693){return _0xa34ebe!==_0x427693;},'tUMXc':'nYTxc','XEiMS':function(_0x25be68,_0x540571){return _0x25be68(_0x540571);},'NCzXg':function(_0x21cb3c,_0xdd9d2e,_0x3f033b){return _0x21cb3c(_0xdd9d2e,_0x3f033b);}};if(timer)_0x56cf4c[_0x38b2bb(0x75)](clearInterval,timer);timeRemaining=0x78,_0x56cf4c[_0x38b2bb(0x240)](updateTimerDisplay),timer=_0x56cf4c[_0x38b2bb(0x2d1)](setInterval,()=>{const _0x1df968=_0x38b2bb;timeRemaining--,updateTimerDisplay();if(_0x56cf4c[_0x1df968(0x25a)](timeRemaining,0x0)){if(_0x56cf4c[_0x1df968(0x27c)]===_0x56cf4c[_0x1df968(0x212)]){_0x4bc722=_0x3da67c[_0x1df968(0x19e)]();const _0x4a6f7f=_0x59c95c['getElementById'](_0x1df968(0x27e)),_0x1e4614=_0x598efc[_0x1df968(0x94)](_0x56cf4c['muAaW']),_0x2d5b1f=_0x58dd74[_0x1df968(0x94)](_0x1df968(0x171)),_0x1309df=_0x56cf4c[_0x1df968(0x24d)](_0x589af3,_0x56cf4c[_0x1df968(0x6c)])||_0x56cf4c[_0x1df968(0x199)](_0x2ac89b,_0x56cf4c[_0x1df968(0x1b0)]);_0x4cf3b3['getElementById'](_0x56cf4c[_0x1df968(0x30d)])[_0x1df968(0x1d1)][_0x1df968(0x1c6)]=_0x1309df?_0x56cf4c[_0x1df968(0x16c)]:_0x56cf4c[_0x1df968(0x1b6)],_0xcad831[_0x1df968(0x94)](_0x56cf4c[_0x1df968(0x21c)])[_0x1df968(0x1d1)][_0x1df968(0x1c6)]=_0x1309df?_0x56cf4c[_0x1df968(0x16c)]:'block',_0x171d90[_0x1df968(0x94)](_0x1df968(0xbb))[_0x1df968(0x1d1)][_0x1df968(0x1c6)]=_0x1309df?_0x56cf4c[_0x1df968(0x1b6)]:_0x56cf4c[_0x1df968(0x16c)],_0x452675[_0x1df968(0x94)](_0x56cf4c['MshcM'])[_0x1df968(0x1d1)]['display']=_0x1309df?_0x56cf4c[_0x1df968(0x1b6)]:_0x56cf4c['OsBPz'],_0x4a6f7f[_0x1df968(0x1d1)][_0x1df968(0x1c6)]=_0x1309df?_0x56cf4c[_0x1df968(0x16c)]:_0x56cf4c[_0x1df968(0x266)],_0x1e4614[_0x1df968(0x1d1)]['display']=_0x1309df?_0x1df968(0x1b8):_0x56cf4c[_0x1df968(0x16c)],_0x2d5b1f[_0x1df968(0x1d1)][_0x1df968(0x1c6)]=_0x1309df?_0x1df968(0x1b8):_0x56cf4c[_0x1df968(0x16c)],(_0x56cf4c['XZZuC'](_0x480395,_0x1df968(0x1c3))||_0x56cf4c[_0x1df968(0x2c5)](_0x2fe5c9,_0x56cf4c[_0x1df968(0x1b0)]))&&_0x13d6d2[_0x1df968(0x94)](_0x56cf4c['rPCTr'])[_0x1df968(0xab)][_0x1df968(0x120)](_0x56cf4c['zsIRG']),!_0x4df8c2(_0x443832)&&_0x56cf4c[_0x1df968(0xa9)](_0x46e48b,0x0)&&_0x56cf4c[_0x1df968(0x2fb)](_0x504256,_0x226ed0['length'])&&(_0x1df68f=_0x502465),_0x56cf4c['jVSeI'](_0x44b769),_0x56cf4c[_0x1df968(0x240)](_0x4c618d),_0x56c631(),_0x56cf4c[_0x1df968(0x240)](_0x9bfe45);}else _0x56cf4c['HrVen'](clearInterval,timer),_0x56cf4c[_0x1df968(0x264)](currentMode,_0x56cf4c[_0x1df968(0x1b0)])?_0x56cf4c[_0x1df968(0x240)](submitQuiz):_0x56cf4c[_0x1df968(0xd2)](_0x56cf4c[_0x1df968(0x2a3)],_0x56cf4c['tUMXc'])?_0x49c13b[_0x1df968(0x129)](_0x56cf4c[_0x1df968(0x80)]):nextQuestion();}},0x3e8);}function updateTimerDisplay(){const _0x4f31d9=_0x38e45b,_0x4f7e2f={'hfxwd':function(_0x12d938,_0x1d5468){return _0x12d938/_0x1d5468;},'ygpZF':function(_0x35abd0,_0x5560a9){return _0x35abd0%_0x5560a9;},'rclnV':function(_0x50fc38,_0x4ebcb8){return _0x50fc38+_0x4ebcb8;}},_0x5c5277=Math[_0x4f31d9(0xaf)](_0x4f7e2f[_0x4f31d9(0x250)](timeRemaining,0x3c)),_0x2566b6=_0x4f7e2f[_0x4f31d9(0x2d2)](timeRemaining,0x3c);document[_0x4f31d9(0x94)](_0x4f31d9(0x237))[_0x4f31d9(0x2a6)]=_0x4f7e2f[_0x4f31d9(0x1d9)](_0x5c5277+':',_0x2566b6['toString']()[_0x4f31d9(0x9a)](0x2,'0'));}function toggleSidebar(){const _0x41c921=_0x38e45b,_0x5c5800={'XyCZr':'quizSidebar','JhOkB':_0x41c921(0x22b)};document[_0x41c921(0x94)](_0x5c5800[_0x41c921(0x155)])['classList'][_0x41c921(0x131)](_0x5c5800[_0x41c921(0x2e7)]);}document[_0x38e45b(0x306)]('DOMContentLoaded',()=>{const _0x9daa90=_0x38e45b,_0x9ea295={'eQAoh':_0x9daa90(0x1a0),'jZwXw':function(_0x204ec1){return _0x204ec1();},'hDTRi':'modeModal','Ygogv':function(_0x314650){return _0x314650();},'EjUhs':_0x9daa90(0x1b8),'BOMCu':_0x9daa90(0x201),'HbbkT':function(_0x2bc891){return _0x2bc891();}};if(resume)_0x9ea295['jZwXw'](loadProgress)?(document[_0x9daa90(0x94)](_0x9ea295[_0x9daa90(0x1a9)])['style']['display']=_0x9daa90(0x176),_0x9ea295[_0x9daa90(0x22d)](initializeQuiz)):(_0x9ea295[_0x9daa90(0x22d)](clearProgress),document[_0x9daa90(0x94)]('modeModal')[_0x9daa90(0x1d1)][_0x9daa90(0x1c6)]=_0x9ea295[_0x9daa90(0x2f5)]);else{if(!window['location'][_0x9daa90(0xb6)][_0x9daa90(0x2cd)](_0x9daa90(0x2ab))){if(_0x9ea295[_0x9daa90(0x141)]!==_0x9daa90(0x201)){if(_0x1fc9b1)return;const _0x38a38f=_0x137b00[_0x9daa90(0x2e8)](_0x3ee01a['getItem'](_0x9daa90(0x1a0)))||{};_0x38a38f[_0x4d1163]={'questionStates':_0x3a2ddb,'stats':_0x23e3e2,'currentQuestionIndex':_0x1dfc7d,'currentMode':_0x57d819,'status':_0x9daa90(0x2f1),'lastSeen':new _0x1a2410()[_0x9daa90(0x257)]()},_0x191dbf[_0x9daa90(0x127)](_0x9ea295['eQAoh'],_0x4feaa2[_0x9daa90(0x275)](_0x38a38f));}else _0x9ea295[_0x9daa90(0x21e)](clearProgress),document['getElementById'](_0x9daa90(0xef))[_0x9daa90(0x1d1)][_0x9daa90(0x1c6)]=_0x9ea295[_0x9daa90(0x2f5)];}else initializeQuiz();}}),document[_0x38e45b(0x306)]('keydown',function(_0x3712db){const _0x317203=_0x38e45b,_0x555d0a={'kYmBD':function(_0x542bba,_0x2470e5){return _0x542bba!==_0x2470e5;},'fLfbF':_0x317203(0xef),'tBkoD':_0x317203(0x176),'FKWyJ':'performanceModal','TJorg':_0x317203(0x230),'JSdew':function(_0x45092c,_0x543356){return _0x45092c>=_0x543356;},'VPMTX':function(_0x278965,_0x365464){return _0x278965<=_0x365464;},'YfaHp':function(_0x54d923,_0x38832b){return _0x54d923-_0x38832b;},'sjyGe':function(_0x562d79,_0x3adebe){return _0x562d79(_0x3adebe);},'EjGuA':_0x317203(0x14f),'TiQCz':function(_0xdc4aea,_0x1217bb){return _0xdc4aea<_0x1217bb;},'vVyjz':function(_0x2d4979,_0x32d823){return _0x2d4979===_0x32d823;},'vUxHy':_0x317203(0x2a8),'Uqmrk':function(_0x3840e1){return _0x3840e1();},'OMxLO':function(_0x2c69e6,_0x28d7a4){return _0x2c69e6===_0x28d7a4;},'koejA':'QeiTH','Zjhae':_0x317203(0x2e6),'kZEVY':function(_0x2a103a,_0x12785f){return _0x2a103a===_0x12785f;},'BRytF':'timed_study','VwxVm':_0x317203(0x152),'fFnKP':function(_0x56bdea){return _0x56bdea();},'RlzVe':_0x317203(0x106),'NlqIC':function(_0x84fb2c,_0x29aa05){return _0x84fb2c===_0x29aa05;}};if(_0x555d0a['kYmBD'](document[_0x317203(0x94)](_0x555d0a['fLfbF'])[_0x317203(0x1d1)][_0x317203(0x1c6)],_0x555d0a[_0x317203(0x1e9)]))return;if(document[_0x317203(0x94)](_0x555d0a[_0x317203(0x22f)])[_0x317203(0xab)][_0x317203(0x2ce)](_0x555d0a[_0x317203(0xa6)])===![])return;if(_0x555d0a[_0x317203(0x1fe)](_0x3712db[_0x317203(0x2a5)],'1')&&_0x555d0a[_0x317203(0x11f)](_0x3712db['key'],'4')){const _0x53bcd9=_0x555d0a[_0x317203(0x303)](_0x555d0a['sjyGe'](parseInt,_0x3712db['key']),0x1),_0x3160b1=document[_0x317203(0x15b)](_0x555d0a[_0x317203(0x255)]);if(_0x555d0a[_0x317203(0x85)](_0x53bcd9,_0x3160b1['length']))selectOption(_0x53bcd9);}else{if(_0x555d0a[_0x317203(0xe1)](_0x3712db[_0x317203(0x2a5)],_0x555d0a['vUxHy']))_0x555d0a[_0x317203(0x18e)](previousQuestion);else{if(_0x3712db[_0x317203(0x2a5)]===_0x317203(0x1f9)||_0x555d0a[_0x317203(0xe1)](_0x3712db[_0x317203(0x2a5)],'\x20'))_0x555d0a[_0x317203(0xe4)](_0x555d0a[_0x317203(0x1a2)],_0x555d0a[_0x317203(0x1fb)])?_0x245871():(_0x3712db['preventDefault'](),_0x555d0a['Uqmrk'](nextQuestion));else{if(_0x555d0a[_0x317203(0xe4)](_0x3712db['key'][_0x317203(0x25c)](),'b')&&(_0x555d0a['OMxLO'](currentMode,_0x317203(0x167))||_0x555d0a[_0x317203(0x2bf)](currentMode,_0x555d0a[_0x317203(0x283)])))_0x555d0a[_0x317203(0x18e)](toggleBookmark);else{if(_0x3712db['key'][_0x317203(0x25c)]()==='m'&&(_0x555d0a[_0x317203(0xe4)](currentMode,_0x317203(0x106))||_0x555d0a[_0x317203(0x2bf)](currentMode,_0x555d0a[_0x317203(0x1a6)])))_0x555d0a['fFnKP'](toggleMarkForReview);else _0x555d0a['vVyjz'](_0x3712db['key'][_0x317203(0x25c)](),'s')&&(_0x555d0a['vVyjz'](currentMode,_0x555d0a[_0x317203(0xdf)])||_0x555d0a[_0x317203(0x195)](currentMode,_0x555d0a[_0x317203(0x1a6)]))&&_0x555d0a[_0x317203(0x18e)](submitQuiz);}}}}});</script>

</body></html>